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Abstract 
The introduction of prostate-specific antigen (PSA) testing about 3 decades ago led to 
the possibility of early detection of prostate cancer (PCa). Although PSA testing 
reduced the mortality rate, it is also associated with high risk of over diagnosis in 
patients with and without PCa. Despite the current drawbacks, it would be a challenge 
to replace PSA testing entirely. Instead, there is a need to develop parallel testing of 
other potential biomarkers that can complement the results from PSA tests. To address 
alternative biomarker sensing, this thesis highlights on the development of 
oligonucleotide-based biosensors for the detection of different biomarkers of PCa.  
Using PSA as a gold standard, the first study of this dissertation investigates the use 
of DNA aptamers to detect PSA using electrochemical impedance spectroscopy (EIS). 
The study compares 6-mercapto 1-hexanol chemistry with sulfo-betaine chemistry for 
the development of PSA aptasensor in terms of performance and selectivity. The 
second study focuses on glycoprofiling in order to complement PSA quantification as 
an additional information for reliable PCa diagnosis. This strategy was developed in a 
microfluidic channel with an optical read out using chemiluminescence. This study 
addresses one of the major problems of cross-reactivity with lectins in glycoprofiling, 
which can be solved using DNA aptamers. A third study concentrates on the 
development of an aptasensor for Alpha-Methylacyl-CoA Racemase (AMACR). 
AMACR has been reported for its high specificity and sensitivity to PCa. For the 
fabrication of the biosensor, a new strategy using polyethylene glycol was developed 
by electrochemical grafting it to a polypyrrole film. Since PCa diagnosis can be 
improved by looking at different biomarkers, an electrochemical platform for 
miRNA/DNA detection using a gold nanoparticle amplification strategy was also 
investigated. The sensor was fabricated using peptide nucleic acids (PNA) probes on 
gold electrodes. The study presents non-Faradaic EIS and amperometric techniques in 
order to exploit the inherent charges of nucleic acids. 
In conclusion, this thesis wants to serve as a potential orientation for overcoming the 
shortcomings of the current PCa testing and contribute towards the development of 
oligonucleotide-based biosensors for PCa biomarker detection and hopefully enhance 
the diagnosis and prognosis of PCa. 
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The work in this thesis aims at developing oligonucleotide-based biosensors for the 
detection of different biomarkers for prostate cancer (PCa). In order to fabricate such 
a biosensor, it is imperative to understand the prostate and the physiological processes 
associated with it in patients with PCa. This Chapter will describe PCa, its current 
diagnosis status, and the potential PCa biomarkers. It will also introduce 
electrochemical biosensors and oligonucleotide-based recognition layers which have 
been used as the foundation for different types of biosensors mentioned in this thesis. 
Part of the work presented in thesis is published in Jolly et al. (Jolly et al. 2015a).  
 
1.1 Prostate cancer 
Cancer is a disease state developed due to an error in the cell division cycle leading to 
abnormal cell growth. There are many factors that can cause this un-programmed cell 
death such as carcinogens, genetic factors, and environmental factors. These factors 
introduce mutations in the genes (p53) which are responsible for programmed cell 
death (Lilja et al. 1987). PCa is a type of cancer associated with the prostate gland. 
The prostate gland is a male reproductive organ that weighs between 7 to 16 grams 
depending on the person (Leissner and Tisell 1979). It is located just below the bladder 
and surrounds the urethra which carries urine from the bladder to the penis (Figure 
1.1). 
Its primary function is to produce fluid that forms the part of semen (Lilja et al. 1987). 
The prostate gland squeezes this fluid which combines with the sperm into the urethra 
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during ejaculation. The fluid produced by the prostate functions by nourishing and 
protecting the sperms. Since the prostate is well connected to numerous lymph nodes, 
it is easier for the cancer cells to escape from its primary site of origin into the lymph 
nodes. From lymph nodes, the cancerous cells enter the blood vessels and migrate to 
secondary sites making the spread of PCa very easy. Some of the most common sites 
of PCa metastatic process are found in bones (Chou and Simons 1997). 
 
Figure 1.1 Prostate gland. Source internet: Cancer Research UK. 
 
1.1.1 Current status and detection techniques 
PCa often develops very slowly and the lack of symptoms during the early stages of 
the disease leads to a late diagnosis of the tumour. Moreover, the current detection 
techniques used in central labs are also surrounded by controversies of being reliable. 
Like any other cancer, if PCa is diagnosed in a late stage, no effective treatments can 
be provided, which leads to patients death. It is due to such reasons that PCa is 
considered as the leading cause of cancer-related mortality among men worldwide 
(Greenlee et al. 2000; Jolly et al. 2015a). PCa accounts for around 7% of all cancer-
related deaths making it the 4th most common cause of cancer-related death in the UK 
(2011). It has also been reported that one man deceases from PCa every one hour 
making it more than 10,000 every year. It has been also projected that PCa will be the 
most common cancer by 2030 (Jolly et al. 2015a; Cancer Research UK (2012)). 
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There has been a steady increase in the number of cases diagnosed all over in the UK 
from 1993 to 2010. This increase could be a result of the adoption of prostate specific 
antigen (PSA) testing in men during the same period. Over 41,000 cases were 
diagnosed in the UK (2010), of which 85% were from England. It has also been 
reported that PCa is predominant in older men above the age of 50 (Kirk et al. 1997; 
Hoffman et al. 2011). Looking at the trend of mortality statistics, there is a significant 
need for better diagnostic tools to facilitate early and accurate diagnosis of PCa. 
Currently, there is not a self-reliant detection technique to diagnose PCa. However, 
there are three techniques which are most commonly practiced worldwide . One of 
these methods is called digital rectal examination (DRE), where the doctor examines 
the irregularities in terms of bumps of the prostate gland by inserting a sterilised 
gloved finger through the rectum (Carvalhal et al. 1999). The second technique is the 
transrectal ultrasound (TRUS) and involves an ultrasound probe being inserted into 
the rectum to image the prostate gland, in order to examine the pathology of the 
tumour. TRUS is also used for biopsy by gliding a needle for sampling tissues (Hara 
et al. 2008). However, the most common test for PCa screening is a blood test where 
the altered levels of PSA are measured (Walter et al. 2006). If the levels of PSA 
exceeds 4 ng/mL, biopsy procedures may be considered (Catalona et al. 1991). All 
these tests have advantages and disadvantages which make them controversial in 
nature. For instance, DRE test is just 59% accurate in diagnosing PCa, which could be 
further increased when combined with biopsy and PSA tests (Basler and Thompson 
1998, Uzzo et al. 1995). In the case of biopsy, many samples are required which is 
quite painful for the patients and could result in a higher risk of critical infections 
(Loeb et al. 2013). Also, PSA levels might be increased due to other factors or 
conditions such as benign prostatic hyperplasia (BPH) and prostatitis. For such reasons 
patients with PCa either escape early diagnosis or have a late diagnosis, both adding 
to the mortality rate (Carter et al. 1992). In October 2011, the US Preventative Services 
Task Force (USPSTF) recommended against PSA screening in all men (Brett and 
Ablin 2011). This emphasized the need for superior biomarkers for the diagnosis of 
PCa. 
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1.1.2 Candidate biomarkers for PCa  
The shortcomings of current detection techniques put a significant need on developing 
a more definitive technique for PCa detection. Presently, a dynamic area of importance 
involves non-invasive or minimally invasive techniques to detect PCa. Researchers 
are looking into potential biomarkers that could detect PCa at an early stage with high 
sensitivity and reliability. According to the National Institutes of Health Biomarkers 
Definitions Working Group, a biomarker is “a characteristic that is objectively 
measured and evaluated as an indicator of normal biological processes, or 
pharmacologic responses to a therapeutic intervention”(Colburn et al. 2001). Table 
1.1 lists some of the candidate biomarkers for PCa that have the potential and are 
clinically persuasive for further investigation to be developed as a potential biomarker 
for diagnostics or prognostics. The list is quite exhaustive, however, this thesis will 
focus mainly on four biomarkers (PSA, glycosylation pattern of PSA, AMACR and 
miRNA) based on their importance and feasibility to be detected using 
oligonucleotide-based approaches.  
 
1.1.2.1  Prostate specific antigen 
In the year 1971, the most important PCa biomarker, prostate specific antigen (PSA) 
was discovered, becoming the foundation and gold standard of PCa detection and 
monitoring (Balk et al. 2003; Hara et al. 1971).  PSA belongs to the family of 
kallikrein proteins which are from a class of serine proteases. There are about 15 
kallikrein proteins with PSA (hK3) being the only kallikrein specific to prostate (Balk 
et al. 2003).  
PSA is synthesised as a 244 amino acid long protein and is called pro-PSA; it serves 
as an inactive form of PSA and has no enzymatic activity (Figure 1.2). Human 
Kallikrein 2 (hK2) enzyme cleaves the pro-PSA in the prostate from the N terminus 
resulting in active PSA which is 237 amino acids long (Takayama et al. 1997). The 
active PSA which is a 30 KDa protein is found in both semen and serum of men.  
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Table 1.1 List of potential biomarkers for PCa 











A Kallikrein protease, 30 KDa which 
proteolysis semenogelin proteins of seminal 
fluids. 
Undergoes glycosylation. 
Sensitivity: 24%, Specificity: 93%; Cut off 
level: 4 ng/ml in serum 
No Catalona et al. 
1991;  
Thompson et al. 
2004;  Özen and 
Sözen 2006;  










Racemase enzyme involved in stereo-
isomerization, bile acid synthesis and β 
oxidation of branched fatty acids. 
Sensitivity: 97%, Specificity: 92% 
yes Jiang et al. 2004b; 
Sreekumar et al. 













Type II Integral membrane protein with cell 
surface carboxy-peptidase function.  It 
translocate to plasma membrane in PCa cells 
while, remain in the cytosol in normal 
prostate cells.  
 
Yes Hara et al. 1971;  




Serum Kallikrein protein with trypsin like activity. 
It cleaves pro-PSA to active PSA and 








Yousef 2002;  









Serum Nuclear matrix protein linked to PCa 
development.  
 
Sensitivity: 92%, Specificity: 94% 
 
Yes Madu and Lu 2010;  




Serum Integral membrane protein with 
structural/regulatory function.  
Yes Madu and Lu 2010; 




Urine A transcription factor which has regulatory 
functions. 
Sensitivity: 66%  Specificity: 88.2%, Cur off 
level: 42.5 ng/ml 
 
Yes Morgan et al. 2011; 









Tissue An olfactory receptor which has been 
reported to be highly expressed in prostate 
epithelial cells. An increased expression has 
been reported in PCa patients 
 Xu et al. 2006; 
Launay et al. 2012 
Annexin A3 
(ANXA3) 
Urine A calcium binding protein involved in broad 
range of cellular and molecular processes. It 
has decreased levels in PCa patients. 
Sensitivity: 50% Specificity: 90% 
 
Yes Schostak et al. 
2009; 
Liu et al. 2009; 









Small (22 nucleotides) non-coding RNAs 
involved in regulation of expression of 
proteins. It acts like fingerprints to tumour 
formation and metastasis. These are either 
upregulated or downregulated in a particular 
disease. 
Yes Yeh et al. 2008; 
Catto et al. 2011; 
Ilic et al. 2013 
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Figure 1.2 Model of PSA biosynthesis in normal and cancer prostate gland (Balk et al. 2003). 
 
The physiological role of PSA, which is present in the range of 0.5 – 2 mg/mL in 
semen, is to de-coagulate semen by breaking down the proteins semenogelin I and II 
(Lilja et al. 1987; Lövgren et al. 1999). 
In semen, about 30% of PSA is enzymatically active, while only 5% of PSA is 
complexed to protein inhibitors. The remaining PSA is made inactive by internal 
cleavages catalysed by hK proteases. Some of the active PSA escapes into the blood 
stream where it is rapidly inactivated by protein inhibitors such as alpha chymotrypsin 
(ACT) and α2-microglobulin (A2M) (Hara et al. 1971). However, in PCa, both active 
PSA and pro-PSA escapes into the blood due to rupture of the basal membrane of the 
prostate. Internally cleaved forms of PSA (with no enzymatic activity) also enter the 
blood stream and remain un-complexed and are taken into free PSA (fPSA) count. 
fPSA together with complexed PSA is termed as total PSA (tPSA) (Takayama et al. 
1997).  
With the introduction of PSA testing, which is more accepted than DRE, there has 
been an increase in the early detection of PCa (Balducci et al. 1997). Although PSA 
testing reduced the mortality rate, it is still associated with high risk of over-diagnosis 
in patients without PCa (Andriole et al. 2009). For instance, if PSA levels are higher 
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than the cut-off levels, biopsy procedures are considered (Catalona et al. 1991). 
However, the levels of PSA in blood in ageing men can also be raised due to other 
factors like benign prostatic hyperplasia (BPH) and prostatitis leading to over 
diagnosis in men (Carter et al. 1992). Due to faulty diagnosis, patients undergo biopsy 
surgery which is painful and also makes patients vulnerable to severe infections. Such 
controversies led to refinements in PSA testing. One of the methods to uncover the 
reason behind the high PSA levels was to quantify independently fPSA and tPSA. 
Lower levels of fPSA have been reported in patients with PCa compared to patients 
with BPH making it a potential indicator of the aggressiveness of the cancer 
(Christensson et al. 1993). However, the amount of fPSA might be higher in patients 
with larger prostate volume, making this method unreliable (Catalona et al. 1998). 
Nonetheless, the combined results of ratio of fPSA to tPSA with tPSA increased the 
confidence of the diagnosis (Velonas et al. 2013). Some other refinements include 
measurement of immunologically detectable forms of PSA on an equimolar basis (the 
equimolar tPSA assay) in order to avoid preferential detection of fPSA (Wians et al. 
2002), and the prostate health index (phi) which can be calculated from a combination 
of tPSA, fPSA and truncated forms of PSA (Filella and Giménez 2013). Such assay 
refinements have driven the PSA tests, especially in the ‘gray zone’ (4-10 ng/mL), to 
somewhat more effective PCa diagnosis and treatment.  
 
1.1.2.2 Glycosylation 
Rapid and robust screening of biomarkers for diagnostic purposes has also led to the 
investigation of glycosylation patterns on protein biomarkers. In order to understand 
the phenomenon of glycosylation, it is important to first define the glycome. Glycome 
represents the complete set of sugar chains (glycans and glycan conjugates) that are 
synthesised by a cell under specific conditions. Glycomics is a study of glycomes 
(Varki et al. 2009) while, glycosylation is a phenomenon where carbohydrate moieties 
are covalently attached to proteins, lipids, ceramide, etc. This phenomenon is one of 
the most abundant and structurally diverse post-translational modifications of proteins 
occurring in the human body (An et al. 2009). It is involved in numerous physiological 
regulatory processes including protein folding (Shental-Bechor and Levy 2009), cell-
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cell or cell-matrix interactions (Rudd et al. 1999) and the immune response (Rudd et 
al. 2001). Such modifications can dramatically change due to alterations in the cellular 
environment. Due to such reasons, glycosylation is associated with pathological states 
of many diseases such as cancer (Christiansen et al. 2014; Gilgunn et al. 2013), AIDS 
(Go et al. 2011), rheumatoid arthritis (Axford 1999), neurodegenerative diseases 
(Hwang et al. 2010) and autoimmune disorders (Goulabchand et al. 2014). Since 
glycosylation is a hallmark of disease states, altered glyco-forms may serve as viable 
candidate biomarkers for early-stage cancer diagnosis (Christiansen et al. 2014; 
Gilgunn et al. 2013). The entire process of alterations in glycan structures usually arise 
from disturbances in the expression and activity levels of various enzymes including 
glycotransferases and glycosidases resulting in protein structural modifications 
associated with cell-specific glycan expression patterns (Bosques et al. 2006; 
Kuzmanov et al. 2013). Although the molecular sub-forms of PSA have enabled better 
utility of PSA testing for PCa detection; but, it still lacks the specificity to differentiate 
between indolent and aggressive cancer. On the other hand, altered glyco-forms might 
serve as applicable candidate biomarkers for early-stage PCa diagnosis and improve 
the specificity of existing PCa biomarkers (Adamczyk et al. 2011; Pihíková et al. 
2015).  
PSA is a glycoprotein with various glycoforms. Thus, the determination of cancer-
associated glycoforms of PSA may help to improve early-stage clinical diagnosis of 
PCa (Meany and Chan 2011). There are plenty of studies showing that altered 
glycosylation patterns allow the possibility of distinguishing patients with PCa from 
those with BPH. For example, the differential binding of PSA in serum to Maackia 
amurensis lectin (MAA). MAA is a lectin that recognises terminal α-2,3 sialylation, 
and binds at a greater concentration to PSA in men with PCa (Ohyama et al. 2004). 
The Sambucus nigra lectin (SNA) detects α-2,6-linked sialic, commonly present in 
healthy men (Saldova et al. 2011). Furthermore, glycoproteins constitute the majority 
of FDA-approved cancer markers and glycosylation patterns are now being widely 
accepted as characteristics of various cancers (Meany and Chan 2011). The 
measurement of such cancer-related glycans of PSA has already been demonstrated to 
improve the specificity of PSA (Peracaula et al. 2003).  
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1.1.2.3 α-methylacyl coenzyme A racemase (P504S) 
Advancements in molecular biological techniques have helped researchers worldwide 
to investigate and discover novel biomarkers for numerous diseases including PCa. 
One of the discoveries that hold great promise is α-methylacyl CoA racemase 
(AMACR), also known as P504S which is an enzyme consisting of 382 amino acids. 
AMACR belongs to the family of racemases and epimerases involved in the synthesis 
and oxidative metabolism of branched-chain fatty acids. AMACR catalyses the 
reaction where (2R)-methylacyl-CoA esters are converted to their (2S)-methylacyl-
CoA epimers (Jiang et al. 2004a; Lloyd et al. 2008). Studies have shown high 
expression levels of the AMACR gene at the mRNA and protein levels in PCa, making 
it a potential candidate biomarker with high specificity for diagnosis (Jiang et al. 2002; 
Jiang et al. 2004b; Rubin et al. 2002). Furthermore, immune-histochemical staining 
studies have demonstrated that AMACR can distinguish benign prostate tissue from 
cancerous prostate tissue with a diagnostic sensitivity of 97% and specificity of 92% 
(Jiang et al. 2004b). Such findings have encouraged many researchers to investigate 
if AMACR is also present in body fluids. Rogers et al. in 2004 detected AMACR in 
urine samples using Western blot analysis (Rogers et al. 2004). More recently, 
Zehentner et al. in 2012 detected the presence of AMACR transcripts in blood and 
urine samples using real-time reverse transcription polymerase chain reaction (RT-
PCR) (Zehentner et al. 2006).  
Although AMACR is highly sensitive to detect PCa, it also comes with some 
limitations. For example, in certain other cancers in patients suffering from 
autoimmune disorders, there is a possibility of production of endogenous AMACR 
antibody and humoral response (Tricoli et al. 2004). Nevertheless, the diagnostic 
efficiency for characterizing PCa stages was increased by combining the AMACR test 
with PSA testing (Cardillo et al. 2005).  
 
  




The progression of PCa also has an impact on the expression levels of microRNAs 
(miRNAs). miRNAs are small (~22 nucleotides) non-coding RNAs that are involved 
in gene regulation. miRNAs bind to their complementary sequences in the 3’-
untranslated region (UTR) of target RNAs and regulate the gene expression (Bartel 
2004). miRNAs play a crucial role in regulating various metabolic and biological 
processes including oncogene processes (Meister 2007). The levels of these miRNAs 
are affected during a disease state such as cancer (Mitchell et al. 2008). miRNAs can 
be potentially detected in body fluids such as serum, plasma, circulating cancer cells 
and therefore makes them a potential diagnostic biomarker (Kuner et al. 2013). 
Consequently, abnormal levels of some miRNAs have been suggested to act like 
fingerprints for prostate tumorigenesis (Brase et al. 2010). miRNAs have therefore 
become an emerging field for their role in both diagnostics and therapeutics (Bader et 
al. 2011). There are several miRNAs which have been reported to be linked with PCa 
(Gordanpour et al. 2012). For instance, miR-21 which is upregulated in different 
tumours including cancer might enhance the processes of metastasis (White et al. 
2011). On the contrary, miR-16-1 and miR-15a which are involved in controlling cell 
proliferation and transformation are downregulated in PCa (Bonci et al. 2008). In 
2013, Larne et al. reported a miRNA index quote (miQ); ((miR-96-5p × miR-183-
5p)/(miR-145-5p × miR221-5p)) which is a ratio of four distinct miRNAs with 
increased discrimination of PCa (Larne et al. 2013). It is worth mentioning that not a 
single miRNA has been successfully validated as a biomarker and therefore detection 
of a panel of miRNAs is needed in order to provide some valuable data to help 
diagnosis of PCa. Recently, several studies demonstrated the tumour-suppression 
characteristic of mir145 which is down-regulated in many cancers like colon cancer, 
ovarian cancer, breast cancer, bladder cancer and PCa (Akao et al. 2007; Ichimi et al. 
2009; Nam et al. 2008; Spizzo et al. 2010; Wang et al. 2015). We used mir145 as an 
example of a target sequence to construct an electrochemical platform which will be 
described in Chapter 6. 
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1.2 Electrochemical biosensor 
Analytical tools have widely exploited biomarkers to investigate biological parameters 
for therapeutics. Such an investigation has further extended the development of new 
therapies (Rolan 1997). In recent years, there is an unprecedented demand on the 
healthcare sector for early and reliable detection of biomarkers. One of the most 
promising technologies to face this challenge is a biosensor.  
 
Figure 1.3 Schematic of a biosensor. Typically, a recognition layer is coated on a transducer. When a specific 
analyte is captured by the recognition system, a change in the properties of the recognition layer occurs. The 
transducer transforms the change because of the binding event into an electrical signal which is in turn amplified 
and processed into a readable signal by the output device. 
 
A biosensor is an analytical device that can be used for detection of an analyte 
(pollutant, viral DNA, antigen or protein), by combining a biological component (e.g. 
enzyme, DNA, antibody, aptamer) that acts as a probe and binds to the target. Such a 
binding event gives rise to a signal which is detected by a transducer (mass sensitive 
(Janshoff et al. 2000), optical (Haes and Van Duyne 2002) or electrochemical (Cass 
et al. 1984)). The transducer signal is then converted into an electrical signal which is 
amplified and converted into an output easily read by a user (Figure 1.3) (Lowe 1984).  
Biosensors are nowadays ubiquitous in biomedical diagnosis as well as a wide range 
of other areas such as point-of-care (PoC) monitoring of treatment and disease 
progression, environmental monitoring, food control, drug discovery, forensics and 
biomedical research. A wide range of techniques can be used for the development of 
biosensors. Their coupling with high-affinity biomolecules allows the sensitive and 
selective detection of a range of analytes. Biosensors are not only characterised by 
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their specificity and selectivity towards their targets, but also by important parameters 
such as dynamic and linear range of detection, limit of detection and sensitivity (Figure 
1.4) (Jaffrezic-Renault 2013). The dynamic range is defined as the range of 
concentrations of analyte where a variation of the signal is observed. This range is also 
characterised by a linear part. The slope of the curve plotted in the linear range 
corresponds to the sensitivity of the biosensor. The lower value measured corresponds 
to the limit of quantification (LOQ) and by extrapolation of this curve the detection 
limit (LOD) can be calculated according to various methods described in analytical 
techniques. The most commonly used method in biosensors devices takes into account 




        (1.1) 
Where sbl is the standard deviation of blank, o is the measurement obtained with blank 
test and 1 is the sensitivity obtained by the slope of the linear part of the calibration 
curve. 
 
Figure 1.4 Presentation of parameters which characterize biosensors. 
 
An electrochemical biosensor is a type of biosensor that involves an electrode surface 
functionalised with a bio-recognition element exploiting a physical/chemical process. 
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Most electrochemical setups typically consist of a cell with a three electrode 
configuration: a working electrode (WE), reference electrode (RE) and a counter 
electrode (CE) placed in an electrochemical solution. Potentials are set between the 
WE and the RE, while the current is measured between the WE and the CE (Figure 
1.5). In measurements involving for example in Amperometric, the CE helps to 
maintain a stable voltage between the WE and the RE. Such a setup minimises the 
workload of RE. As a result, such a configuration allows the establishment of the 
potential of the WE against a known RE without compromising RE stability by passing 
a current through it (Wang 2006).  
 
Figure 1.5 Electrochemical cell with three electrode configuration. 
 
In order to monitor a measurable signal of the recognition event occurring on the 
interface of a WE, redox marker molecules can be used. Redox markers are indicators 
which can undergo a redox reaction. A redox process is a chemical reaction (reduction 
and oxidation), where molecules with redox activity are capable of exchanging 
electrons with the WE and as a result, a measurable current can be detected.  
The signal that is gathered at the WE consists of two phenomena, namely electron 
transfer and mass transfer. In a solution, mass transfer is explained by the movement 
of the redox molecules towards the electrode surface from the bulk electrolyte 
solution. Mass transfer follows the theory of diffusion which is a phenomenon that 
involves the movement of mass down a concentration gradient. Once the redox marker 
molecule comes close to the electrode surface within the nanometer (nm) scale, the 
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next phenomenon predominates, which is electron transfer. The consequence of 
electron transfer results in detection of a measurable current. The region where the 
electron transfer takes place is called a double layer (DL, also called an electrical 
double layer) region. 
Binding of analyte to the recognition element results in an electrical change which can 
be measured in the form of current transfer (amperometric, chronocoulometric), 
voltage (potentiometric and field effect transistors), impedance (impedimetric), 
conductivity (conductometric) or ion charge across the electrode (Thévenot et al. 
2001). 
The scope of this thesis with respect to detection techniques is limited to impedimetric 
and amperometric. These techniques will be described in detail in Chapter 2 along 
with other characterisation techniques used.  
 
1.3 Oligonucleotide-based recognition layer 
Over the last few decades, there is an increasing number of applications that have been 
developed for oligonucleotide-based biosensing systems in genetics and biomedicine. 
Oligonucleotide-based sensors consist of the use of oligonucleotides (DNA, RNA or 
synthetic analogue to naturally occurring nucleic acids) as a recognition layer. 
Oligonucleotides are short sequences of repeated nucleotide units. These nucleotides 
are linked together via phosphodiester bonds with the backbone being composed of 
alternating phosphate and sugar (deoxyribose in DNA and ribose in RNA) residues 
(Cohen 1989). Oligonucleotides are unmodified or chemically modified polymers 
(DNA or RNA) that are relatively small (12-25-mer) introducing an expanded range 
of applications in molecular genetics research and in forensics. The suffix “mer” is 
often used (derived from the Greek for “part”) to denote the length of an 
oligonucleotide. In the natural world, oligonucleotides exist mainly as small 
noncoding RNAs (e.g. miRNAs). Such oligonucleotides are commonly synthesised 
using solid phase chemistry. Chemical modifications of the sugar-phosphate backbone 
or the bases are often used to increase the stability and half-life of the oligonucleotides. 
In general, oligonucleotides work by hybridising to their complementary sequences. 
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They are used in many different ways including as “primers” in polymerase chain 
reaction (PCR), as “probes” in microarray analysis or in situ hybridisation, and in 
biosensing applications. The explosion of knowledge about gene expression and gene 
regulation mechanisms has led to many new opportunities to develop oligonucleotide-
based technologies. In recent years, there is hardly a field in biology in which the 
potential of using synthetic oligonucleotides has not been explored. The reason for 
such a turnover is mainly due to the emergence of different molecular cloning 
techniques along with the simultaneous development of varied methods for efficient 
oligonucleotide synthesis. The primary motivations behind these developments for the 
biochemists have been not only the huge biological potential but also immense 
demand for synthetic oligonucleotides. Synthetic oligonucleotides or nucleic acid 
analogues are compounds which are structurally similar to naturally occurring RNA 
or DNA. Some of the artificial nucleic acids include peptide nucleic acids (PNA), 
locked nucleic acids (LNA), glycol nucleic acids (GNA) and threose nucleic acids 
(TNA), which differ from naturally occurring RNA or DNA in the backbone structure 
of the molecule. Consequently, availability of these synthetic oligonucleotides has led 
to a revolution in solving molecular biology problems along with promising 
applications in biosensing. This section will focus on DNA aptamers and PNA for 
biosensing applications. 
 
1.3.1 DNA aptamers 
DNA or RNA aptamers are short single-strand oligonucleotides, which have gained 
immense interest as bioreceptors in biosensors (aptasensors) or medical therapy 
(Hianik and Wang 2009; Iliuk et al. 2011). Their specificity is akin or higher than 
those of antibodies, with dissociation constants (Kd) in the range from nanomolar (nM) 
to picomolar (pM) levels. An important advantage of their use in biosensor devices is 
their high affinity to proteins and other molecules with low molecular weight, for 
example, toxins (Castillo et al. 2012; Evtugyn et al. 2009). Aptamers have several 
advantages over antibodies because of varied advantages, for instance, aptamers are 
much more stable than antibodies, making them suitable for applications in special 
conditions such as high temperature or extreme pH.  
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Figure 1.6 Example of aptamer structures: (A) Two-dimensional stem-loop structure of anti-PSA DNA aptamer 
(Savory et al. 2010); (B) multiple stem-loop structure of anti-AMACR DNA aptamer (Yang et al. 2014); (C) 
Crystal structure representing quadruplex conformation of anti-thrombin DNA aptamer (Macaya et al. 1993). 
 
Another advantage is that aptamer-based biosensors can be regenerated without loss 
of integrity and selectivity (Mairal et al. 2008; Tombelli et al. 2005). One very 
interesting property of an aptamer is the conformational change that it undergoes once 
bound to its target, this property has been widely utilised within biosensing 
applications (Jolly et al. 2015b; Radi et al. 2006). The aptamers are known to form 
loops, stems, hairpins, triplexes or quadruplex structures. Figures 1.6A and 1.6B show 
an anti-PSA DNA aptamer in its stable loop configuration and an anti-AMACR DNA 
aptamer with multiple loop structures (Savory et al. 2010; Yang et al. 2014). The 
formation of loops is due to the specific interactions between nucleotides, adenine, 
and thymine or guanine and cytosine present in DNA aptamer chains. Quadruplexes 
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are nucleic acid sequences that are rich in guanine and are able to form a four-stranded 
structure (Figure 1.6C). The quadruplex structure is further stabilised by the presence 
of a cation, especially potassium, which sits in a central channel between each pair of 
tetrads.  
Aptamers can be easily chemically modified by various functional groups, such as 
thiol, amine or azide as well as biotin groups. This modification allows the 
immobilisation of aptamers to various solid supports. For example modification of 
aptamers with thiols allows their association on the gold surface using Au-S 
interactions (Jolly et al. 2015b) or modification with azido groups via click chemistry 
(Hayat et al. 2013). In another case, one end of DNA or RNA aptamers can be 
modified with biotin and binding of these biomolecules through solid support is 
realized via avidin, streptavidin or neutravidin bridges (Cavic and Thompson 2002; 
Centi et al. 2007; Liss et al. 2002; Ostatná et al. 2008). 
Aptamers were introduced in 1990 by two independent research groups: Turek et al. 
used the term SELEX (generalised scheme of systematic evolution of ligands by 
exponential enrichment) for selecting RNA ligands against T4 DNA polymerase; and 
Ellington et al. coined the term in-vitro selection (Ellington and Szostak 1990; 
Robertson and Joyce 1990; Tuerk and Gold 1990). In contrast to antibodies that are 
obtained by molecular biology techniques, aptamers are prepared by a synthetic 
method using an in-vitro selection procedure. Once an aptamer sequence is identified, 
it can be synthesised with high purity, reproducibility, and relatively low cost. 
Although aptamers have a greater advantage over antibodies, they still possess a 
number of limitations, for example, degradation by nucleases (DNAse and RNAse) or 
protein fouling in serum due to DNA binding proteins (Keum and Bermudez 2009; 
Sylvia et al. 1975). The SELEX approach starts with a random library containing 1013-
1016 ssDNA or RNA sequences (Iliuk et al. 2011; Song et al. 2008). The library is 
incubated with a target to initiate the first cycle of selection. This is typically followed 
by iterative cycles of absorption, recovery of bound DNA/RNA, and amplification. 
Isolation of the bound DNA/RNA is the most critical step to ensure purity and 
selectivity. For example, the aptamer-target complex can be separated by filtration 
through nitrocellulose or by affinity chromatography from the unbound DNA/RNA 
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sequences. The bound aptamers are then eluted and amplified by RT-PCR (for RNA 
libraries) or PCR (for DNA libraries) to generate new pools for the next selection 
cycle. An ideal aptamer selection procedure requires around 10-15 cycles. A 
generalised SELEX method is presented in Figure 1.7. 
 
Figure 1.7 Generalised scheme of systematic evolution of ligands by exponential enrichment (SELEX). Adapted 
from Song et al. (Song et al. 2008). 
 
The high specificity of aptamers and the possibility of developing aptamers against 
different binding sites of target analyte offer high variability of assay configuration 
(Figure 1.8) (Hianik and Wang 2009; Song et al. 2008). The first simple assay consists 
of the attachment of aptamers onto a support and the interactions of aptamer/target can 
be directly monitored (Figure 1.8A) (Formisano et al. 2015). Sandwich assay consists 
of capturing the target by specific aptamer method followed by interactions with 
another aptamer or antibody (Figure 1.8B, 1.8C, and 1.8D). Similar to immunosensing 
assays, these aptamers can be modified with nanoparticles (Pavlov et al. 2004) or 
electrochemical markers (Kang et al. 2008) which enhance the electric signal or allow 
amplification of the aptamer mass.  
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Figure 1.8 Examples of different assays based on aptamers. (A) Capture of analyte by immobilised aptamers. (B) 
Sandwich type assay with aptamers using two aptamers specific to two different sites of the analyte. (C) Capture 
of the analyte by the immobilised aptamers while a secondary antibody is used to detect in a modified ELISA 
format. (D) Capture of analyte by an immobilised antibody while aptamer is used as a secondary probe in a 
modified ELISA format. 
   
1.3.2 Peptide nucleic acids  
Emerging molecular biology and biochemistry techniques have pushed the field of 
biology towards usage of synthetic oligonucleotides. Such synthetic oligonucleotides 
are nucleic acid analogue compounds which are structurally similar to natural 
DNA/RNA nucleic acids. PNA is a synthetic polymer which is similar to DNA/RNA, 
first synthesised by Nielsen et al. in 1991 (Nielsen et al. 1991). The backbone of a 
PNA molecule consists of a repeat of units of N-(2-aminoethyl) glycine units linked 
via an amide bond (Figure 1.9). Such a modification changes the negative charges of 
the DNA sugar-phosphate backbone to a neutral charge of the peptide-like backbone. 
PNA sequences, like any peptide sequence, is depicted with an N-terminus and a C-
terminus. In a PNA, the four naturally occurring nucleobases namely adenine, 
cytosine, guanine, and thymine are connected to the central amine of the peptide 
backbone via a methylene bridge and a carbonyl group (Hyrup and Nielsen 1996).   
PNA has several advantages over DNA due to its neutral charge and proper base-
pairing. PNA can bind to its complementary target oligonucleotide with higher affinity 
and specificity by following the rules of Watson-Crick base-pairing (Egholm et al. 
1993). As a consequence, PNA/DNA duplex demonstrates higher thermal stability and 
there is no dependency of PNA/DNA duplex stability on the ionic strength of the 
solution in which hybridisation is performed (Hyrup and Nielsen 1996; Wang 1998).   
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Figure 1.9 Chemical structure model of PNA (sequence N-GTA-C) hybridised with its complementary DNA 
(sequence 5′-TAC-3′)(Nielsen et al. 1991). 
 
Because of its unique physicochemical and biochemical properties, PNA as a bio-
receptor opens up many applications (biological and diagnostic) which would not be 
achievable with naturally occurring oligonucleotides. Wang et al. in 1996 first 
demonstrated the use of PNA for biosensing applications with a detection limit of 10 
pM (Wang et al. 1996). In this approach, PNA probes were adsorbed on the carbon 
paste electrodes and hybridised with the complementary strand. The hybridisation was 
detected using a Co(phen)3+3 redox indicator via the chronopotentiometry technique 
(Wang et al. 1996). Since then, there has been many a report on the use of PNA as 
probes for the development of electrochemical sensors (Cai et al. 2015; Du et al. 2013; 
Raoof et al. 2011; Zhang et al. 2008). Keighley et al. in 2008 fabricated a label-free 
PNA-based electrochemical impedance based sensor (Keighley et al. 2008). This work 
demonstrated how the inherent neutral charges of PNA can be exploited on an 
impedimetric platform. The same methodology forms the foundation of the biosensor 
development for DNA/miRNA detection which is presented in Chapter 6.  
 
  
Chapter 1  21 
 
1.4 General overview of the project 
This particular thesis is based on a project entitled “Cancer Diagnosis- Parallel Sensing 
of Prostate Cancer Biomarkers” which is one of the sub-projects within the Marie 
Curie Initial Training Network-PROSENSE focussing on the diagnosis of PCa. The 
principal aspect of the current work is to study biomarkers, probe immobilisation, and 
development of detection techniques. The core aim of the project is the development 
of oligonucleotide-based electrochemical platforms. This thesis draws light into four 
PCa biomarkers that could be detected with oligonucleotide-based electrochemical 
platforms. In parallel, this thesis will also detail different surface chemistries that have 
been employed for the development of biosensors for their potential clinical 
application. As a whole, the objectives can be broadly divided into different stages, 
namely: selection of biomarkers, characterising specific probes for detection of 
biomarkers, optimization of immobilisation techniques, and finally electrochemical 
sensing. 
This particular thesis highlights the following points: 
1 Characterisation of oligonucleotide-based probes when restricted to the electrode 
surface. 
2 Different strategies for the development of oligonucleotide-based biosensors 
using different surface chemistries. 
3 Use of electrochemical techniques (impedimetric and amperometric) for the 
development of highly sensitive transduction techniques for sensing. 
4 Evaluation of sensor performance for its selectivity properties. 
 
1.4.1 Outline of thesis 
In order to develop biosensors for diagnosis of PCa, it is essential to understand the 
physiology of PCa and biomarkers associated with it. Until now Chapter 1 discussed 
the potential biomarkers for PCa along with a short introduction to biosensors. Since 
the main focus is on oligonucleotide-based biosensing, Chapter 1 could not close 
without introducing DNA aptamers and PNA as recognition layers for biosensor 
fabrication.  
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Chapter 2 details oligonucleotide-based approaches to fabricate biosensors, more 
specifically sensors for cancer diagnosis. For fabrication of a reliable and sensitive 
aptasensor, surface chemistry plays a crucial role. Therefore, the Chapter extends into 
different surface chemistries that have been employed in the reported work. 
Electrochemical detection techniques are further explained with different 
electrochemistry principles and specific detection techniques used in the study. 
The oligonucleotide probes for sensor development have been characterised using 
different techniques. Chapter 2 will also present characterisation techniques other than 
electrochemical, like surface plasmon resonance (SPR) and Fourier transform infrared 
spectroscopy (FT-IR) that have been used in the course of the development of the 
biosensors.  
The outcome from independently developed systems is summarised at the end of each 
relative Chapter. Since PSA has been widely used for PCa screening, it is a good case 
study to start oligonucleotide-based electrochemical detection, which is presented in 
Chapter 3. An anti-PSA DNA aptamer was used as a probe to capture PSA and was 
detected using the electrochemical impedance spectroscopy (EIS) technique. It 
highlights the importance of surface chemistry in terms of surface coverage by DNA 
aptamers in order to enhance binding efficiency. Following that, spacer molecules 
such as 6- mercapto 1-hexanol (MCH) and thiol terminated sulfo-betaine were 
investigated for their effect on sensitivity and selectivity of the aptasensor.   
Chapter 4 presents a study of glycoprofiling that was performed to compensate some 
of the limitations of PSA testing. Such a study was performed in a microfluidic channel 
where DNA aptamers were immobilised to capture PSA. Finally, a secondary antibody 
or a lectin was used for quantification and glycoprofiling of PSA, respectively.  
In Chapter 5, AMACR is used as the biomarker. Again, DNA aptamer based 
biosensors were constructed for AMACR detection. Two different DNA aptamer 
sequences were characterised for their binding efficiency for the development of a 
biosensor. In order to implement polyethylene glycol (PEG) based surface chemistry, 
a new strategy was developed. It employed the use of poly(pyrrole) films which were 
electrochemically modified with PEG via a one-step process. Such a surface was then 
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used to attach an anti-AMACR DNA aptamer for subsequent detection of AMACR 
using an amperometric technique. 
After witnessing the anti-fouling efficiency of PEG on the surface of the electrode, 
detection of miRNAs was performed using PEG linkers, as described in Chapter 6. 
The study investigates the use of PNA probes to selectively capture synthetic RNA as 
a proof of concept. A non-Faradaic EIS approach was utilised using positively charged 
gold nanoparticles (AuNPs) as a simple amplification strategy. The sensitive detection 
with EIS was validated on the same platform by using thiolated ferrocene molecules. 
The current peaks of ferrocene were monitored using an amperometric technique. 
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 Materials and Methods 
 
This Chapter will cover technical details about the immobilisation of probes on the 
electrode surface and physical principles of electrochemical techniques used for both 
detection as well as characterisation. Furthermore, the main focus is on self-assembled 
monolayer and polypyrrole surface chemistry along with particular electrochemical 
techniques (Electrochemical Impedance Spectroscopy and Square wave 
Voltammetry) used in this work. 
 
2.1 Immobilisation techniques 
In order to fabricate a successful biosensor, surface engineering of the sensor 
transducer plays a key role. Surface chemistry has been demonstrated as a tool to 
engineer biosensor surfaces and is one of the most crucial aspects for biosensor 
construction. It is also our very first aspect of the fabrication step where specific 
oligonucleotide-based probes are immobilised on the electrode surface. The proper 
control of the immobilisation step is essential in order to have good sensitivity, 
selectivity and stability of the biosensor (Campuzano et al. 2006). There have been 
many electrode surfaces reported for immobilisation, for example; gold, graphene, 
glassy carbon, carbon nanotubes, gold nanoparticles, glass, etc. The work in this thesis 
majorly employs planar gold electrode surface for the biosensor fabrication. Broadly, 
immobilisation techniques could be divided into physical adsorption, covalent 
binding, affinity and entrapment. These techniques pose advantages and 
disadvantages, some of which are listed in Table 2.1. 
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Table 2.1 Immobilisation techniques 
Immobilisation 
strategy 
Type of interaction Advantages Disadvantages References 
Physical  Noncovalent 





rapid, simple and low 
cost 
It may result into 
random orientation of 
probe followed by 
instability of layer in 
different conditions 
like change in ionic 
strength of buffer, pH 
or other reagents 










between the probe 
and the electrode 
surface 
It ensures good stability 
(bond can be broken 
under extreme 
conditions), results into 
well-ordered layer, high 
degree of control and 
thickness of electrode 
surface, high sensitivity 
and orientation 
 
It may need prior 
modification of 
probes and linker 
molecules. It can be 
slow, irreversible 
process and expensive 
Li et al. 
2012; Jolly 
et al. 2015 
Affinity Specific interactions 
like between 
streptavidin and 





specificity and well 
controlled 
 
It employs use of 
biocompatible linkers 
and therefore are 
expensive 
Ma et al. 
2013; Zhang 
et al. 2013 
Entrapment or 
encapsulation 
Involves trapping of 





Results in high 
entrapment of probes, 
high thermal stability, 
stability against 
nucleases, no covalent 
modification needed, 
well controlled polymer 
growth 
 
Could result into 
leaching of probes 




Jolly et al. 
2016 
 
This thesis will mainly focus on covalent immobilisation such as self-assembled 
monolayer (SAM) and polymer chemistry. 
 
2.1.1 Self-assembled monolayer 
There are many immobilisation techniques being reported for aptamer attachment to 
surfaces depending on the electrode surface and application. Specifically for gold 
electrode surfaces, self-assembled monolayer (SAM) is one of the most highly 
reported techniques because it results in a highly controlled density of biological probe 
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and thickness on the transducer surface (Hong et al. 1999). The key aspect to take into 
consideration for the immobilisation of oligonucleotide-based probes on gold surfaces 
is to have an optimum density (Keighley et al. 2008). Thiols, sulphides and disulphides 
have demonstrated very high affinity towards gold by forming a covalent bond 
between the sulphur and gold atoms, making alkane thiol-based SAMs very popular 
(Figure 2.1) (Bain et al. 1989; Bain and Whitesides 1989; Love et al. 2005).  
 
Figure 2.1 SAM formation on gold substrates. Adapted from Love et al. 2005. 
 
Sulphur in the proximity of gold undergoes the following reaction: 
𝑅𝑆𝐻 + 𝐴𝑢 ⇔ 𝑅𝑆 − 𝐴𝑢 + 𝐻+ + 𝑒− 
The sulphur-gold reaction is spontaneous with 80%-90% coverage within the first few 
minutes, but a well organised layer is formed in no less than 12-16 hours (Schreiber 
2000). The formation of well organised SAMs depends not only on factors such as 
presence of contaminants and surface quality (roughness and purity), but also on the 
length of the alkane thiols (Finklea 1996; Darling et al. 2002). In 2005 Love et al. 
determined the maximum density of alkane thiol on gold surfaces to be 4.64 x 1014 
molecules/cm2 with a gap of 4.99 Å between two adjacent molecules (Love et al. 
2005). The time-dependent well organised SAM formation undergoes two main steps 
where there is spontaneous assembly within the first few minutes. In the early stages, 
alkane thiols lie flat on the gold electrode surface through physisorption, called the 
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‘lying down’ phase (Camillone Iii et al. 1994). Thereafter follows a chemisorption 
process where a semi-crystalline structure is formed due to van der Waals forces 
resulting in lateral movement until a tilt angle of about 30˚ between the hydrocarbon 
chains and the electrode surface is achieved (Love et al. 2005). It is worth mentioning 
that the ability of the thiols to move laterally along the gold surface results in the 
formation of well-ordered layering and healing any defects (Ulman 1996).  
In such a process, even the terminal groups of the alkane thiol affect the SAM 
properties which define its interactions with the biological molecules. For example, a 
carboxylate group can be used to bind an amine terminated DNA aptamer using ethyl 
(dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS) 
activation step (Jolly et al. 2015). Sagiv et al. (Sagiv 1980) in 1980 demonstrated a 
chemisorbed monolayer using siloxane chemistry on a silicon surface. Chapter 4 will 
explain further silane based immobilisation of DNA aptamers on glass substrates.  
Since SAM provides the provision of having various functional terminal groups, it 
permits the researchers to engineer novel and controlled biosensor designs. SAMs 
have been used to immobilise various molecules from biological (enzymes (Fang et 
al. 2003), DNA aptamers (Jolly et al. 2015), peptides (Laurent et al. 2008) etc.), 
chemicals (ferrocene (Mukherjee et al. 2013)) to metals (gold nanoparticles (Bertok 
et al. 2013), copper (Nishizawa et al. 1997), etc.) and more. Chapter 3 and Chapter 6 
will further discuss different types of SAMs on the gold substrate to fabricate 
biosensors. The tailoring of SAM layers have led to the establishment of mixed SAMs. 
Keighley et al. (Keighley et al. 2008) in 2008 demonstrated the effect of DNA probe 
density using co-immobilised binary SAM on gold electrodes on hybridisation 
efficiency. In 2010 Wu et al. (Wu et al. 2010) reported a ternary SAM on screen 
printed gold electrodes as a potential antifouling SAM for amperometric detection of 
oligonucleotides. Furthermore, by tuning the composition of mixed SAMs, the number 
of functional groups can be monitored. In fact, by carefully selecting the spacer 
molecules, the desired hydrophobicity or hydrophilicity, as well as significant 
chemical reactivity, could be achieved. Such a strategy could impede non-specific 
binding and therein improve the electrochemical signals (Herne and Tarlov 1997).  
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2.1.2 Poly(pyrrole)-based immobilisation 
Conducting polymers are organic materials that conduct electricity. The most 
conductive polymers used for electrochemical biosensor constructions are 
poly(pyrrole) (PPy), polythiophene and polyaniline (Figure 2.2).  
 
Figure 2.2 Organic conductive polymers: (black) poly(pyrrole); (red) polythiophene; (blue) polyaniline. 
 
Among them, PPy is one of the most extensively used conducting polymers in the 
design of bioanalytical sensors (Peng et al. 2009; Ramanavičius et al. 2006). This is 
due to its copious properties such as redox activity (Han et al. 2005), ion-exchange 
and ion discrimination capacities (Johanson et al. 2005; Weidlich et al. 2005), strong 
absorptive properties (Azioune et al. 2005; Chehimi et al. 1999), catalytic activity 
(Khomenko et al. 2005) and biocompatibility (Wang et al. 2004). PPy as a polymer 
can be further characterised by its high electrical conductivity, hydrophilic character 
and high stability in water (Andrade 1985). In fact, its low oxidation potential enables 
a pyrrole polymer film to be grown from an aqueous solutions which is compatible 
with most of the biological elements (Asavapiriyanont et al. 1984). 
 
2.1.2.1 Synthesis of poly(pyrrole) films 
PPy films can be synthesised by either chemical or electrochemical methods. The first 
method consists of chemical oxidation of pyrrole monomers in aqueous or organic 
solutions in the presence of a metal catalyst. Rodriguez et al. synthesised PPy in the 
presence of hydrogen peroxide or iron chloride in acetonitrile or water (Rodriguez et 
al. 1997). Chemical synthesis of PPy is limited by a purification step from catalyst and 
secondary products. Also the composition and structure are not well defined and many 
defects in the polymer chain can occur resulting in a decrease in conductivity. More 
often, a PPy film is formed by electro polymerisation of its monomers. This method 
allows a reproducible well-defined structures and properties of the polymer. As a result 
  
Chapter 2  44 
 
a film is obtained with known thickness. The polymerisation mechanism of the 
succession of electrochemical and chemical reaction is represented in Figure 2.3. 
 
Figure 2.3 Mechanism of electro-polymerisation of PPy. 
 
Electro polymerisation is achieved through a few electrochemical steps. The first step 
consists of the electrochemical oxidation of monomers to form radical cations. This is 
followed by dimerization via coupling of radical/radical with the elimination of two 
protons. Dimers can easily be oxidized because of stabilisation of radical cations. The 
oxidised dimer can be coupled with another oxidized monomer or dimer. 
Polymerisation is terminated when a radical cation is no longer reactive or when the 
last reactive chain is blocked by steric effects.  
 
2.1.2.2 Immobilisation onto poly(pyrrole)  
Different strategies are investigated to immobilise biomolecules on PPy. For example, 
biomolecules can be entrapped in a polymer film during electro polymerisation of 
monomers. In 1999 Wang et al. reported a label-free approach consisting of the 
introduction of single-strand DNA as doping ions during electro polymerisation of 
PPy films (Wang et al. 1999). DNA hybridisation was monitored by the decrease in 
current changes of PPy due to the reduction in conduction. A similar approach was 
reported by Komarova et al. in 2005, where an electrochemical DNA sensor was 
constructed with an ultrathin film of conducting PPy doped with an oligonucleotide 
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probe (Komarova et al. 2005). A low detection limit of 0.16 pM was demonstrated 
using chronoamperometry measurements. However, such an approach faces certain 
drawbacks such as possible denaturation of biomolecules (in the case of enzymes), 
leaching of probes from the polymer or uncontrolled orientation of probes in the 
polymer layer which can decrease the performance of the sensor.  
Another method consists of direct physical adsorption of biomolecules on PPy films 
as reported in the literature and are mostly for enzymatic biosensors (Ahuja et al. 2008; 
Apetrei and Apetrei 2013), however, changes in the ionic strength or pH can cause the 
release of biomolecules from the surface, especially during the regeneration step of 
the sensor by acidic solutions.  
The covalent approach to anchor biomolecules on PPy films is also well developed. 
Biomolecules carrying amine, carboxylic or activated ester groups can be covalently 
attached to a functionalised polymer film on its nitrogen or carbon positions. For 
instance, a pyrrole monomer can be modified by chemical groups and then electro 
polymerised to form a PPy film bearing the function to be able to react with 
bioreceptors. Pyrrole monomers can be simply modified with carbonyl chain ending 
with chemical groups, which can then interact with biomolecules. There are some 
examples of pyrrole modifications, where the pyrrole monomer was modified with 
propylic acid (Dong et al. 2008), 3-aminopropyl (Bisht et al. 2005) and activated ester 
as N-hydroxysuccinimide (Ionescu et al. 2006; Ionescu et al. 2007) (Figure 2.4).  
 
Figure 2.4 Structures of pyrrole derivatives: (black) pyrrole propylic acid, (red) N-3-aminopropylpyrrole, (blue) 
pyrrole NHS. 
 
In 2002 Rodrı́gez et al.(Rodrı́gez et al. 2002) synthesised pyrrole modified with biotin 
set apart by a polyethylene glycol chain, which prevented the biosensor from non-
specific interactions (Figure 2.5 black). In the literature, the combination of pyrrole 
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with some redox markers was also described and was used, for example, for the 
modification of pyrrole with nitrilotriacetic acid (NTA) for complexation of Cu2+ ions 
(Figure 2.5 blue). Such a complexation of Cu2+ ions allowed immobilising an histidine 
modified antibody specific for a herbicide atrazine (Ionescu et al. 2010) or histidine 
modified thrombin aptamers (Xu et al. 2013).  
 
Figure 2.5 Structures of pyrrole monomers functionalised with PEG-biotin (black) and with NTA (blue). 
 
 
3-substituted PPy has demonstrated an advantage in maintaining its full intrinsic 
electrical properties compared to N-modification. Modification of pyrrole in the 3’ 
position allows immobilisation of the bioreceptors and a direct measurement of 
sensing processes. A first example was demonstrated through covalent attachment of 
bioactive peptides inhibitors of enzymes. The interaction of peptides and enzymes was 
followed through the electrochemical properties of the PPy layers. This work 
demonstrated, for the first time, a proven concept that PPy could be used as a 
molecular wire for transduction of biological events (Garnier et al. 1994). Covalent 
binding of ssDNA probe was demonstrated for the first time in 1997 (Korri-Youssoufi 
et al. 1997a; Korri-Youssoufi et al. 1997b). In this case two monomers of pyrrole were 
substituted by a N-hydroxyphtalamide group and acetic acid group and then 
electrochemically polymerised. The copolymer film allowed from one side covalent 
linking of DNA probe to the monomer modified with N-hydroxyphtalamide. This 
linking was possible by functionalisation of the DNA probe with amine groups which 
can be attached to the PPy layer via an amide link. The second side modifications of 
pyrrole by carboxylic groups allowed protecting the surface against non-specific 
interactions due to electrostatic repulsion of negatively charged DNA (Garnier et al. 
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1999). Since this work, various studies using this copolymer have been published 
aiming at improving the sensitivity of the detection system (Garnier et al. 2007; Korri-
Youssoufi and Yassar 2001) and studying the electrical properties of the PPy layers 
(Tlili et al. 2005). For example, Peng et al. developed various functionalised pyrrole 
monomers bearing acid functions for DNA sensors. In a first approach, a monomer 
pyrrole bearing butanoic acids was synthesised. After electro polymerisation, a ssDNA 
probe bearing amine group was covalently attached to the PPy via an amide link 
(Figure 2.6) (Peng et al. 2005). Later the group reported modifications of pyrrole with 
the same function through unsaturated carbon chain of various lengths (Peng et al. 
2007a; Peng et al. 2007b) (Figure 2.6).  
 
Figure 2.6 Pyrrole derivatives developed by Peng et al.(Peng et al. 2007a; Peng et al. 2007b; Peng et al. 2009) 
Modifications of pyrrole with (black) butanoic acid; (red) 3-pyrrolylacrylic acid; (blue) 5-(3-pyrrolyl) 2,4-
pentadienoic acid. 
 
Various methods have been developed with PPy in biosensor devices throughout the 
last decade. However, electrochemical modification of PPy is very new and gaining a 
lot of interest; thanks to its easy one step procedure. Chapter 5 will demonstrate the 
use of a conducting PPy film on gold surfaces for the development of an 
electrochemical aptasensor taking into account electrochemical modification 
procedures. 
 
2.2 Electrochemical techniques 
To fully understand the typical setups for an electrochemical measurement, it is crucial 
to describe the environment around the electrode/solution interface. This section will 
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further describe the techniques that have been employed for the characterisation and 
detection of a particular analyte.  
 
2.2.1 Electrochemical interface 
Electrochemistry is defined as a study that investigates the correlations between the 
electrodes (containing electrons) and electrolytes (containing ions) resulting in 
electrical properties and chemical effects respectively (Bard and Faulkner 1980). In 
most of the electrochemical studies, the main focus is on the factors that affect the 
transportation of the charges across the electrode/electrolyte interface. In fact, in an 
electrochemical cell, generally, the interest is only on the working electrode (WE). 
With the help of the voltage applied, one can easily modulate the potential of the WE. 
When the potential of the WE is pushed to higher negative values, electrons tend to 
flow from the electrode surface to the electrolyte solution. Such an effect is due to the 
gain of energy by the electrons to escape the surface and fill the vacant holes of the 
ions in the electrolyte solution. Such an effect is attributed to a reduction current. 
Similarly, an oxidation current is created when the potential of the WE is driven to 
more positive potentials. Such a reaction involving transportation of electrons between 
the electrode and the electrolyte solution is termed as a Faradaic reaction. A Faradaic 
reaction follows Faraday’s law given by i=nF, where the quantity of electricity passed 
(i) is directly proportional to the rate of reaction and amount of electrons (n) (Bard and 
Faulkner 2001) and F is Faraday Constant. On the other hand in a non-Faradaic 
process, there is no flow of electrons involved, leading to accumulation of charges at 
the electrode/electrolyte interface causing polarisation of electrodes.  
In an electrolyte solution, a potential applied to the electrode causes redistribution of 
the charges leading to changes in surface potential. At a given potential, the 
electrode/electrolyte interface is in principle characterised by the theory of the 
electrical double layer (DL); more specifically by the double layer capacitance (Bard 
and Faulkner 1980). The electrical DL can be simply explained as the rearrangement 
processes of the charges in the electrolyte in close proximity to the electrode surface 
in order to counter balance the charge irrespective of the potential of the electrode 
  
Chapter 2  49 
 
(Bard and Faulkner 2001). Electrical DL was best described by Otto Stern in 1924 
who suggested combining the theory of Helmholtz model and Gouy-Chapman model 
(Figure 2.7). 
In Stern’s model, immersion of the electrode in an electrolyte solution produces a high 
electric field and presents a row of firmly adsorbed counter ions. It is worth mentioning 
that this area represents a low relative permittivity. The region established between 
the electrode surface and the centres of adsorbed ions is called the inner Helmholtz 
plane (IHP); as we move further away from this region an ionic cloud (diffuse layer) 
is present. Such an ionic cloud consists of balancing processes occurring between 
electrostatic and thermodynamic motions. Also, as we move beyond the IHP, the 
permittivity increases exponentially. Such an arrangement also affects the electrical 
potential (Ψ) from the electrode surface to the bulk electrolyte. Up to the IHP, the 
electrical potential decreases quasi-linearly, while it decreases exponentially within 
the diffuse layer. 
 
Figure 2.7 Schematics of the electrical double layer by the Gouy–Chapman–Stern model. Adapted from Bard et 
al. (Bard and Faulkner 2001). 
 
Beyond the IHP, ions approach to the electrode surface due to electrostatic attraction, 
however, staying distant as non-specifically adsorbed molecules. Such molecules are 
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solvated and form the outer Helmholtz plane (OHP). Moreover, the two regions 
formed by the IHP and OHP form the Stern layer. The molecules further away from 
this layer lack the competency to compensate with the overall charges, thus forming 
the diffuse layer. Because of these two Helmholtz planes, there is a capacitance due to 
the DL. It consists of two capacitances in series; one is called the Stern capacitance 
and the second is the capacitance of the diffuse layer. The distance covered from the 
OHP to the point where the ions are affected by the electrostatic effect of the surface 
is defined by the Debye length (thickness of the diffuse layer). In cases like 
impedimetric and potentiometric biosensors, the limit of detection (LOD) is majorly 
dependent on the Debye length (λD) (Bard and Faulkner 2001). It is imperative to study 
the ionic effect on the sensitivity of the sensor and is well advised to work within the 
Debye length range (Figure 2.8). It is also well known that many biomolecules have 
inherited charges even under physiological conditions. For instance, DNA/RNA 
molecules are negatively charged due to a sugar-phosphate backbone which can be 
considered as a cylindrical structure of about 1.5-2 nm in diameter with an estimated 
length of the nucleotide to be 0.34 nm (Piunno et al. 1999). On the other hand, the 
charge on the proteins is generally dependent on the pH of the solution. The net charge 
of the protein be calculated by knowing the isoelectric point of the protein. The 
isoelectric point is characterised by the pH at which the net charge of the protein is 
zero.  
 
Figure 2.8 Schematic of difference in antibody size and DNA aptamer size with respect to electrical double layer. 
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Stern et al. (Stern et al. 2007) demonstrated that the surface of the biomolecules in an 
electrolyte is surrounded by its counter charges resulting in Debye screening. For an 




         (2.1) 
Where ε0 and εr are the permittivity’s of free space and dielectric constant of the 
solution respectively, k is Boltzmann constant, T is temperature, NA is Avogadro’s 
number, q is the electron charge and I is the ionic strength. The ionic strength can be 





2         (2.2) 
Where cj is the concentration of ion j and 𝑧𝑗 is the charge of the jth ionic species. 
Therefore, the DL thickness is inversely proportional to the square root of the ionic 
strength of the electrolyte solution. Although the Debye length is a limiting factor for 
the sensitivity of a biosensor, researchers have come with alternatives to overcome 
such a screening effect. Gao et al. in 2015 demonstrated the use of polymer chains 
(like PEG) on the electrode surface to increase the effective screening length resulting 
in detection of biomolecules in a high ionic strength electrolyte solution (Gao et al. 
2015). There are other studies that have demonstrated new strategies to work under 
high ionic strength electrolyte solutions (Jang et al. 2015; Kulkarni and Zhong 2012; 
Stern et al. 2010). 
 
2.2.2 Electrochemical impedance spectroscopy 
Electrochemical impedance spectroscopy (EIS) is a label-free electrochemical 
technique that has been widely used as a detection system. It exploits the electrical 
properties of the molecules to be detected by measuring the changes in the impedance 
at the electrode/electrolyte interface (Bond and Scholz 2010; Lasia 2002).  
EIS measurements are usually based on the measurement of Faradaic processes; 
employing a redox couple in an equal concentration of reduced and oxidised forms in 
order to simplify the analysis. A Faradaic process is the charge transferred across the 
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WE and electrolyte interface as a result of an electrochemical reaction. In EIS, a small 
AC voltage is superimposed on the formal potential of the respective redox couple. 
The resistance of the system is, therefore, mainly a result of how easily the redox 
couple can reach the electrode surface. The measurement is then scanned on a range 
of frequencies, typically spanning from 0.1-1 MHz to 0.1-0.01 Hz. For the current 
study the range used was 100 kHz to 100 mHz. In order to perform such an analysis, 
a potentiostat with a frequency-response analyser (FRA) is used. Although EIS 
investigates the full frequency span response, it could be easily implemented in a 
practical biosensor by possibly selecting a single frequency. 
EIS is a measure of the AC current flowing between the electrodes into the bulk 
electrolyte of the cell. Furthermore, the term “spectroscopy” refers to the 
measurements recorded by scanning the frequency of the AC signal. A small AC 
voltage is applied to maintain a certain thermodynamic equilibrium at the 
electrochemical interface which aids in easy separation of mass transfer and electron 
transfer. Such a sinusoidal voltage signal can be expressed as a function of time (V 
(t)): 
𝑉(𝑡) = 𝑉0sin (𝑡)         (2.3) 
Where, V0 is the amplitude of the voltage signal and  refers to angular frequency 
(=2πf). f refers to the frequency in Hertz (Hz). As a consequence, an AC current 
signal (I (t)) as a function of time is obtained. I (t) obtained with the same frequency 
(f) is also referred to current density which is expressed as: 
𝐼(𝑡) = 𝐼0sin (𝑡 + )       (2.4) 
Where Io is the current amplitude and  is the phase angle which depends on the 
impedance of the respective system. Such a process of applied voltage and current 
measured can also be represented as shown in Figure 2.9: 
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Figure 2.9 AC signal of applied voltage and obtained current response. 
 
The impedance is measured by applying a small AC voltage signal, through which the 
real and the imaginary part of the impedance are obtained. In principle, the 
measurement works by applying the potential (Vt) and measuring the current (It) at the 











        (2.5) 
In order to represent a complex impedance, Euler’s expression is employed which is 
expressed as: 
exp(𝑗) = 𝑐𝑜𝑠 + 𝑗𝑠𝑖𝑛()        (2.6) 
Where j is an imaginary number equal to (-1)1/2. Also, equation 2.3 and 2.4 can be 
further expressed as a function of time: 
𝑉(𝑡) = 𝑉0𝑒𝑥𝑝(𝑗𝑡)         (2.7) 
𝐼(𝑡) = 𝐼0𝑒𝑥𝑝 (𝑗𝑡 + 𝑗)        (2.8) 
Therefore, impedance can be expressed as a complex number using equations 2.7, 2.8 




= 𝑍0 exp(𝑗) = 𝑍0(𝑐𝑜𝑠 + 𝑗𝑠𝑖𝑛) = 𝑍
′ + 𝑗𝑍′′     (2.9) 
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The real part of impedance (Z’) is described as the resistance to the flow of current by 
the circuit, whereas the electrical energy storage ability by the circuit is reflected by 
the imaginary part of the impedance (Z”). In other words, the real and imaginary part 
of impedance are associated with the resistive and capacitive components of the 
biosensor interface. 
The impedance of the electrochemical interface is usually interpreted through 
biosensor specific equivalent electrical circuits. The most common circuit is the 
Randles equivalent circuit (Figure 2.10) that includes the solution resistance (Rs), the 
resistance for electron transfer (Rct), the DL capacitance (Cdl) and a Warburg 
impedance element (W). While the W element gives information about the diffusion 
of redox couple through the surface layer, the Rs values depend only on the solution 
along the distance between the WE and RE. Constant phase element (CPE) models the 
capacitive behaviour of the double layer replacing the infrequently ideal; however, the 
deviations from an ideal capacitance (n = 1) are reasonably small.  
 
Figure 2.10 Randles equivalent circuit where Rs is the solution resistance, Rct is the charge transfer resistance 
(impedance), Cdl is the double layer capacitance and ZW is the Warburg element. 
 
The slight modification that was introduced in the Randles equivalent circuit was the 
replacement of Cdl by a CPE. The impedance of CPE is given by equation 2.10: 
𝑍𝐶𝑃𝐸 = 𝑌0(𝑗)
−𝛼        (2.10) 
Where, ω is the frequency, Y0 is the magnitude of admittance, α is an exponent with a 
value between 0 and 1 (In a CPE, α < 1). It is important to know that neither Y0 nor α 
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are dependent on frequency in ZCPE. From the ZCPE, it is also possible to get an 






         (2.11) 
In principle, Faradaic currents are affected by diffusion processes. Furthermore, W 
represents the pseudo-impedance due to the mass transfer, which is simply the 
diffusion of ions from the bulk solution to the electrode surface. W at lower frequencies 
becomes predominant with a phase angle of 45˚ in a diffusion controlled Faradaic 
process. 
The results from an EIS response can be represented in a Nyquist plot (Figure 2.11). 
This plot enables a direct comparison of the Rct values given by the diameter of the 
semicircle along the Z’ axes.  
 
Figure 2.11 Typical Nyquist Plot. 
 
2.2.2.1 Non-Faradaic EIS experiments 
A non-Faradaic EIS experiment is performed in the absence of a redox couple. As a 
consequence, only capacitive changes are monitored. In such a measurement, specific 
importance is given to the double layer capacitance (𝐶𝑑𝑙) rather than the charge 
transfer resistance (𝑅𝑐𝑡) of the system (Tsouti et al. 2011). One of the common 
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approaches of calculating capacitance reported in the literature is based on the 
assumption that the 𝑅𝑐𝑡 and W contributions can be neglected (Couniot et al. 2015). 
Consequently, a simplified equivalent circuit is obtained, consisting of a resistor in 
series with a capacitor as shown in Figure 2.12. 
 
Figure 2.12 Equivalent circuit for a non-Faradaic measurements. 
 
As a result, equation 2.9 can be represented as: 




∗        (2.12) 





         (2.13) 
Another approach that has been reported includes calculation of a complex capacitance 
(C*). In such cases, a C* can be calculated from EIS data using the following 







= 𝐶′ + 𝑗𝐶′′         (2.14) 
Where 𝐶′ and 𝐶′′ are calculated from the measured values of Z’’ and Z’. Furthermore, 
C* can be plotted as a Cole-Cole plot. Figure 2.13 depicts an example of non-Faradaic 
EIS measurement of the electrode modified with a PNA sequence (left is a Nyquist 
plot and right is calculated capacitance from EIS data, diameter of the semicircle of 
which gives an estimate of the capacitance of the system).  
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Figure 2.13 Figure showing a Nyquist plot (left) representing the impedance of the system. On the right is a 
Cole-Cole plot representing the capacitance of the system calculated from impedance data. 
 
There are numerous reports that have demonstrated the development of capacitive 
sensors (Berggren et al. 2001; Tsouti et al. 2011). Regardless of the simplicity of 
measurement, a capacitive sensor based on electrode-electrolyte interfaces needs a 
compact insulating layer. To address such an issue, in Chapter 5 and Chapter 6, a PEG-
based SAM has been employed in order to obtain a compact and defect-free SAM 
which will prevent leakage currents. Leakage currents are important to exclude as they 
could result into short-circuiting the metal electrode and solution phases, which in turn 
may affect the detection of the target (Berggren et al. 2001). PEG was employed in 
the immobilisation procedures because it has been reported that longer linkers form 
well organised SAMs (Porter et al. 1987). Although there are numerous studies on 
capacitive sensors, many results among them have demonstrated contradictory results 
(i.e. showing both increment and decrement of capacitance using the same sensor type 
and target analyte) (Daniels and Pourmand 2007). Rational explanations are given for 
every specific contradictory result. Nevertheless, no self-contained study has been 
performed in order to clearly correlate molecular binding events occurring at the 
electrode surface to EIS signals. As a consequence, the signal changes obtained have 
been attributed to changes in various factors, for example, dielectric properties, 
displacement of water molecules, the addition of a metal-like surface, electrostatic 
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interactions, and the conformation of molecules onto the surface electrodes and so on. 
Using such an approach, Chapter 6 reports on the development of a capacitive PNA-
based biosensor for the detection of miRNAs using AuNPs as an amplification 
technique. 
 
2.2.3 Amperometric detection  
Amperometric biosensors are based on measurement of current produced in a solution 
due to a chemical reaction when a fixed potential is applied across the electrodes. 
However, when the current is measured as a function of potential, it is called 
voltammetry (Grieshaber et al. 2008). In principle, either the analyte directly results 
in a redox reaction at the electrode surface or the current is generated using an 
electroactive mediator which interacts with the target molecule (Luppa et al. 2001). 
Amperometric techniques are considered some of the most powerful and sensitive 
techniques, even though most of them often employ redox mediators (Thévenot et al. 
2001).  
On application of a potential in voltammetry experiments, currents are generated as a 
result of three factors: capacitive currents, Faradaic currents and adsorption effects. 
Capacitive currents and adsorption currents make up the background current which 
does not add any information to the analytical information about the electrochemical 
reaction. It is worth mentioning that such background signal could be a cumulative 
effect of the redox reaction of impurities present in the solution. On the other hand, 
the Faradaic current could provide the analytical information about the processes of 
interest in the electrochemical setup. 
 
2.2.3.1 Cyclic voltammetry 
A well established and widely used amperometric technique is cyclic voltammetry 
(CV). The main aspect of using a CV is to attain a signal in the form of a current from 
the system under investigation with respect to the constraints responsible for the 
production of an electrochemical reaction. Such a response occurs by imposing a 
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varying electrode potential of the WE (potential sweep) between two set potential 
limits as shown in Figure 2.14 (Bard and Faulkner 1980).  
 
Figure 2.14 Potential plot of a redox reaction diffusing in solution (a); Cyclic voltammetry of a fully reversible 
redox reaction at the gold working electrode in 10 mM PBS, pH 7.4 containing 10 mM ferro/ferricyanide 
[Fe(CN)6]3-/4- vs. Ag/AgCl reference electrode (b). 
 
By doing so, if it happens that in the solution, some molecules can lose electrons 
(oxidation) or gain electrons (reduction), the CV scan will show its respective peaks. 
This technique allows recognition and quantification of a large number of compounds, 
and also to study chemical reactions. For example in Figure 2.14, when the voltage 
applied to the WE increases and reaches closer to the reduction potential of the redox 
molecule, which in this case is [Fe(CN)6]
3-/4-, WE loses an electron which becomes 
associated with [Fe(CN)6]
3- and in turn becomes reduced. Such a flow of electrons 
from the electrode to the solution causes the appearance of a reduction peak in the 
voltammogram. After an initial peak, there is an asymptotical decrease in the Faradaic 
current with the diffuse layer. The opposite occurring when the electrode potential 
moves towards the oxidation potential of the redox couple in a reversible process. Such 
a system can be described by the Randles-Sevčik law which describes the effect of 









𝑐       (2.15) 
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Where A is the electroactive area of the electrode, n is the number of electrons involved 
in the transfer process, F is Faraday’s constant, 𝐷 is the diffusion coefficient of the 
redox species, 𝑆 is the scan rate, T is temperature and 𝑐 is the bulk concentration of 
the redox species. In a CV, certain parameters such as the scan rate, can account for 
the reversibility of some reactions. In other words, the potential scan can produce a 
peak current for all analytes that can be reduced in the range of the potential sweep. 
The current (I) in the system which is measured either continuously or at specific 
times, corresponds to the electronic transfer allowing reduction of metal ions on the 
electrode surface (cathode) and is mainly the sum of Faradaic current, If, and non-
Faradaic current, Ic. 
If results from the redox reactions of the analytes at the interface of 
electrode/electrolyte. If constitutes the major component for quantitative analysis of 
test compounds. If can be influenced by the following three factors: 
1. The diffusion rate (mass transfer) of the oxidized electroactive species in the 
electrolyte solution towards the electrode (and vice versa for a reduced 
species). 
2. The electron transfer rate at the electrode/electrolyte interface in case of 
irreversible reaction. 
3. The rate of the chemical reactions preceding or following the electron transfer. 
In fact, the current (I) is not only a function of the potential (E) but also of time, t. On 
the other hand, Ic is due to the CDL represented by the interface between the surface 
layer of the electrode and the adjacent layer of the solution given by: 
 𝐼𝑐 = 𝐶𝐷𝐿
𝑑𝑣
𝑑𝑡
         (2.16) 
Where 𝑣 is the potential applied to the electrode surface. The capacitive current 
depends on the surface of the electrode, the rate of change of potential with time and 
the composition of the medium, but not on the concentration of the test compound. It 
is always suggested to have a reasonable low scan rate since Ic increases linearly with 
the scan rate. In this dissertation, CV has been employed as a characterisation 
technique as well as a fabrication technique to perform polymerisation. 
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2.2.3.2 Square wave voltammetry 
CV, as explained in the previous section, produces both Faradaic and non-Faradaic 
currents and as a result of which the differentiation of analytical peaks from 
background signal becomes difficult. In order to circumvent the non-Faradaic or 
capacitive currents, methods like square wave voltammetry (SWV) have been 
developed (Bard and Faulkner 2001) (Figure 2.15). Such voltage pulsed techniques 
results in an increase in the ratio of Faradaic current to non-Faradaic current, thus the 
sensitivity of the measurement.  
 
Figure 2.15 Square Wave voltammetry potential variation waveform. 
 
The excitation signal in a SWV measurement consists of a repetitive symmetrical 
square wave pulse of amplitude Vsw superimposed on a staircase wave of potential step 
height ΔV and with a pulse period t, where the forward pulse of the square wave 
coincides with the staircase step. The net current, inet, is achieved by taking the 
difference between the forward current and reverse current (itotal – ireverse) which is 
calculated at the end of each half cycle respectively. With such a subtraction, the non-
Faradaic current is further suppressed. The peak height obtained from SWV, due to 
  
Chapter 2  62 
 
redox reaction, is directly proportional to the concentration of the electroactive 
species.  
 
2.3 Other characterisation techniques 
Apart from the electrochemical techniques mentioned earlier, surface plasmon 
resonance (SPR) and Fourier transformation infrared spectroscopy (FT-IR) were also 
used during the development of specific biosensors reported in this thesis.  
 
2.3.1 Surface Plasmon Resonance 
Surface plasmon resonance (SPR) offers a powerful and rapidly developing technique 
for the study of molecular interactions, where the probes are confined to the surface. 
It not only offers a label-free detection but also provides real-time quantitative data 
for the molecular interactions. In general, a SPR technique consists of one probe which 
is immobilised on the SPR chip (for example DNA aptamers specific to PSA, Figure 
2.16) and the analyte in the solution which is flowed over the surface (e.g. PSA). 
Finally, the binding interactions are measured by monitoring the slight changes in the 
refractive index (RI) at the sensor surface using optical methods.  
SPR is a phenomenon that occurs when a polarized light hits a thin metal film at the 
interface of media with different RI. The generation of plasmons occurs through 
proper coupling of incident light to free electrons of the metal. Such a phenomenon 
can be accomplished by employing an attenuated total reflection technique (ATR). In 
ATR, plasmons are generated by an induced evanescent wave under total internal 
reflection conditions. Under total internal reflection conditions, an evanescent wave 
penetrates into the metal and decays exponentially in the perpendicular to the metal 
surface into the medium. The depth of the evanescent wave from the sensor surface is 
within 300 nm depending on the gold thickness and RI of the medium over the metal 
surface, which is useful for measurements (Van Der Merwe 2001). When a light is 
directed to the metal film, at a certain incident angle, the light wave vector matches 
the metal plasmons wave vector resulting in the resonance of the plasmons. During 
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such a condition, energy from the photons are transferred to plasmons, resulting in a 
minimum on the reflectance intensity, thus defining the SPR spectrum (Salamon et al. 
1997). SPR techniques excite and detect collective oscillations of free electrons also 
known as surface plasmons, via the Kretschmann configuration, in which light is 
focused onto a metal film through a glass prism and the subsequent reflection is 
detected (Figure 2.16). 
 
Figure 2.16 Surface Plasmon Resonance schematics (SPR). The excitation of surface plasmons results in a dark 
line in the reflected beam, and the angular position of the dark line shifts as a molecule-binding event takes 
place. SPR causes an intensity dip in the reflected light at the sensor surface. A shift in the curve represents 
molecular binding. 
 
At a certain incident angle, the plasmons are set to resonate with light, resulting in the 
absorption of light at that particular angle as explained in the previous paragraph. This 
creates a dark band line in the reflected beam (Figure 2.16). That dark band line can 
be observed as a dip in SPR reflection intensity. A shift in the reflectivity curve (Figure 
2.16) represents a molecular binding event taking place either on or near the metal 
film, or a conformational change in the molecules bound to the film (like in the case 
of DNA aptamers). By monitoring this shift vs. time, researchers can study molecular 
binding events. 
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In this dissertation, SPR is used mostly as a characterisation technique to investigate 
the binding characteristics of probes when restricted to the electrode surface especially 
for anti-DNA aptamers for PSA and anti-DNA aptamers for AMACR. SPR has also 
been used to study the layer by layer formation of polymer films as described in 
Chapter 5.  
 
2.3.2 Fourier Transform Infrared Spectroscopy 
Fourier transform infrared spectroscopy (FT-IR) employs the IR radiation through the 
sample under study. In such a situation, some of the radiations are absorbed by the 
sample while some are transmitted. Consequently, a spectrum is generated which 
represents a molecular fingerprint of the sample under study as a result of absorption 
and transmission of IR. Absorption peaks represented in the spectrum correspond to 
the frequencies of vibrations between atom bonds making up the material under study 
(Alben and Fiamingo 1984; Faix 1992; Stuart 2005). Since no two unique molecular 
structures produce the same spectrum, FT-IR becomes a useful analytical technique 
for characterisation. 
FT-IR spectrometry was developed in order to simultaneously measure all of the IR 
frequencies. By employing an interferometer, which is a simple optical device, such a 
simultaneous measurement could be performed. An interferometer in principle can 
produce a signal with all the IR frequencies encoded in it. A FT-IR instrument consists 
of a source, an interferometer, a sample, a detector and a computer. The source is 
employed to emit an IR energy, the beam produced is passed through an aperture 
which is used to modulate the amount of energy that will be exposed to the sample 
under study. 
The beam enters the interferometer where the beam is split into two optical beams 
using a beam splitter. The beams, after passing through their respective mirrors, 
combine again at the beam splitter producing an interferogram. An interferogram 
consists of the unique property of each data point which makes up the final signal 
(about each IR frequency). 
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The beam later passes through the sample where parts of the beams are reflected or 
transmitted by the sample giving it the characteristics of that particular sample. The 
resultant beam is finally passed to the detector for the final measurements. Through a 
computer, Fourier transformation of the detected spectrum is performed which 
involves decoding of all the frequencies and converting into a user-friendly spectrum 
output.  
In order to study thin films, powders, polymers or even strongly absorbing materials, 
Attenuated total reflectance (ATR) technique is used in conjunction with FT-IR 
spectroscopy. ATR-FTIR is different from other spectroscopic techniques as it 
depends on total internal reflection along with attenuation of a total reflection.  
The ATR crystal simply comprises an IR transparent material with a high RI and 
polished surfaces as shown in Figure 2.17. 
 
Figure 2.17 Attenuated Total Reflection (ATR) principle. 
 
The IR beam enters the ATR crystal at an incident angle of typically 45° (relative to 
the crystal surface) and therein is totally reflected at the crystal to sample interface. 
Because of the wave-like property of the incident beam, the light is reflected by a 
virtual boundary surface and not directly by the boundary surface. The virtual 
boundary lies within the optically less dense sample. Such an effect is called the Goos-
Hänchen effect. Such an effect refers to the lateral displacement of an incident wave 
under a total internal reflection effect that occurs at the interface of two mediums with 
different RI. During ATR, there is a fraction of light that reaches into the sample under 
study and is known as an evanescent wave. Lateral displacement occurs as a result 
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from the propagation of an evanescent wave parallel to the interface. The penetration 
depth of the resultant evanescent wave depends on the wavelength, the RI of the ATR 
crystal and the sample and angle of the entering light beam. The evanescent wave 
decays exponentially up to a few microns (ca. 0.5 - 5 μm) from the surface. In the 
spectral regions of IR, where the sample absorbs only certain energy, the evanescent 
wave is attenuated and is measured by the detector. After internal reflections, the IR 
beam exits the crystal and is captured by the IR-detector.  
FT-IR in this thesis has been employed to study the surface modification of 
polypyrrole on gold electrodes. It was used as a validation technique to confirm the 
electrodeposition of PEG on polypyrrole films as described in Chapter 5. 
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 Aptamer-based impedimetric 
sensing of PSA 
 
This Chapter will provide a presentation on the development of an aptasensor for the 
detection of PSA, which is currently the gold standard for PCa biomarkers. The study 
will focus on EIS as a detection technique and 
SPR as a validation tool. The Chapter will 
highlight the effect of buffer conditions on the 
EIS signal, the effect of anti-PSA DNA 
aptamer surface density on PSA binding 
efficiency, the transition from 6-mercapto-1-
hexanol (MCH) to thiol terminated sulfo-
betaine based self-assembled monolayer 
(SAM) for enhanced antifouling properties.  
The work presented in this Chapter has been published in Formisano et al. (Formisano 
et al. 2015) and Jolly et al. (Jolly et al. 2015) 
 
3.1 Background 
In recent years, a range of assays for PSA such as electrochemical assays (Okuno et 
al. 2007; Panini et al. 2008), enzyme-linked immunosorbent assay (Acevedo et al. 
2002), cantilever assay (Wee et al. 2005), and chemiluminescent immunoassay 
(Albrecht et al. 1994; Seto et al. 2001) have been developed which are mostly based 
on antibodies as recognition elements. In this study, instead of using antibodies, an 
anti-PSA DNA aptamer (Chapter 1, Figure 1.6a) was utilised as a molecular 
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recognition element to detect PSA. Since the development of an anti-PSA DNA 
aptamer by Savory et al. (Savory et al. 2010) in 2010, only one group reported the 
detection of PSA using anti-PSA DNA aptamers (Liu et al. 2012). Gold nanoparticles 
(AuNPs) were used for the layer by layer construction of a PSA aptasensor. AuNPs 
were encapsulated by graphitized mesoporous carbon and bovine serum albumin 
(BSA) was used as a blocking molecule to reduce non-specific binding (Liu et al. 
2012). Affinity-based immobilisation for DNA aptamer was used for the fabrication 
process. Amperometric techniques namely, cyclic voltammetry (CV) and differential 
pulse voltammetry (DPV) were used as measurement techniques with a limit of 
detection (LOD) of 0.25 ng/mL (or 7.58 pM).  
To develop sensitive and selective electrochemical aptasensors, electrode surface 
chemistry is one of the biggest fields of investigation. Research worldwide is typically 
focussed on finding the most suitable recognition platform to give a stable 
organization to the sensor interface leading to optimised binding efficiency and signal 
outcome (Lee et al. 2005; Putzbach and Ronkainen 2013). For sensing applications, 
shorter thiols are normally preferred to provide partial access to the redox markers to 
an underlying metal surface. In contrast, such a mechanism might not hold true for 
every application like the development of aptasensors, where the length of the linker 
can have an effect on target binding to its respective aptamer (Balamurugan et al. 
2006).  
With the motivation to develop a simple fabrication strategy, a simple and sensitive 
PSA aptasensor is reported in this Chapter by employing a new type of thiol terminated 
sulfo-betaine molecules. Furthermore, a demonstration of electrochemical 
measurement using the constructed PSA aptamer biosensor is given and discussed. 
 
3.2 Bio-functionalisation on gold surface 
Prior to bio-functionalisation, gold disk working electrodes with a radius of 1.0 mm 
(ALS, Japan) were cleaned using mechanical polishing, followed by electrochemical 
cleaning as described by Keighley et al. (Keighley et al. 2008b). First, the electrode 
surfaces were mechanically polished for 2 minutes with 1 µm diamond solution 
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(Buehler, USA) and thereafter for 5 minutes with 50 nm alumina slurry (Buehler, 
USA) on respective polishing pads (Buehler, USA). A sonication process for 10 
minutes between each step was performed, followed by rinsing with MilliQ water in 
order to remove any remaining particles. Electrodes were then subjected to 
electrochemical cleaning in 0.5 M H2SO4 (Sigma, UK) by scanning the potential 
between the oxidation and reduction of gold, −0.05 V and +1.1 V versus an Ag/AgCl 
reference electrode (RE), for 50 cycles until there was no further change observed in 
the voltammogram. The electrochemical cleaning was performed using a three-
electrode cell setup with gold electrodes as WE with a μAUTOLAB III/FRA2 
potentiostat (Metrohm Autolab, Netherlands). Ag/AgCl (KCl) was used as a RE 
(BASi, USA) connected via a salt bridge filled with 10 mM PBS, pH 7.4 (prepared 
from Tablets, Sigma, UK) and a Pt counter electrode (ALS, Japan). After 
electrochemical cleaning, electrodes were washed with a surplus amount of MilliQ 
water to remove any acid residues. Finally, electrodes were cleaned with ethanol and 
were left to dry in a dustless environment for several minutes. 
In this study, two different PSA aptasensors based on thiol surface chemistry are 
presented. For successful EIS measurement, it is necessary to have a good reliable 
SAM on the gold electrode surface in order to have a reproducible sensor.  One of the 
most accepted approaches to achieve this goal is by alkanethiol chemistry as described 
in Chapter 2. Alkanethiols can be easily adsorbed and form a SAM (Love et al. 2005) 
on a clean gold surface through gold-sulphur bonds. For the study, all aqueous 
solutions were prepared using 18.2 MΩ cm ultra-pure water (MilliQ) with a Pyrogard 
filter (Millipore, UK) and all other reagents were of analytical grade.  
 
3.2.1 SAM with thiolated anti-PSA DNA aptamers 
The first SAM studied comprised of a thiol-terminated anti-PSA DNA aptamer (5′-
HS-(CH2)6-TTT TTA ATT AAA GCT CGC CAT CAA ATA GCT TT-3′ (synthesised 
by Sigma, UK) and MCH (Sigma, UK) in different ratios, immobilised on clean gold 
electrodes (Figure 3.1).  
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Clean gold electrodes were exposed to 150 μL of mixed anti-PSA DNA aptamer/MCH 
immobilisation solution for 16 hours in a humidity chamber at 4˚C. The DNA 
immobilisation solution consisted of immobilisation buffer (Table 3.1) with a 
calculated amount of anti-PSA DNA aptamers and MCH. 
 
Figure 3.1 Self assembled monolayer (SAM) of co-immobilised thiolated anti-PSA DNA aptamer with 6-
mercapto-1-hexanol (MCH) on gold surface (before and after binding of PSA). 
 
A high concentration of MCH (10 mM) was prepared in pure ethanol (HPLC grade, 
Sigma, UK) which was diluted to working concentration in immobilisation buffer and 
binding buffer respectively. 
Table 3.1 Buffers used and their composition 
Buffer  Composition 
Immobilisation 
buffer 
10 mM Tris-HCl containing 10 mM KCl, 10 mM MgCl2 (pH7.4) 
Binding Buffer  0.1 M phosphate buffer (PB) solution containing 0.1 M KCl and 0.05% Tween20 (pH 
7.4) 
Measurement buffer 10 mM ferro/ferricyanide [Fe(CN)6]3-/4- in 0.1 M phosphate buffer (PB) solution 
containing 0.1 M KCl (pH 7.4) 
*All the chemicals used for buffer preparation were purchased from Sigma, UK 
 
Prior to the addition of MCH, anti-PSA DNA aptamers were heated to 95˚ C for 10 
minutes followed by gradual cooling over half an hour to room temperature to fold 
stable structures of aptamers (Savory et al. 2010). After immobilisation, electrodes 
were rinsed with MilliQ water to remove any unattached anti-PSA DNA aptamers and 
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MCH. In order to ensure complete thiol coverage of the gold surface, the electrodes 
were thereafter backfilled with 1 mM MCH for 1 hour. Electrodes were then rinsed 
with MilliQ water and placed in the binding buffer for 1 hour to stabilise the SAM. 
Anti-PSA DNA aptamer/MCH immobilisation solutions were prepared in the range 
of ratios from 1:9, 1:49, 1:99, 1:199 and 1:499 to optimise the anti-PSA DNA aptamer 
surface coverage for maximum binding efficiency.  
 
3.2.2 SAM with amine terminated anti-PSA DNA aptamers 
In the second part of the Chapter, a new molecule called thiol terminated sulfo-betaine 
((R)-3-((2-(5-(1,2-dithiolan-3-yl)pentanamido)ethyl)dimethylammonio)propane-1-
sulfonate) has been used for the development of a PSA aptasensor. Thiol terminated 
sulfo-betaine was synthesised as a 398.60 g/mole molecule according to a previously 
published method (Bertok et al. 2013). It contains both positive and negative charges 
and acts like a zwitterion (Figure 3.2). It has been previously reported as a potential 
candidate to reduce non-specific binding and increase the sensitivity of the sensor 
performance. However, there has been no application with aptamers reported to date. 
 
Figure 3.2 Chemical structure of thiol terminated sulfo-betaine. 
 
For the aptasensor fabrication, clean gold electrodes were immersed in a 1 to 99 ratio 
of two thiols (11-Mercaptoundecanoic acid, MUA (Sigma, UK): thiol terminated 
sulfo-betaine) and incubated for 16 hours. A stock solution of 10 mM MUA was 
prepared in pure ethanol (HPLC grade) and a stock solution of thiol terminated sulfo-
betaine was prepared in water. All the solutions were prepared fresh before use. These 
two thiols form the SAM layer as shown in Figure 3.3. The electrodes were rinsed 
with MilliQ water and prepared for the second step of modification which involved 
attachment of the bio-recognition element. 
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Amine terminated anti-PSA DNA aptamer (5′-NH2-(CH2)6-TTT TTA ATT AAA 
GCT CGC CAT CAA ATA GCT TT-3′, synthesised by Sigma, UK) was immobilised 
using standard amine coupling reaction with the carboxylate groups (Hermanson 
2013).  
 
Figure 3.3 Fabrication schematic with amine terminated anti-PSA DNA aptamers. 
 
The carboxylate groups of MUA are activated by a mixture of 0.2 M N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, Sigma, UK) and 
0.05 M N-hydroxysuccinimide (NHS, Sigma, UK). The reaction follows the 
conventional coupling principle as shown in Figure 3.4. The carboxylate groups of 
MUA are activated by a cross-linker (EDC), which forms a highly reactive 
intermediate called O-acylisourea. Such an intermediate is highly unstable in aqueous 
solution and undergoes hydrolysis in a few seconds. Yet, this can be overcome by 
using NHS in the reaction, which reacts with the O-acylisourea and forms another 
intermediate product with an active ester functional group demonstrating enhanced 
stability in aqueous media. Finally, in the presence of a primary amine (such as in our 
case, an amine terminated anti-PSA DNA aptamer), the sulfo-NHS group can be 
replaced leading to the formation of a stable amide bond.  
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Figure 3.4 Principle of EDC/NHS chemistry on MUA using amine terminated anti-PSA DNA aptamers (adapted 
from Hermanson et al. 2013). 
 
The electrodes were incubated in a mixture of EDC/NHS for 20 minutes followed by 
incubation with 1 µM amine-terminated anti-PSA DNA aptamer prepared in binding 
buffer for 2 hours leading to covalent attachment of aptamers on the activated SAM. 
Later, the electrodes were washed with MilliQ water and incubated with 1 M 
ethanolamine (pH 8.5, Sigma, UK) for half an hour to block all the un-reacted sites of 
MUA. Finally, the electrodes were rinsed with MilliQ water and placed in the binding 
buffer for stabilization for 1 hour. 
 
3.3 Effect of changing buffers on stability of SAM 
Before any investigation on the efficiency of an aptasensor to detect the analyte of 
interest via EIS measurement, it is important to understand the dynamics of the SAM 
on the EIS signal itself. Therefore, a study was performed with both types of fabricated 
PSA aptasensor, namely SAM with MCH and SAM with thiol-terminated sulfo-
betaine, to investigate the stability of the SAM when incubated in two different 
buffers. In order to obtain reliable data from an EIS measurement, it is vital to monitor 
the stability of the aptasensor. It is often reported in the literature that the binding of 
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proteins to aptamers is performed in a different buffer from the measurement buffer. 
Hence, we investigated if the change in Rct values of the fabricated sensor was due to 
the binding of protein and not because of buffer effects. These samples were tested 
first of all for stability in 0.1 M PB (pH 7.4) containing 0.1 M KCl. Measurements 
were then taken in 0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]
3-/4- and 0.1 M KCl. 
Figure 3.5 (left) represents the time that an electrode can take to give stable Rct values 
without the addition of any protein. It should be noted that the stabilisation time profile 
depends on the surface chemistry and buffers used. The total time for stabilisation of 
the sensor can be minimised by careful sensor design and storage conditions. Once a 
stable Rct has been recorded as shown in Figure 3.5, electrodes were then immersed in 
10 mM Tris-HCl (pH 7.4 containing 10 mM KCl, 10mM MgCl2 and 0.05% Tween20 
for 30 minutes.  
 
Figure 3.5 Left Graph representing the change in Rct of an electrode over 30 minutes interval time in 0.1 M PB 
(pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl (n=1). Right represents effect of change in buffer 
conditions on SAM stability with MCH functionalised electrodes (left) and Sulfo-betaine functionalised (right)in 
0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl. Electrodes were first immersed for 30 
minutes in 10mMTris-Hcl (pH7.4 containing 10mMKCl, 10mM MgCl2 and 0.05% Tween20 and then EIS 
measurement was performed in 0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl. The error 
bars represent the standard deviation obtained for three samples. 
 
The EIS measurement was again recorded and the results obtained from both 
aptasensors are represented in the Figure 3.5 (right). It can be clearly seen that 
regardless of the surface chemistry used, the buffer can cause instability of the SAM 
which is reflected in the change in Rct of the system. One of the reasons for such 
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instability could be due to changes in the ionic strength of the buffers used. As 
indicated, both of the aptasensors were stabilised in 0.1 M PB containing 0.1 M KCl 
which is a result of equilibrium in dynamics of the SAM in the buffer. However, if the 
ionic strength is changed, such as in this case by using 10 mM Tris-HCl, there is a 
change in the dynamics of the SAM. Such a disturbance could be attributed to the 
rearrangement of the SAM comprising of anti-PSA DNA aptamers. Hence, it is very 
important to maintain the same buffer conditions throughout the EIS measurement in 
order to obtain reliable data. 
 
3.4 Effect on Rct on binding of PSA with DNA aptamer 
Co-immobilisation of thiol-terminated anti-PSA DNA aptamers and MCH onto gold 
electrodes was used to fabricate functional electrodes for PSA detection as described 
in the previous section. The EIS measurements were performed using a µAUTOLAB 
III potentiostat (Metrohm AG) using a three-electrode cell configuration with SAM 
functionalised gold electrodes as a WE and a Hg/Hg2SO4 and a Platinum wire as RE 
and CE, respectively. The impedance spectrum was measured in measurement buffer 
within a frequency range 100 kHz to 100 mHz, with a 10 mV a.c. voltage 
superimposed on a bias d.c. voltage of 0.195 V vs. Hg/Hg2SO4 (corresponding to the 
formal potential of the redox couple). The RE was connected via a salt bridge filled 
with 0.1 M PB containing 0.1 M KCl (pH 7.4). 
With these electrodes, Nyquist plots for the system were recorded in an EIS 
measurement (see example of typical curve in Figure 3.6), where the Rct of the SAM 
prepared (co-immobilised DNA aptamer and MCH) was determined by fitting the data 
to the simple Randles equivalent circuit as described in Chapter 2 (Bard and Faulkner 
2001; Keighley et al. 2008b). 
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Figure 3.6 EIS characteristics for anti-PSA DNA aptamer/MCH functionalised gold electrodes in 0.1M 
phosphate buffer (PB) solution containing 0.1 M KCl (pH 7.4) containing 10 mM ferro/ferricyanide [Fe(CN)6]3-
/4-. Reduction in Rct was recorded on binding of PSA with anti-PSA DNA aptamer in binding buffer for 30 
minutes. The PSA concentration was 10 µg/ml (Jolly et al. 2015). 
 
For binding studies, different concentrations of PSA (Merck Chemicals Ltd., UK) 
were prepared in the binding buffer using the standard PSA stock solution received 
from the company. Upon incubation with 10 µg/mL PSA, a reduction of 13% in Rct 
was observed reflecting binding with anti-PSA DNA aptamers (Figure 3.6). This 
decrease obtained is contradictory to what has been reported by Liu et al. (Liu et al. 
2012) for PSA where an increase in Rct has been observed. Nevertheless, a reduction 
of Rct upon aptamer-analyte interactions has also been reported earlier in literature. 
For example in 2005, Rodriguez et al. reported the development of an aptasensor to 
detect lysozymes, where a decrease in Rct upon binding of the lysozyme to its specific 
anti-lysozyme DNA aptamer was attributed mainly due to the screening of charges on 
the DNA aptamer (Rodriguez et al. 2005). More recently, Miodek et al. in 2015 
reported development of a thrombin aptasensor based on a ternary SAM where again 
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a reduction in Rct upon binding of thrombin was reported at lower analyte 
concentrations (Miodek et al. 2015).  
Such a reduction in Rct could be attributed to many factors. Zhang et al. in 1995 
characterised total PSA from the human seminal fluid, reporting an isoelectric point 
of PSA between 6.8 and 8 depending on the amount of glycosylation (Wang et al. 
1981; Zhang et al. 1995). Since the measurements were performed in pH 7.4, it is 
likely that PSA is neutrally charged. However, PSA might screen the charges of the 
anti-PSA DNA aptamer upon the binding event. Eventually, it could be that more 
positive charges are exposed outwards because of the protein architecture and the 
binding itself, which could result in a reduction on the electrostatic barrier to the 
ferro/ferricyanide anions towards the electrode surface, leading to lowering of the Rct 
value of the system. 
 
3.5 Effect of Surface coverage on PSA binding 
Optimisation of probe density on the electrode surface plays a very crucial role for 
good biosensor performance. Surface coverage and spacing of probe molecules are 
dependent on the concentration of the co-immobilised probes with other thiol 
components. One can assume that there is a dynamic competition between different 
thiol components until equilibrium is attained. For optimal concentrations of thiol, 
there is a trade-off between the surface density of the thiolated bioreceptors and the 
capture efficiency for the analyte, so that the best signal output is achieved. For 
instance, in DNA detection, as reported in the literature, the maximum percentage 
change in Rct upon hybridisation with fully complementary target oligonucleotides was 
obtained with samples functionalised with 20% mole fraction of PNA probes 
(Keighley et al. 2008b). When using DNA probes, the mole fraction reduced to 10% 
(Keighley et al. 2008a). Furthermore, Biogiotii et al. in 2012 reported the effect of 
surface density of ssDNA probes on the nuclease digestion (Biagiotti et al. 2012). 
Therefore, a similar investigation was carried out with PSA aptasensors to better 
evaluate the aptasensor and the aptamer itself. Dose response with different ratios of 
DNA aptamers to MCH can be found in Formisano (2015). 
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It can be assumed that steric hindrance can majorly affect the binding efficiency of 
PSA to an anti-PSA DNA aptamer when confined to an electrode surface. Because of 
folding of the DNA aptamers upon binding of PSA, steric hindrance can be a limiting 
factor and affect binding. Furthermore, steric hindrance can also take place because of 
the size of the protein (PSA) and also the spacing is needed so that PSA is able to 
identify the sequence on the anti-PSA DNA aptamer for binding. Hence, a range of 
anti-PSA DNA aptamer mole fractions were studied. 
The variation of the initial Rct of the electrodes, as determined by EIS, with the mole 
fraction of anti-PSA DNA aptamer to total thiol (DNA aptamer + MCH) in the 
immobilisation solution is shown in Figure 3.7. EIS measurements show increasing 
values of initial Rct as the amount of DNA aptamers is increased: 1.06 ± 0.04 kΩ, 0.7 
± 0.15 kΩ, 1.63 ± 0.16 kΩ, 1.86 ± 0.16 kΩ and 11.90 ± 0.17 kΩ for 0.002, 0.005, 0.01, 
0.02 and 0.1 mole fraction of DNA aptamer to total thiol respectively. Although it is 
expected that the lower the DNA aptamer mole fraction, the lower the initial Rct, the 
results obtained with 0.002 mole fraction were contradictory. The reason could be that 
at 0.002 DNA aptamer mole fraction, the SAM formed is more homogenous compared 
to 0.005 mole and thus increases the initial Rct. 
These fabricated samples were then studied for their binding efficiency with PSA in 
terms of change in Rct characterised by EIS. The results are represented in Figure 3.7. 
PSA concentration of 10 µg/mL was chosen to perform the comparative analysis 
between the different DNA aptamer mole fraction fabricated sensors. At the highest 
mole fraction of DNA aptamer studied, i.e. 0.1 DNA aptamer mole fraction, a 
negligible signal change of 0.9% + 1.2 (data not presented in the graph) was recorded 
mainly because the DNA aptamers were densely packed on the electrode surface 
leading to steric hindrance. The signal change detected increased when the DNA 
aptamer concentration was lowered and the best results were recorded with 0.01 DNA 
aptamer mole fraction with nearly 14% change. 0.002 DNA aptamer mole fraction 
showed higher signal change compared to 0.005 for the same reason as already 
explained for initial Rct values. The large standard deviation seen on the bar graph can 
be attributed to sample to sample variation since at such a low concentration of DNA 
aptamers, even a slight variation between samples in the number of DNA aptamers 
  
Chapter 3  88 
 
immobilised on the electrode surface can have a significant effect on the number of 
PSA molecules binding to it. 
  
 
Figure 3.7 Initial Rct of fabricated PSA aptasensor (right axis) over a range of DNA aptamer mole fraction 
measured in 10 mM ferro/ferricyanide [Fe(CN)6]3-/4- in 0.1M phosphate buffer (PB) solution containing 0.1M 
KCl (pH 7.4) using EIS . Change in percentage Rct of fabricated PSA aptasensor (left axis) over a range of DNA 
aptamer mole fraction measured after 30 minutes incubation with 10 ug/ml PSA. The error bars represent the 
standard deviation obtained for three samples. 
 
The EIS signal recorded is a cumulative effect of many factors such as mass loading, 
screening of charges, ionic strength, etc. Therefore, a similar study to investigate the 
effect of DNA aptamer mole fraction for PSA detection was performed by another 
technique called Quartz Crystal Microbalance with Dissipation mode (QCM-D), 
which has been reported by Formisano et al.(Formisano et al. 2015). Experiments with 
QCMD technique were performed and optimised by Formisano (2015). Unlike EIS, 
QCM-D measurements are not expected to be affected by conformational changes of 
the DNA aptamer. The QCM-D response is a result of the change in oscillating 
frequency that is more dependent on the changes in mass bound to the crystal. 
Furthermore, QCM-D results confirmed a similar effect of surface density of DNA 
aptamers on PSA binding. It is worth mentioning that a control protein called human 
serum albumin (HSA, Sigma, UK) was used to investigate non-specific binding. From 
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demonstrated a clear distinction between specific binding of PSA and non-specific 
binding of HSA up to 400 nM.  
 
Figure 3.8 Dose response with thiolated anti-PSA aptasensor for different PSA concentrations in 0.1 M PB (pH 
7.4) containing 10 mM [Fe (CN) 6]3−/4− and 0.1 M KCl. PSA incubation time was for 30 min. The error bars 
represent the standard deviation obtained for three samples. 
 
Using 0.01 DNA aptamer mole fraction, a complete dose response was performed 
using PSA concentrations from a range of 0.01 ng/mL to 10 µg/mL (Figure 3.8). From 
the dose response, it can be seen that the aptasensor fabricated could potentially detect 
PSA above the range of 60 ng/mL (or 2 nM), which is 6 times higher than the upper 
limit of any clinical PSA range in blood.   
Although the sensitivity of the sensor was not within the clinical range, it was worth 
studying the antifouling efficiency of the fabricated aptasensor. The antifouling 
efficiency depends highly on the composition of the SAM. Therefore, the next stage 
of the investigation was to use the samples fabricated with optimised DNA aptamer 
































Chapter 3  90 
 
HSA, being the most abundant protein found in human blood was used as a suitable 
candidate as a control protein. Upon exposing the aptasensor to 100 µM HSA, an 
increase in the Rct value of around 12.5% was recorded (Figure 3.9). Such an effect 
could be a blocking effect due to occupancy of free MCH spaces on the sensor surface 
by HSA molecules. With the non-specific attachment of HSA, there is an increased 
physical barrier to redox couples in the solution to reach the sensor surface and thus 
increasing the Rct of the system.   
 
Figure 3.9 EIS characteristics for DNA aptamer/MCH functionalised gold electrodes in 10 mM 
ferro/ferricyanide [Fe(CN)6]3-/4- in 0.1M phosphate buffer (PB) solution containing 0.1 M KCl (pH 7.4) before 
(black) and after (red) incubation with 100 µM HSA (red) as a consequence of non-specific binding. 
 
Although it is quite interesting that the PSA aptasensor could potentially differentiate 
HSA from PSA, in a more complex medium like blood this could lead to decreased 
sensitivity. Instead, a high concentration of HSA could be used to block the potential 
sites for non-specific binding and then these samples could be used to detect PSA in 
real blood samples. Such a step would minimise further binding of non-specific 
proteins and hence reduce fouling. The possibility of which needs further investigation 
to discern whether blocking with HSA will decrease binding of PSA with DNA 
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aptamer or not. However, it is not preferred in an ideal biosensor for clinical 
applications. In fact, fouling of biosensor surfaces in the form of protein adsorption 
poses serious challenges which can reduce the sensitivity of the device. To mitigate 
such a biofouling effect, surfaces can be modified with polymer brushes like PEG, 
polyzwitterions, polysaccharides and even polypeptoids (Banerjee et al. 2011).  
 
3.6 Electrochemical analysis with amine terminated DNA 
aptamers 
The results obtained in the previous section led us to the next step of using a new 
spacer molecule called thiol terminated sulfo-betaine (sulfo-betaine) which has been 
reported for its antifouling capabilities (Bertok et al. 2013b) . Zwitterionic SAMs are 
a promising class of antifouling brushes that could be used as an alternative to widely 
used PEG surfaces (Holmlin et al. 2001; Kane et al. 2003; Kuang and Messersmith 
2012). Various literature has reported the use of sulfo-betaine methacrylate and 
carboxy-betaine methacrylate, demonstrating enhanced anti-fouling performance 
comparable or even better than PEG (Yang et al. 2008; Zhang et al. 2006). In this 
particular setup, a derivative of sulfo-betaine was used to prepare a mixed SAM with 
MUA. Finally, amine terminated anti-PSA DNA aptamers were immobilised via 
conventional EDC/NHS coupling agents through an amide link.  
 
3.6.1 Co-immobilisation of sulfo-betaine with thiolated DNA aptamers  
During the course of investigating sulfo-betaine as a possible molecule to fabricate 
aptasensors with antifouling effects, it was also interesting to determine if sulfo-
betaine can be co-immobilised with thiolated DNA aptamers directly on the gold 
surface. The reason was to ease the immobilisation protocol by excluding multiple 
steps to just one step fabrication. Also, it would eradicate the effects of rate of diffusion 
because of different solvents. Samples fabricated in this way were characterised by 
EIS. A very low initial Rct in the range of 30-60 ohms was recorded. This very low Rct 
indicates that the SAM formed on the gold surface is not a compact layer, leading to 
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the non-homogeneous surface. As a consequence, there is easy diffusion of redox 
couples to the gold surface causing low initial Rct values.  
 
3.6.2 EIS characterisation of aptasensors with amine terminated aptamers 
The Nyquist plots obtained with the sulfo-betaine system do not follow the 
conventional Randles equivalent circuit (Figure 3.11). Instead, two semi-circles are 
observed, which can be represented by the equivalent circuit in Figure 3.10. The 
reasons for dual semi-circles could be explained by the processes happening during 
the immobilisation step. The sulfo-betaine solution was prepared in MilliQ water and 
MUA in pure ethanol. When these two solutions were mixed together to prepare the 
immobilisation solution, the efficiency of immobilised molecules on the surface was 
governed by the diffusion factor. As such there could be areas on the gold surface 
confined to sulfo-betaine and also areas confined to MUA causing the presence of two 
semi-circles in the Nyquist plots. 
For the study, 1% MUA mole fraction was used to prepare the first SAM layer based 
on the results from section 3.5. However, it should be noted that the final concentration 
of DNA aptamers will be less than 1% depending on the efficiency of covalent 
coupling via EDC/NHS. An attempt to optimise the surface coverage was performed 
by changing the ratio of MUA to sulfo-betaine, however, the outcome proved it to be 
challenging. It was assumed that the different diffusion rates of MUA and sulfo- 
betaine, and the flexibility of the sulfo-betaine chain, were the main factors affecting 
the density of DNA aptamer on the surface. Adding to this, the efficiency of the 
EDC/NHS coupling reaction also plays a vital role. As a consequence, there was a 
large difference in the initial Rct from sample to sample.  
Nevertheless, these functionalised electrodes were used to detect PSA. The Rct of the 
SAM prepared with amine terminated DNA aptamers was determined by fitting data 
to a modified Randles equivalent circuit shown in Figure 3.10. We assume the first 
SAM layer to be constant, which is reflected by the semi-circle of a higher frequency 
range while the Rct was obtained from the second semi-circle at lower frequencies, 
which can be attributed to a SAM layer that changes with PSA binding. 
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Figure 3.10 Modified Randles equivalent circuit to represent SAM prepared with amine terminated DNA 
aptamers. 
 
For better evaluation of the PSA aptasensor, a complex capacitance was also defined, 
as explained in Chapter 2. Figure 3.11b represents a Cole-Cole capacitance plot using 
EIS data obtained at high frequencies before and after PSA binding. A fast capacitive 
process is observed at high frequencies represented by a semi-circle, followed by an 
ultra-slow process represented by a larger semicircle (Roling et al. 2012). Such a 
phenomenon is typical of impedance based sensors using redox couples in the 
electrolyte (Fernandes et al. 2014). Assuming that the impedance of the system is 
dominated by the electrostatic potential barrier of the DNA aptamer layer towards the 
negatively charged redox marker in the electrolyte, the increase of conductive paths 
upon binding with PSA could be attributed to the reduction in the net charge of the 
biolayer and, therefore, consistent with the hypothesis of DNA charge screening by 
PSA. 
 
3.6.3 Dose response with sulfo-betaine/MUA surface chemistry 
Electrodes functionalised with amine-terminated anti-PSA DNA aptamers via 
EDC/NHS coupling on a mixed SAM layer of MUA and sulfo-betaine were used for 
the dose response study with different concentrations of PSA. The EIS characteristics 
recorded for different PSA concentrations are represented in Figure 3.11. Generally, 
two semicircles are observed in the Nyquist plot, a small semicircle, and larger 
semicircle at high and low frequencies respectively. The small semicircle obtained at 
high frequencies, could have been due to relaxation effects of the SAM (Fernandes et 
al. 2014). The Rct recorded from the first semicircle remains relatively constant (ΔRct 
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< 5%) throughout the experiments. As with the aptasensor in section 3.4, again a 
negative signal change was recorded on binding with PSA. 
 
Figure 3.11 Left graph representing EIS characteristics for amine terminated functionalised gold electrodes 
(blue) in 10 mM ferro/ferricyanide [Fe(CN)6]3-/4- in 0.1M phosphate buffer (PB) solution containing 0.1 M KCl 
(pH 7.4).A decrease in Rct on incubation with different PSA concentration was recorded. Right graph 
representing the Cole-Cole capacitance plots for higher frequencies. Incubation of functionalised sensor with 
PSA concentration was 30minutes. 
 
Since, sulfo-betaine and MUA are considerably longer than MCH, we observe 
significantly higher values of Rct than what has been reported in section 3.5. A dose 
response curve with different concentrations of PSA is shown in Figure 3.12. The 
binding curve obtained follows a Freundlich-type of equation (ΔRct/Rct∝ [PSA]n) until 
1000 ng/ml, after which it slowly tends to saturation. With this configuration, the 
sensitivity was increased and it was possible to detect PSA concentrations lower than 
1 ng/mL (around 33 pM). By increasing the linker size from C6 spacer to C17 spacer 
(MUA+C6), it is possible that we have also increased the binding efficiency of the 
aptasensor (Balamurugan et al. 2006). However, the signal change recorded at lower 
PSA concentrations was relatively small. The reason for such a small signal change 
could be the net effect of different processes happening at the molecular level. The 
first dominating event happening is the change in the conformation of DNA aptamers 
on binding with PSA which should result in an increase in Rct. 
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Figure 3.12 Dose response for amine terminated functionalised gold electrodes with different PSA 
concentrations in 0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl. The error bars represent 
the standard deviation obtained for four samples. 
 
Our assumption is that at such low concentrations of DNA aptamer, it is likely that all 
the aptamers are already in their stable folded conformation and hence leading to the 
effect of DNA aptamer conformational changes on Rct is no longer observed. In 
addition, there is the screening of negative charges of DNA aptamers upon binding 
with PSA resulting into reduction in Rct. On the other hand, a competitive effect might 
be observed to the binding of PSA molecules resulting into a further passivation of the 
electrode, which can hinder the access of the redox probes to a close distance of the 
electrode and hence increase in Rct. The charges of protein also add on to Rct values, 
which may be on either direction depending on the protein surface charge. 
Consequently, the net Rct of the system depends on the combination of all the factors. 
Nevertheless, when compared with MCH chemistry, a 60 fold increase in the 
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3.6.4 Dose response using surface plasmon resonance  
Surface plasmon resonance (SPR) experiments were carried out in a dual-channel 
SPR7000DC from Reichert Technologies (USA). Gold coated SPR sensors were 
immobilised in situ with the anti-PSA DNA aptamer as per the described method in 
section 3.2.2, using thiol-terminated sulfo-betaine. Measurements were carried out in 
10 mM PBS with 0.05% Tween 20 under flow conditions at 25 °C. The flow rate was 
kept constant at 25 µl/min upon injection of different protein concentrations, allowing 
20 minutes for binding followed by 5 minutes for dissociation of unbound protein.  
The binding of the aptamer with PSA was validated by means of SPR data. Using the 
same surface immobilisation process as for the sulfo-betaine impedimetric 
aptasensors, the SPR signal was monitored upon injection of different concentrations 
of PSA. Figure 3.13 shows the SPR equilibrium response values for each PSA 
concentration. A typical hyperbolic dose response is observed: y = ymax * c/(Kd+c) 
where c is the concentration and Kd the affinity constant.  
  
Figure 3.13 Left shows an example of characteristic SPR curves with 1 ng/mL and 25 ng/mL of PSA. Right shows 
the variation in the equilibrium SPR signals with respect to the baseline for different concentrations of PSA. 
Measurements were carried out in 10 mM PBS with 0.05% Tween 20. The line is a fit of the data to a hyperbolic 
dose response equation. The error bars represent the standard deviation obtained for three samples. 
 
Fitting the data yields an affinity constant of Kd = 9.50 ± 0.47 ng/ml (or 0.29 nM) with 
a root mean square (RMS) value of 0.99. To the best of the author’s knowledge, this 
is the first time that a value of Kd was calculated by any research group. After this 
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work was published, many research groups have reported the Kd value of anti-PSA 
DNA aptamer which lies in nM range depending on the immobilisation and detection 
techniques (see Table 3.2 and Table 4.4).  
 
3.6.5 Antifouling properties of sulfo-betaine surface chemistry 
After successful sensitive detection of PSA, electrodes with sulfo-betaine surface 
chemistry were studied for non-specific adsorption. Again 100 µM HSA (circa 67 
µg/mL) was used as a control protein. HSA was incubated with amine-terminated 
DNA aptamers functionalised electrodes and the results were compared with 
electrodes modified with thiolated DNA aptamers (Figure 3.14).  
The results clearly indicate a significant difference in Rct change between SAM 
prepared with sulfo-betaine and SAM prepared with MCH. Furthermore, a negligible 
signal change (< 1%) was recorded where sulfo-betaine was used to prepare the SAM, 
as compared to a high Rct change with the SAM composed of MCH. Such an enhanced 
antifouling effect could be predominantly due to the creation of a hydration layer by 
sulfo-betaine moieties since zwitterions bind strongly to water (Figure 3.15). Such a 
hydration layer prevents proteins to penetrate through the water layer and adsorb on 
the surface (Tegoulia et al. 2001; White and Jiang 2010).  
 
 
Figure 3.14 Change in Rct on incubation with HSA with functionalised electrodes with amine terminated DNA 
aptamers (left) and thiolated DNA aptamers (right) in 0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 
0.1 M KCl. 100 µM HSA was used with 30 minutes incubation time. Number of samples per data point: 4 
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Furthermore, the aptasensor was also challenged with hK2 protein as a control. hK2 
was chosen as a control protein candidate, since it shows the most stringent conditions, 
sharing 80% homology with PSA in protein sequence. Upon incubation with 10 ng/ml 
and 100 ng/ml of hK2, Rct decreases by -1.1% and -1.6%, respectively (Figure 3.16). 
 
Figure 3.15 Thiol terminated sulfo-betaine based SAM representing formation of hydration layer to prevent non-
specific binding. 
 
For comparison, decreases of -6.0% and -14.3% were observed for similar 
concentrations of PSA. These results indicate that not only that the sulfo-betaine 
moiety effectively prevents non-specific interactions, but the aptamer is also highly 
selective towards PSA. 
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3.7 Summary 
This Chapter reports a development of a PSA aptasensor with enhanced antifouling 
chemistry to detect the biomarker of interest in complex samples. The Chapter 
presented and discussed the incorporation of molecules like MCH or thiol terminated 
sulfo-betaine to enable optimization of the sensor surface for increased sensitivity and 
reduced non-specific binding.  
This Chapter reports the use of thiol terminated sulfo-betaine with DNA aptamers as 
a promising spacer molecule. Although the optimization of surface density was a 
challenge, the fabricated aptasensors could potentially be used to detect PSA levels 
lower than 1 ng/ml (around 30 pM), which falls within the clinical range found in 
blood (1-10 ng/ml). The Chapter also demonstrated how important it is to perform 
stability tests of the fabricated aptasensors in order to obtain reliable data. 
Since this experimental work was performed and published, a handful of other 
research groups have reported the development of PSA aptasensors based on 
electrochemical detection techniques as listed in Table 3.2. Many of the PSA 
aptasensor developments is either based on the use of complex polymer composites or 
with amplification steps. For instance, Kavosi et al. reported a triple amplification 
strategy for the detection of PSA (Kavosi et al. 2015). The group developed the system 
by modifying the surface of glassy carbon electrode with graphene oxide and chitosan 
composite to covalently attach anti-PSA antibodies and thionine as redox probes. 
Finally, Dendrimers modified with AuNPs were used to immobilise thiolated anti-
PSA DNA aptamers and HRP linked aptamers to complete the sandwich assay with 
the primary antibodies on the polymer films. Such a system was used to capture PSA 
and a LOD of 0.15 pM was achieved using EIS.  Tahmasebi and Noorbakhsh reported 
the development of a PSA aptasensor based on chitosan and carboxylated carbon 
nanotubes composites on glassy carbon electrodes with a limit of detection of 0.75 
ng/mL (Tahmasebi and Noorbakhsh 2016). Although groups have reported better 
sensitivity than what has been presented in this Chapter, the simplicity of our approach 
to detect PSA within the clinical range sets our strategy apart. 
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Table 3.2 Comparison with existing state of art related to electrochemical PSA aptasensor 
Detection 
principle 
Electrode Strategy LOD/ Kd Reference 
DPV & CV GCE 
AuNPs encapsulated in graphitised mesoporous 
carbons deposited on GCE followed by 
immobilisation of streptavidin which was used to 




Liu et al. 
2012 
 

















et al. 2015 
EIS GE 
SAM of DNA probes which are partially 
complementary to DNA aptamer was used to 









Graphene chitosan composite deposited on GCE 
followed by immobilisation of antibodies and 
thionine to capture PSA. 
AuNPs–PAMAM functionalised with mixture of 
PSA aptamer and biotinylated-PSA aptamer was 
used for completing the sandwich type 
immunoreaction. (Horseradish peroxidase) HRP–
streptavidin was used as an electrochemical label 












Deposition of Quinone based polymer followed 























Carboxylated carbon nanotubes (CNTs) mixed 
with chitosan was physically adsorbed on the 
electrode surface. Amine terminated DNA 











*DPV: Differential Pulse Voltammetry 
*CV: Cyclic Voltammetry 
*GCE: Glassy Carbon Electrode 
*AuNPs: Gold nanoparticles 
*GE: Gold Electrode 
*EIS: Electrochemical Impedance Spectroscopy 
*SPR: Surface Plasmon Resonance 
*QCMD: Quartz Crystal Microbalance with Dissipation Signals 
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 Aptasensors for both 
quantification and multi-glycan profiling of 
PSA  
 
Since PSA alone does not fulfil the requirements to discriminate between different 
stages of PCa, this Chapter will present the development of a dual biomarker detection, 
namely the amount of PSA and glycoprofiling of PSA. Deviating from the usual 
electrochemical techniques, such an assay 
development was studied using optical 
methods. Two novel sandwich-based 
immunoassays for PSA detection are 
reported, in which the capture antibody is 
replaced by an anti-PSA DNA aptamer. A 
detector molecule (antibody or a lectin) is 
used to quantify PSA along with 
glycoprofiling by a chemiluminescence 
approach.  
The work presented in this Chapter has been published in Jolly et al. (Jolly et al. 2016)  
 
4.1 Background 
Replacing the antibodies in a classical ELISA configuration has enabled the 
development of sophisticated assays which are more robust, reproducible and 
economical (Tennico et al. 2010; Toh et al. 2015). Such reformed ELISA methods 
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have also been validated in a microfluidic setup, which holds great promise as a 
potential point-of-care (PoC) device. For instance, Su et al. recently reported a lab-on-
paper cyto-device to demonstrate detection of cancer cells together with multi-glycans 
profiling on living cancer cells (Su et al. 2015). In 2011, an aptamer-based ELISA 
approach was reported by Liu et al. for the detection of rare cells using 
chemiluminescence (Liu et al. 2011). Chemiluminescence is a phenomenon of 
emission of light as a result of a chemical reaction. It is a type of luminescence where 
light is emitted from a substance as a consequence of the transition from an 
electronically excited state to the ground state. It is distinct from photoluminescence, 
which is also referred as fluorescence, where the phenomenon is initiated by the light 
of a particular wavelength. In this Chapter, enhanced chemiluminescence is being 
employed for the detection of the analytes. Anti-PSA antibody or streptavidin-tethered 
with the enzyme horseradish peroxidase (HRP) are used for quantification or 
glycoprofiling studies, respectively. Such an enzyme catalyzes the substrate having 
chemiluminescent characteristics like luminol (3-Aminophthalhydrazide). Such a 
reaction of luminol oxidation is carried out in the presence of HRP and hydrogen 
peroxide (H2O2) as an oxidant, to generate excited state intermediates. The excited 
intermediated produced during the reaction returns to the ground state by emitting light 
at a wavelength of 425 nm. 
This Chapter reports the development of aptamer-based ELISA for quantification of 
free prostate specific antigen (fPSA) in a microfluidic device. Along with the 
quantification of fPSA, glycoprofiling could effectively serve as a complementary 
procedure for enhanced diagnosis and monitoring of PCa and potentially reduce the 
levels of false positives through blood tests. Thus, this Chapter also reports multi-
glycan profiling of fPSA using an aptamer-based sandwich assay in a microfluidic 
chemiluminescence sensor. Since PSA is a glycoprotein with various glycoforms 
(Isono et al. 2002; Végvári et al. 2012; Vermassen et al. 2012), the determination of 
cancer-associated glycoforms of PSA might help to improve early-stage clinical 
diagnosis of PCa (Meany and Chan 2011).  
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4.2 Materials and Methods 
4.2.1 List of reagents  
Table 4.1 lists the reagents used for the development of the sensor. The antibodies 
were diluted in 10 mM PBS (pH7.4) and filtered using a 0.4 µm syringe filter to 
remove any un-dissolved salt crystals and impurities. All aqueous solutions were 
prepared using MilliQ water and filtered before use. Table 4.2 lists the accessories 
used to perform the microfluidic assay. 
Table 4.1 List of reagents 




5’-H3N-(CH2)6-TTT TTA ATT AAA GCT 
CGC CAT CAA ATA GCT TT-3’ 







5’-H3N-(CH2)6-TTT TTA ATT AAA GCT 
CGC CAT CAA ATA GCT TT-Cy5-3’ 
PSA specific DNA aptamer 









(5’-H3N-(CH2)6-AAA AAT TAA TTT 
CGA GCG GTA GTT TAT CGA AA-3’ 
Control sequence Sigma, 
UK 
30C-CP1017 f-PSA Antigen (target) Fitzgerald, 
UK 
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Pierce (Supersignal® West Femto 
Substrate Trial Kit – 34094 and 
Supersignal West Pico – 35065) 














Table 4.2 List of microfluidic accessories 
Material Source 
Syringe tips LS20 Instech Laboratories, Inc., USA 
Polyethylene tubing BTPE-90 Instech Laboratories, Inc., USA 
Tubing adaptors SC 20/15 Instech Laboratories, Inc., USA 
Microtube Eppendorf tubes (1.5 mL) Sigma, UK 
Syringes 1 mL CODAN Medical ApS, DK 
Syringe Pump NE-300 New Era Pump Sustems, Inc, USA 
 
4.2.2 Fabrication of PDMS microchannel structures 
A patterned SU-8 mould was supplied by INESC Microsistemas e Nanotecnologias 
(Portugal). Several microfabrication steps are performed in order to obtain a well-
defined microchannel in a polydimethylsiloxane (PDMS) structure. Briefly, the 
fabrication of the PDMS microchannels was performed using soft lithography. 
Fabrication of hard mask, SU-8 mould, and PDMS devices were adapted from 
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literature as described by Novo et al (Novo et al. 2013) and Soares et al. (Soares et al. 
2014). The process can be divided into three main categories, namely the aluminium 
(Al) mask fabrication, SU-8 mould fabrication and microchannel fabrication (Figure 
4.1).  
 
Figure 4.1 Microfabrication steps. (Aluminium mask fabrication) A clean glass substrate is coated with an 
aluminium layer and a positive photoresist followed by exposure of the photoresist by mask less lithography and 
developing of the photoresist. An aluminium wet etchant removes the uncovered aluminium and the remaining 
photoresist is stripped off. (SU-8 mould fabrication) A clean silicon substrate is coated with a negative 
photoresist and exposed to UV light, using the aluminium mask produced. The photoresist is developed and the 
unexposed areas are removed. (Microchannel fabrication) PDMS is poured on top of the silicon substrate with 
pattern, cured in a baking step and removed from the mould. After surface oxidation of both surfaces, the 
patterned PDMS device is sealed to a clean glass to produce micro channel devices. 
 
Briefly, for the fabrication of the Al mask, a thin and homogeneous layer of Al is 
deposited on a clean glass substrate by reactive magnetron sputtering. In sputtering, 
argon atoms are in-fluxed into a vacuum chamber containing both the Al target and 
the glass substrate. With the application of a DC voltage between the Al target and the 
glass substrate, a discharge plasma is created for the ionization of the argon atoms. 
The highly energetic positive ions produced undergo a collision with the target 
cathode, which removes surface atoms of the target (Al) and emits secondary electrons 
of the target (Arvinte 2011). The energy released as a consequence of the collision 
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corresponds to the voltage drop between Al target and plasma. Specifically in a 
magnetron sputtering, a strong magnetic field is created near the target area to increase 
the efficiency. Due to the induced magnetic field, there is a higher attraction of the 
electrons to the target instead of the substrate. Such an attraction results in a longer 
traveling distance of the electrons and hence a higher chance to ionize further argon 
atoms. As a consequence, a stable plasma is created containing a high ion 
concentration. The formation of the required design of the microchannels on the Al 
layer can be realised by photolithography based on light-sensitive photoresists. A 
photoresist that dissolves in a specific solvent, when exposed to light is called a 
positive resist, whereas a negative resist does not dissolve due to cross-linking 
interaction because of light (Madou 2002). Although there are different ways to expose 
a specific pattern on a photoresist, but a simple technique is to place an optical opaque 
mask with the required features on top of the positive resist. Such a step will cover the 
areas of interest. In a direct write lithography (DWL), usually, a laser beam is 
integrated into a programmable machine and scans the photoresist line by line, using 
a computer aided software. Such a process comes under mask-less lithography, which 
is usually more time-consuming compared to traditional mask lithography. Later, the 
substrate is washed with a specific solvent to remove the area of photoresist which 
was exposed to the laser beam. The exposed layer of Al can be chemically etched and 
the remaining resist is stripped off using a photoresist-strip solution. The mask 
obtained can be used to create an inverse replica mould of the desired features.  
For the SU-8 (Microchem, USA) mould fabrication, a negative photoresist is spin 
coated on a clean silicon substrate. Later, the Al mask created in the previous steps is 
mounted on the photoresist. Finally, the resist is exposed to UV radiation. The mould 
is then developed in propylene glycol monomethyl ether acetate (Sigma-Aldrich, 
Portugal) (Soares et al. 2014b).  
Later, the mould patterns were transferred to polydimethylsiloxane (PDMS) to obtain 
the microfluidic devices for the experiments. PDMS is composed of repeating units of 
silicon atoms attached to one oxygen and two methyl groups. PDMS is used in this 
study because of varied advantages like optical transparency in the wavelength from 
240 to 1100 nm enabling easy optical detection using chemiluminescence and 
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impermeable to liquid (McDonald and Whitesides 2002). The PDMS devices 
consisting of microchannels with width, w = 200 µm, height, h = 20 µm and length, 
l = 1 cm were sealed to a cleaned glass substrate via an UV-ozone treatment for 6 min 
at 28-32 mW/cm2 (UVO cleaner 144AX, Jelight Company Inc., USA) for surface 
oxidation. The surface oxidised PDMS and glass substrates were then brought together 
and gently pressed to ensure bonding. After 1 day, these microfluidic devices are 
permanently sealed and ready for the experiments. 
 
4.2.3 Optical image acquisition and analysis 
The fluorescence signal from the microchannel was recorded using a fluorescence 
microscope (Leica DMLM) connected to a digital camera (Leica DFC300FX). The 
chemiluminescent signal was acquired using a microscope after flowing luminol, with 
an exposure time of 10 sec and 10x optical gain, all in a dark background. The acquired 
images were later analysed using ImageJ software (National Institutes of Health, 
USA). The values presented here after correspond to the background normalised 
average measurements from three independent experiments, each with three regions 
of interest along the microchannel. 
 
4.3 Microfluidic Aptamer Assays 
Surface functionalisation of aptamers for both fPSA quantification and glycoprofiling 
studies were performed according to the steps listed in Table 4.3. The following steps 
for quantification and glycoprofiling were always performed immediately after the 
surface functionalisation procedure. New microfluidic structures were used in each 
experiment. 
Figure 4.2 represents the microfluidic device setup. The microfluidic channel is 
connected via tubing to the syringe tubes. Syringe tubes are placed on a multi-channel 
syringe pump to control the flow rates and perform a multiplexed assay. On the right, 
a magnified image of the PDMS structure containing microfluidic channel is shown. 
It consists of inlet channels connected to the syringe tubes and the outlet channels for 
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waste. All the tubings were connected carefully in order to avoid any dead space that 
could lead to entrapment of air. 











1 Silanisation GOPTS 0.3 15  5%, 10%, 25%, 
50% and 100% 
Dilutions in water 






1X PBS 0.4 5, 10, 15, 30  10 µM Activation needed 





1X PBS 0.5 15 10 mM, pH 8.5 To block all unreacted 
sites of silane 
6 Washing 1X PBS 5 2 Milli-Q water Rigorous 





1X PBS 0.5 10 Both at 100 
µg/ml 
Detector molecule  




1X PBS 0.5 10 100 µg/ml Only in case of 11b 
10 Washing 1X PBS 5 1 Milli-Q water Final wash – stringent 
11 Detection 
Substrate 





Only for HRP 
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Figure 4.2 Microfluidic assay setup. Left shows the connection of microfluidic structure to the syringe pump via 
tubing. Right represent the microfluidic device magnified view with inlets and outlets 
 
 
Figure 4.3 Schematic of microfluidic channel functionalisation for assay experiments. 
 
Furthermore, the immobilisation steps listed in Table 4.3 can be represented as a 
schematic shown in Figure 4.3. For the control experiment, the second step of aptamer 
immobilisation was replaced by using a random DNA sequence of the same length 
and modification as that for PSA specific DNA aptamer. 
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4.4 Effect of DNA aptamer surface coverage on the 
chemiluminescence signal 
With the aim of developing a sensitive microfluidic assay for fPSA detection, various 
optimisation steps were performed. Since the mode of immobilisation proposed was 
covalent grafting of DNA aptamers, GOPTS silane was used to minimise the steps. 
GOPTS is an epoxy organosilane which has the coupling reactivity with several 
nucleophiles including primary amines (Bañuls et al. 2013). Therefore, such a silane 
can be used to attach antibodies or amine modified oligonucleotides by an epoxide 
ring opening (Figure 4.4) (Ramachandran et al. 2008).  
 
Figure 4.4 Scheme of bio conjugation procedure for GOPTS via oxidative ring opening based using primary 
amine (ideal case). 
 
Anti-PSA antibody with FITC label was used to optimise the concentration of GOPTS 
used for silanisation. Briefly, GOPTS with the different concentration ranging from 
5%, 10%, 50% and 100% in water was used to silanise the microfluidic channel. After 
washing steps, anti-PSA Ab labelled with FITC was flowed for 15 minutes. After 
washing away non-specifically bound antibodies, the channel was visualized using a 
fluorescence microscope with a compatible filter to the applied fluorophore (Olympus 
Microscope CHX41, blue excitation filter). 
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Figure 4.5 Optimisation of concentration of GOPTS for immobilisation of probes. Photoluminescence (PL) 
signal presented is by using only Ab labelled with FITC as a case study. 
 
Figure 4.5 represents the photo luminescence (PL) signal also called fluorescence 
signal, obtained with the different concentration of GOPTS. A low fluorescence signal 
with both 5% and 10% GOPTS is observed. The probable reason could be low 
coupling efficiency of antibodies to free epoxide rings and/or poor coverage of 
GOPTS on the surface. Nevertheless, the signal increased drastically with 50% and 
maximum signal with 100% GOPTS demonstrating an intense fluorescence signal as 
a result of enhanced coupling on the surface. Therefore, for further optimisation steps, 
100% GOPTS was used to silanise the microfluidic channel.  
For the development of the sensors, it is imperative to optimise both the physical and 
chemical aspects of the microfluidic biosensor, namely the dimensions of the 
microchannel, flow-rates, and probe immobilisation strategies. The first two 
parameters were previously optimised at INESC-MN and validated with an antibody-
based ELISA system to detect fPSA and the optimised steps were used in the present 
study without further modification (Madaboosi et al. 2015). 
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However, this Chapter reports the use of anti-PSA DNA aptamer as a capture antibody 
and hence it is crucial to optimise the surface coverage of the probe. The surface 
density of probes, in particular, plays a vital role in fabricating an efficient biosensor 
irrespective of the detection technique used as reported by different research groups 
(Jolly et al. 2015; Keighley et al. 2008a; Keighley et al. 2008b; Madaboosi et al. 
2015). Also, as demonstrated in Chapter 3, an optimum spacing between the aptamers 
on the surface allows minimal steric hindrance effects in order to successfully capture 
the target and undergo conformational changes. For efficient binding of fPSA in the 
microfluidic channel via anti-PSA DNA aptamers, the immobilisation time of anti-
PSA DNA aptamers was investigated. The optimisation was performed after fPSA 
capture using anti-PSA DNA aptamers, followed by detection with an anti-fPSA 
antibody labeled with the reporter enzyme horseradish peroxidase (anti-fPSA Ab-
HRP). A fixed concentration of DNA aptamer equal to 10 µM in 10 mM PBS (pH 7.4) 
was flowed for different time intervals and a fixed fPSA concentration of 10 ng/mL 
was chosen for the experiment. From Figure 4.6, it can be seen that as we increase the 
time of immobilisation of DNA aptamers from 5 min to 15 min, an increase in the 
chemiluminescence signal was observed. The signal increased from 12.5 + 1.6 a.u. 
with 5 min incubation to 55.5 + 6.9 a.u. with 15 minutes.  
 
Figure 4.6 Chemiluminescence signal with different time periods of DNA aptamer immobilisation upon PSA 
binding, detected by anti-fPSA Ab-HRP.  
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However, as the time was further increased to 30 min, the chemiluminescence signal 
was reduced to 41.5 + 4.8 a.u. Such a decrease could be attributed to the presence of 
high density of the anti-PSA DNA aptamer on the surface. As a result of too densely 
packed anti-PSA DNA aptamer, there is a decrease in PSA binding due to steric 
hindrance effects as also seen in Chapter 3 (Formisano et al. 2015). Thus, to achieve 
an effective PSA detection in the described microfluidic channel, 15 min was chosen 
as the immobilisation time for all the subsequent experiments. 
 
4.5 Estimation of DNA aptamer surface coverage on the 
microfluidic channel 
Nano spotting experiments were performed to estimate the surface coverage of anti-
PSA DNA aptamers. For the experiments, anti-PSA DNA aptamers modified with a 
C-6 amine at the 5’ end and labelled with a Cyanine3 on the 3’ were spotted on the 
surface of the thin film of PDMS following the procedure reported by Novo et al. 
(Novo et al. 2011). A non-contact nano-spotter (Nanoplotter NP2.1, GeSiM, 
Germany) was used to spot anti-PSA DNA aptamer solutions with a piezoelectric 
pipette (Pico tip with a capacity to dispense single droplets with volumes down to 
∼56 pL) mounted on a computer controlled stage (Novo et al. 2011). Different 
concentrations of anti-PSA DNA aptamer solutions ranging from 1 µM, 3 µM, 5 µM, 
8 µM and 10 µM were used to prepare the calibration curve. The total number of times 
a droplet solution was dispensed and the degree of hydrophilicity of the ozone treated 
PDMS film at a particular location determines the diameter and amount of DNA 
aptamers at that spot. The temperature was fixed at 16 °C and humidity was adjusted 
to near the dew point to increase the evaporation time of the droplets, ensuring 
homogeneous drying. 
The nano-spotting method allows a precise and robust deposition of the solution with 
controlled volume of anti-PSA DNA aptamers onto a surface using a computer-aided 
micro-spotter (Novo et al. 2011). In the experiment, the aptamer solution is filled in a 
Pico tip that enables spots on the surface by dispensing the anti-PSA DNA aptamer 
solution in a non-contact mode (50 drops per spot). Known volumes from 50 droplets 
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of varied concentrations of anti-PSA DNA aptamer-Cy3 were spotted on a specific 
location on the PDMS film. The photoluminescence (PL) signal was measured from 
each deposited spot on the PDMS film. Fluorescence was obtained as a result of 
adsorbed anti-PSA DNA aptamer-Cy3 and the total number of anti-PSA DNA 
aptamers adsorbed per unit area was calculated. Each DNA aptamer occupies an area 
of 6.16 × 10
-6 µm2 assuming that all the DNA aptamers are in their single-stranded 
state and lying perpendicular to the surface, where a single stranded DNA has a 
hydrodynamic radius of 1.4 nm. 
 
Figure 4.7 Nano-spotting of DNA aptamer labelled with Cy3 to estimate the surface density. The inset image 
shows the optical micrograph of DNA aptamers labelled with Cy3 covalently immobilised in the microchannel. 
 
The data obtained can be used to make a correlation between the total number of anti-
PSA DNA aptamer-Cy3 in the spot and the fluorescence intensity from the spot 
(Figure 4.7). The curve obtained was then used for determining the surface density of 
the immobilised anti-PSA DNA aptamers in the microfluidic channel at a known 
concentration. The inset in Figure 4.7 shows the PL signal of a typical relative surface 
coverage when anti-PSA DNA aptamers are immobilised in a microfluidic channel. 
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surface coverage of 1.37 × 10
13 molecules/cm2 was estimated from the obtained PL 
signal in the microchannel (PL signal: 12.80 + 1.68 a.u.) with the covalently grafted 
anti-PSA DNA aptamer-Cy3. 
 
4.6 Selectivity study using the microfluidic aptamer-based ELISA 
sensor 
The development of a reliable biosensor depends on various factors including the 
resolution to differentiate between specific and non-specific binding. The selectivity 
of the sensor was investigated with various control experiments to confirm that the 
signals obtained with fPSA were due to the specific capture of fPSA by the anti-PSA 
DNA aptamers immobilised in the microfluidic channel. It is an essential step in a 
biosensor development procedure to be sure that the signal monitored is due to the 
capture of the target. Particularly in a sandwich-type of assay, the probability of false 
positives increases, as it employs two levels of capture. Therefore, stringent control 
experiments are required in order to develop a reliable sandwich assay.  
As this Chapter is a demonstration of the prospective of an aptamer-based ELISA 
assay in a microfluidic channel, the role of anti-PSA DNA aptamers as a probe to 
capture fPSA was tested by using two rigid control experiments (Figure 4.8). In the 
first control experiment, the channel was first silanised and then blocked with 
ethanolamine without any immobilisation of anti-PSA DNA aptamers (Figure 4.8, #3). 
In the second control study, a random DNA sequence of the same length as of the ant-
PSA DNA aptamer was immobilised on the microfluidic channel (Figure 4.8, #4) 
following the same protocol as described in the method section. Such a study was 
performed in order to confirm the role of DNA aptamer as a replacement of primary 
antibody as a capture probe. When the channels from the control experiments were 
observed under the microscope, a negligible change of less than 2 a.u. when compared 
with blank measurement was noticed. Whereas, the signal obtained from micro 
channels functionalized with anti-PSA DNA aptamers were as high as 55.5 + 6.9 a.u. 
when compared with blank measurement. The results obtained assures the specific 
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binding of fPSA to anti-PSA DNA aptamers and subsequent sandwich based detection 
using anti-fPSA Ab labelled with HRP. 
 
Figure 4.8 Selectivity studies with aptamer-based ELISA. (1) Specific detection of fPSA (10 ng/mL) by anti-PSA 
DNA aptamers and thereafter, detected by anti-fPSA labelled with HRP. (2) Signal obtained when no fPSA (0 
ng/mL) was flowed. (3) Signal change when no aptamer was immobilised in the microchannel and 10 ng/mL 
fPSA was flowed. (4) When a random DNA sequence as a control was used and 10 ng/mL fPSA was flowed (5) 
Signal change with 10 ng/mL hK2. (6) Signal change with 4% HSA. 
 
The microfluidic biosensor developed was also challenged with two control proteins 
using human Kallikrein 2 (hK2) (10 ng/mL) (Figure 4.8, #5) and human serum 
albumin (HSA) (40 mg/mL) (Figure 4.8, #6). hK2 as described in Chapter 1 is another 
serine protease from the same kallikrein family as fPSA. It was chosen as a control 
protein candidate of interest since it shares 80% structural homology with the fPSA. 
Although the levels of hK2 are 100 fold lower than that of PSA in clinical samples, 
this protein was stringently chosen since it served as an appropriate control to evaluate 
the aptamer-based approach over an antibody-based approach using ELISA (Hong 
2014; Vaisanen et al. 2006). With an aptamer-based ELISA system, an appreciable 
differentiation in signal change between hK2 and PSA was monitored; the former, 
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#5). This can be distinctively differentiated from 10 ng/mL PSA (Figure 4.8, #1) with 
a difference of 55 a.u.  
 
Figure 4.9 Comparison of antibody based ELISA with aptamer based ELISA on cross-reactivity with homologous 
proteins. 
 
To make a stronger point, classical ELISA was performed by adsorption of capture 
antibodies in the microfluidic channel and followed by the flow of 10 ng/mL hK2 
protein, and finally, a detector antibody labeled with HRP. The channel was then 
analyzed under a microscope. The results show a high level of cross reactivity of up 
to 20 a.u. and the inability of the antibodies to differentiate hK2 from PSA (Figure 
4.9). The high cross reactivity could be due to the fact that most of the antibodies 
raised against PSA exhibit certain cross-reactivity with the hk2 due to similar epitopic 
regions. As another control protein, 4% HSA was used to test matrix interference 
effects and a slight decrease in chemiluminescence signal (~1 a.u.) was observed 
(Figure 4.8 #6). This could be attributed to the blocking effect of HSA, leading to 
decreased non-specific binding of detector antibodies.  
 
4.7 Quantification of fPSA using the microfluidic biosensor 
With established enhanced selectivity of the aptamer-based ELISA, aptamer 
functionalised microfluidic channels were used for the quantification of fPSA. The 
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aim of the study was to investigate the sensitivity of the developed biosensor. For 
quantification analysis, the assay was based on a sandwich ELISA format, where anti-
fPSA antibodies labeled with HRP were used to detect the fPSA captured by the 
immobilised DNA aptamers (Aptamer-Antibody Assay). A wide working range of 
fPSA concentrations ranging from 0.01 ng/mL to 50 ng/mL were used in the current 
study. It is important to highlight that each assay was performed in a new microchannel 
immediately after immobilisation since PDMS structures with such small footprint can 
be easily produced in large numbers and disposability avoids the use of complex 
generation procedures and potential accumulation of non-specific binding. As seen 
from Figure 4.10, a significant increase in the chemiluminescence signals is observed 
between 1 ng/mL and 25 ng/mL of fPSA concentrations, which lies within the cutoff 
range (gray area) of PSA in blood. It can be immediately observed that the background 
signal is not limiting the detection sensitivity at the clinically relevant concentrations 
while still being detectable using the CCD camera of the microscope. This confirms 
that the ethanolamine blocking works effectively in providing a fit-for-purpose level 
of non-specificity. 
 
Figure 4.10 Quantification of fPSA using anti-fPSA Ab-HRP. Images represent the chemiluminescence signals 
from microscopy. 
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The response obtained for fPSA quantification follows a Hill dose-response equation 





n) where c is the concentration. The 
dissociation constant (Kd) for the dose response was calculated as 9.82 ng/mL with a 
root mean square (RMS) value of 0.98. The value of ymax, which is the end value 
calculated from the fitting was 92.17 a.u., and n = 1.32. The fabricated biosensor could 
potentially differentiate 0.5 ng/mL of fPSA with a chemiluminescence value of 
11.90 + 1.49 a.u., which is higher than the y0 value (8.5 a.u.) calculated from the 
fitting. 
 
4.8 Multi-glycoprofiling of fPSA 
The change in a carbohydrate linkage of particular carbohydrate moieties, such as 
sialic acid plays a major role in glycoprofiling of PSA. As explained in Chapter 1, 
glycoprofiling can indicate not only the type of pathological process but, more 
importantly, in some cases also its stage. There are direct and indirect methods to 
perform protein glycoprofiling after the release of glycans from intact glycoproteins. 
Various analytical techniques such as HPLC, capillary electrophoresis, and mass 
spectroscopy, can be used to further analyse the glycans. However, these techniques 
are both laborious and expensive (Adamczyk et al. 2014; Domann et al. 2007; 
Thaysen-Andersen and Packer 2014).  
It is worth mentioning that direct glycoprofiling methods that have been reported in 
the literature are based on recognition elements such as lectins (Katrlik et al. 2010), 
anti-carbohydrate antibodies (Smith and Cummings 2010) or other glycan binding 
proteins. Since these bio recognition elements are specific to glycans and not a 
particular protein, they are capable of recognizing specific glycan structures 
irrespective of the molecule. Such an approach based on the use of proteins 
(antibodies, lectins) have a major limitation such as cross-reactivity of the recognition 
element with other components present in the sample resulting in false positives. 
Moreover, using antibodies for diagnostic applications have drawbacks such as high 
costs, poor stability over time and difficulty in engineering them to suit the sensing 
platforms (Haupt and Mosbach 2000). Also, the protein itself can have its glycoforms 
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and increases false positives. One alternate promising class of receptor that can address 
this major issue with current detection platforms are aptamers. Thus, a similar 
aptamer-based assay design was also used for fPSA glycoprofiling, utilizing lectins as 
glyco-recognition elements (Aptamer-Lectin Assay). This is demonstrated by 
profiling the fPSA carbohydrate content using two biotinylated lectins specific for 
sialic acid: (i) Sambucus nigra lectin (SNA) binding preferentially to sialic acid 
attached to terminal galactose in α-2,6 linked sialic acid and (ii) Maackia amurensis 
lectin II (MAA II), a lectin recognizing terminal α-2,3 sialylation of PSA. The increase 
of α-2,3 linked sialic acid is highly presented in PCa patients (Ohyama et al. 2004).  
Since we employed commercial fPSA obtained from healthy donors, no interaction 
with MAA II lectin was expected. Thus, MAA II lectin was used as a negative control 
for a commercial non-malignant fPSA. The fabricated biosensor using lectins was able 
to distinguish between α-2,6 linked sialic acid and α-2,3 linked sialic acid as shown in 
Figure 4.11. This finding is in agreement with published studies (Saldova et al. 2011). 
The working range is slightly shifted when compared to quantification experiments, 
the concentrations ranging from 3 ng/mL to 50 ng/mL fPSA. As seen from Figure 
4.11, the fabricated biosensor could potentially differentiate 3 ng/mL fPSA from the 
blank measurement with a difference of 5.64 + 0.50 a.u. using chemiluminescence. 
However, a significant increase in the chemiluminescence signal was observed 
between 5 ng/mL of PSA to 50 ng/mL of PSA concentration which lies within the cut-
off range (grey zone) of PSA in the blood. Nevertheless, here the major focus was on 
the potential occurrence of sialic acid with different linkages on PSA surface in a 
multiglycan profiling approach, thus establishing the difference between the two lectin 
forms using an aptamer-based ELISA. 
Again, a dose response fitting was performed using the same Hill equation that was 
used with quantification of PSA in Figure 4.11, on the data points obtained with SNA 
lectin. A Kd of 12.5 ng/mL of PSA with a root mean square value of 0.99 was obtained. 
The value of ymax which is the end value calculated from the fitting was 72.08 a.u., and 
n = 1.96.  
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Figure 4.11 Multi-glycan profiling for fPSA detection. Blue data points were obtained using a SNA lectin 
whereas, red data points were obtained using an MAA II (control) lectin. Images represent the 
chemiluminescence signals from microscopy for SNA lectin at different concentrations of PSA. 
 
Considering the y0 value calculated to be 1.53 a.u. from the fitting, the fabricated 
biosensor could differentiate 3 ng/mL of fPSA with chemiluminescence value of 
12.20 + 1.36 a.u. In the control experiments, MAA II lectin did not show any binding 
to PSA in the whole concentration range studied. The differentiation in signal from 
the two lectins could be observed for fPSA concentrations above 3 ng/mL.  
 
4.9 Summary 
This Chapter presents a simple novel aptamer-based microfluidic ELISA assay for the 
optical detection of fPSA in the clinical range with high sensitivity. The integration of 
quantification of PSA with multi-glycan profiling of fPSA could serve as a potential 
platform for PoC devices in PCa diagnosis. A sensitive quantification of PSA of 0.5 
ng/mL and multi-glycan profiling where the specific lectin (SNA) could differentiate 
a response from the control lectin (MAA II) at fPSA concentration down to 3 ng/mL 
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is demonstrated. Table 4.4 presents a list of reported state of art technologies for the 
optical detection of PSA. It can be seen the LOD obtained with the presented biosensor 
is lower or comparable to the reported technologies. 
Table 4.4 Comparison of state of art technologies 







DNA aptamers conjugated with 
fluorescent dye were 
immobilised on nanoparticles via 
π–π stacking 
 









DNA aptamer modified with 
fluorophore and Guanine rich 
region 
1 ng/mL Cha et al. 
2014 
Fluorescence MoS2nanosheet DNA aptamer modified with 
fluorophore 
 
0.2 ng/mL Kong et 
al. 2015 





DNA aptamers were 
immobilised on gold surfaces 
<10 ng/mL Zhang et 
al. 2015 
Chemiluminescent Glass/PDMS DNA aptamers immobilised in 
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The study addresses how the use of aptamers could be an effective methodology to 
handle the current antibody limitations with cross-reactivity issues in glycoprofiling. 
It also shows how aptamers could be used as a potential tool for multi-glycan profiling 
of biomarkers with high sensitivity and selectivity in a simple microfluidic channel. 
This approach can be easily extended to a wide range of other biomarkers available 
for PCa, a step towards multiplexing, which is of great interest for PCa diagnosis. The 
simultaneous detection of protein cancer biomarkers together with their levels of 
glycosylation provides enhanced diagnosis and prognosis of the disease. 
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 Polymer-based electrochemical 
sensing of AMACR  
 
This Chapter reports on the development of a sensitive aptasensor based on a 
poly(pyrrole) (PPy) – polyethylene glycol (PEG) platform for the detection of α-
methylacyl-CoA racemase (AMACR; P504S), an upcoming biomarker for prostate 
cancer. The work demonstrates a simple 
strategy of covalent modification of PPy 
films formed on the electrodes by using 
PEG derivatives, without prior need of 
chemical functionalisation of the pyrrole 
monomer. Square Wave Voltammetry 
(SWV) was utilised to characterise the 
aptasensor and surface plasmon resonance 
(SPR) as a validation tool. The Chapter also 
presents the successful application of the aptasensor with human plasma samples. 
The work presented in this chapter has been submitted for publishing. 
 
5.1 Background 
Recently, several research groups have tried to develop biosensors for AMACR 
detection. However, most of them employ antibodies as a probe for detection (Lin et 
al. 2012; Maraldo et al. 2007; Wang and Yau 2014). In 2014, Yang et al. (Yang et al. 
2014) first reported an anti-AMACR DNA aptamer (AMC51) and demonstrated a 
fluorescent enzyme-linked aptamer assay (ELAA) for AMACR detection, which 
  
Chapter 5  135 
 
featured a low detection limit of 0.44 nM. In this work, we present the development 
of an electrochemical AMACR aptasensor based on electro-patterned polyethylene 
glycol (PEG) on polypyrrole (PPy) film. PEG as a polymer has been widely used to 
develop biosensors, due to its anti-fouling properties (Nogues et al. 2012; Rodriguez 
Emmenegger et al. 2009; Sharma et al. 2004; Statz et al. 2005). However, it becomes 
very difficult to employ PEG in an electrochemical platform since it is also an 
insulating polymer. Nevertheless, several research groups have demonstrated the use 
of PEG on an electrochemical platform. Estrela et al. (Estrela et al. 2010) developed 
an electrochemical biosensor for cyclin-dependent kinase protein detection using 
peptide aptamers and PEG. Kjallman et al. (Kjällman et al. 2008) reported a DNA-
based biosensor using PEG. In 2013, Hayat et al. (Hayat et al. 2013) demonstrated a 
design of PEG-aptamer for detection of ochratoxin A; however, the strategy employs 
the modification of aptamers with PEG. In order to overcome the shortcomings of 
directly using PEG, we propose the use of organic conducting polymers such as PPy 
as a foundation of grafting PEG onto a surface.  
PPy has attracted a lot of attention in the past decades from those developing 
biosensors because of its redox properties (Han et al. 2005) and high electrical 
conductivity (Andrade 1985) along with being a suitable interface for bioreceptors 
association (Azioune et al. 2005; Kausaite-Minkstimiene et al. 2011; Raoof et al. 
2004). PPy has been used to immobilise various types of biomolecules through various 
methods as described in Chapter 2. Miodek et al. (Miodek et al. 2015) developed an 
E-DNA sensor for Mycobacterium tuberculosis based on an electrochemical method 
to directly modify the CNTs coated by an un-functionalised PPy film with the 
macromolecular polymer–dendrimer hybrids. This was done by electro-oxidation of 
the amine groups of dendrimers that can bind to CNTs as well as to the PPy surface.  
In this work, we design an aptasensor specific for human recombinant AMACR 1A 
protein based on PEG (PEG derivative) electro-patterned on PPy layer and associated 
with an ANTA/Cu2+ complex. Modification of the PPy film by PEG molecules can 
lead to minimised non-specific binding. On the other, hand association of redox 
molecules such as copper complexes with PPy can enhance the electrical properties of 
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the film and improve the sensitivity of detection (Chebil et al. 2010; Chebil et al. 
2013). 
 
5.2 Fabrication of functional AMACR aptasensor 
Gold disk working electrodes with a radius of 1.0 mm were cleaned as detailed in 
Chapter 3. An additional step of chemical cleaning was included with piranha solution 
(3 parts of concentrated H2SO4 with 1 part of H2O2 (Sigma, UK)) for 5 minutes, 
between the mechanical polishing and the electrochemical cleaning. Figure 5.1 
represents a schematic of the fabrication strategy (1-6).  
 
Figure 5.1 Schematic representation of aptasensor manufacture:(1) Electro-deposition of pyrrole on gold 
electrodes;(2) subsequent electro-patterning of PEG molecules using its amines present on one of terminus; (3) 
Attachment of  ANTA to carboxyl end of PEG via covalent bonding with EDC/NHS coupling agents; (4) 
Immobilization of  copper ions; (5) Immobilization of His-tagged DNA aptamers; (6) detection of AMACR. 
 
A clean gold electrode surface was modified with PPy (1) followed by electrochemical 
immobilisation of poly(ethylene glycol) 2-aminoethyl ether acetic acid (PEG, Sigma, 
UK) molecules (2). The free carboxylate groups of PEG were used to covalently attach 
Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate (ANTA, Sigma, UK) via an amido link 
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(3). Immobilised ANTA was later used to attach copper molecules via coordinate 
chemistry (4). Finally, a Histidine tagged AMACR specific DNA aptamer 
[5’(His)6TTT TTT CCC TAC GGC GCT AAC CCA TGC TAC GAA TTC GTT GTT 
AAA CAA TAG GCC ACC GTG CTA CAA-3’] (Eurogentec, UK) was immobilised 
onto the PPy-PEG backbone through the ANTA/Cu2+ complex (5). The fabricated 
aptasensor was then used to detect AMACR protein (6).  
 
5.2.1 Selection of anti-AMACR DNA aptamer 
To fabricate a successful aptasensor, it is crucial to fully characterise the aptamer to 
be used for it. The performance of the aptasensor is majorly dependent on the 
biological recognition unit. For AMACR, two types of DNA aptamers have been 
developed. The first aptamer was developed by Base Pair Biotechnologies (AM-
310_2) as a 32 nucleotide long DNA aptamer. More recently, Yang et al. reported a 
60 nucleotide long DNA aptamer (AMC51) for AMACR detection (Yang et al. 2014). 
To perform surface characterisation, classical binary SAM layer was utilised using 
thiol modified DNA aptamers from both the sources. 0.01 total DNA aptamer mole 
fraction was used, similar to what is described in Chapter 3. Such a characterisation 
was performed using surface plasmon resonance technique (SPR). 
A pre-treatment step for aptamer activation was performed where the aptamers were 
heated to 95˚C for 5 minutes followed by gradual cooling to room temperature (Yang 
et al. 2014). 50 nm gold coated SPR gold chips, supplied from Reichert Technologies 
were used for studying the reaction on SPR. Prior to their modification, the chips were 
cleaned using piranha solution (3:1 H2SO4:H2O2) for 20 seconds and rinsed thoroughly 
with Milli-Q water and dried using nitrogen gas. All buffers were filtered through 0.2 
μm filters and degassed for 2 hours by sonication prior to the experiment. The mixed 
SAM was immobilised on the SPR chip following to protocol previously described. 
Different concentrations of AMACR were prepared in 10 mM PBS (pH 7.4). Human 
recombinant AMACR 1A was expressed and purified as reported by Darley et al. 
(Darley et al. 2009) and Yevglevskis et al. (Yevglevskis et al. 2014a; Yevglevskis et 
al. 2014b). 
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The results from SPR are shown in Figure 5.2. From binding studies, a significant 
distinction in the binding efficiency can be observed between the two aptamers. 
Clearly, DNA aptamer (AMC-51) reported by Yang et al. showed enhanced binding 
capabilities as compared to AM-310_2 from Base Pair Biotechnologies. Such a 
significant difference could be attributed to their respective reported dissociation 
constant values (Kd). It could be assumed that as the AM-310_2 aptamer has a high 
dissociation constant of around 480 nM, there is a quick detachment of the protein 
after binding. On the other hand, AMC51 has nearly a 10 fold lower Kd value of 49 
nM. Therefore, from the results obtained, this Chapter will focus on the employment 
of AMC51 for the fabrication of an electrochemical aptasensor.  
 
Figure 5.2 Real time SPR curves obtained with different concentrations of AMACR using AMC51 aptamer (left). 
Right graph shows the SPR response with anti-AMACR DNA aptamers from two sources; AM-310_2 from Base 
Pair Biotechnologies (black) and AMC51 from Taiwan National University (blue). Error bars represent standard 
deviation obtained from three independent samples. 
 
5.2.2 Optimisation of polymerisation and PEG deposition 
The optimal conditions of polymerisation and PEG association were performed by 
investigating different parameters such as the thickness of the PPy layer and the 
potential range of electro-deposition. Such steps were practiced to engineer an intense 
oxidation peak of ANTA/Cu2+ redox complex and efficient AMACR detection. The 
thickness of the PPy layer strictly depends upon conditions of polymerisation such as 
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range of potential, number of cycles and concentration of pyrrole monomer. The range 
of potential and concentration of pyrrole monomer were chosen based on previous 
literature while number of cycles were varied in this study (Appendix I.3). Initially, 
three cycles of pyrrole electro-deposition were chosen to optimise the electro-
oxidation of PEG. However, the optimal parameters of PEG deposition should also be 
chosen based on the efficiency of further steps such as ANTA and copper attachment. 
Covalent grafting of ANTA on PPy-PEG via EDC/NHS chemistry and copper 
immobilisation were fixed to 30 minutes each.  
Electrochemical impedance spectroscopy (EIS) was used to evaluate the different 
optimisation steps. EIS measurements were performed using a µAUTOLAB III / 
FRA2 potentiostat apparatus, using a three-electrode cell setup with an Ag/AgCl 
reference electrode and a Pt counter electrode. The impedance spectrum was measured 
in 10 mM PBS measurement buffer (pH 7.4) with a 10 mV a.c. voltage superimposed 
on a bias d.c. voltage of 0.17 V vs. Ag/AgCl. Briefly, a clean gold electrode surface 
was modified with PPy by scanning the potential from -0.4 V to 0.9 V vs. Ag/AgCl 
with a scan rate of 100 mV.s-1 in the presence of 50 mM purified pyrrole monomer 
(Sigma, UK) dissolved in 0.5 M lithium perchlorate (LiClO4, Sigma, UK) for two 
cycles. Electro-polymerisation was performed using a three-electrode configuration in 
a small volume cell (BASi, USA) containing 250 µL of pyrrole monomer. A typical 
CV characteristic of PPy polymerisation performed with two cycles is shown in Figure 
5.3. 
Surface characterisation of PPy coated gold SPR chips was performed using a 
scanning electron microscopy (JSM-6480Jeol, Japan) at 1000X magnification with 
acceleration voltage of 5 kV to acquire SEM images. The SEM micrograph shows 
characteristic structures of PPy deposited on gold electrodes (Figure 5.3, right). This 
morphology is characteristic for PPy growing in water and present initiation of 
“cauliflower” structures as described in the literature (Miodek et al. 2015). After 
reaction, the electrode was rinsed with Milli-Q water. 
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Figure 5.3 Cyclic voltammetry of pyrrole electro polymerisation showing characteristic current peaks that 
increased with consecutive scans confirming the deposition of a conducting polymer on the surface (left). SEM 
micrograph showing characteristic structures of polypyrrole deposited on gold electrodes with two cycles (right). 
 
PEG molecules were immobilised on the PPy film by covalent bonding via electro-
oxidation of amine groups of PEG. In order to modify the generated PPy film with 
PEG bearing both amine and carboxyl groups, the electrochemical pattering of PEG 
was performed using the optimised conditions. The modification was realised by the 
electrochemical oxidation of amine groups of PEG which was again performed in the 
small volume cell containing 250 µL of 1 mM PEG dissolved in Milli-Q water 
containing 0.5 M LiClO4 by cycling the potential between 0.0 to 1.1 V vs. Ag/AgCl 
for 5 cycles (Appendix I.1) with the scan rate of 50 mVs-1.The mechanism of such a 
reaction assumes formation of radical cations on nitrogen atoms which covalently 
attach to the nucleophilic groups such as aromatic ring resulting in the rupture of the 
double bond carbon=carbon and formation of carbon-nitrogen bonds (Adenier et al. 
2004; Zhang et al. 2005). 
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Figure 5.4 Nyquist plot depicting variation in charge transfer resistance of PPy modified gold electrode (black) 
after dipping it in PEG solution (red without applying the potential) (left). Cole-Cole plot of PPy modified 
surface (right). 
 
From EIS data, a small Rct for PPy modified gold electrodes was obtained equal to 80 
Ω and a large capacitance of around 163 µF (Figure 5.4). Since PEG is an insulating 
polymer, an increase in the Rct values was expected upon grafting of PEG on a PPy 
film.  
From Figure 5.5 it can be seen that a high Rct of ca. 200 kΩ was obtained after 
electrochemical PEG deposition and the capacitance decreased to nearly 2 µF. The 
significant decrease in capacitance observed on the attachment of PEG to the PPy film, 
which decreased further upon attachment of ANTA/Cu2+ and the His-tagged DNA 
aptamer, could be attributed to a series capacitor effect, where the final capacitance 
decreases upon addition of layers on the same surface. Such a change was compared 
with a control experiment with electrodes immersed in PEG solution where no 
electrochemical oxidation was performed and electrodes showed a non-significant 
change in Rct (Figure 5.5, left), which further validated the electrochemical approach. 
Such an electrochemical functionalisation has been demonstrated earlier in the case of 
attachment of aliphatic amines to surfaces such as glassy carbon (Ghanem et al. 2008) 
or CNTs (Adenier et al. 2004) and recently on CNTs coated with PPy material 
(Miodek et al. 2015). 
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Figure 5.5 Electrochemical impedance spectroscopy characterisation of different layers (left).Cole-Cole plot 
depicting the changes in capacitance at different layer formation (right). 
 
Immobilisation of ANTA/Cu2+ complex and the His-tagged aptamers was performed 
using the protocol reported by Chebil et al. (Chebil et al. 2010). The carboxylic acid 
groups on the free end of the deposited PEG was used to covalently attach ANTA. 
First, electrodes were subjected to a 2:1 ratio of EDC/NHS (160 mM/80 mM) in water 
for 20 minutes. Electrodes were then rinsed with Milli-Q water and immersed in 7 mM 
ANTA dissolved in 10 mM PBS (pH 8.5) for 30 minutes. The electrodes were then 
rinsed well with Milli-Q water and the unreacted activated carboxylate groups were 
blocked with 10 mM ethanolamine (pH 8.5, Sigma, UK) for 30 minutes. Finally, the 
electrodes were immersed in a solution of 3.5 mM copper acetate (Sigma, UK) 
dissolved in 20 mM acetate buffer (pH 4.6) for 25 minutes. During the process the 
copper molecules associated with ANTA attached onto the surface via coordinate 
chemistry. The covalent attachment of ANTA onto PPy-PEG showed a reduction in 
the Rct values. From the Cole-Cole plot (Figure 5.5 right) a further reduction in 
capacitance after PEG deposition was recorded pointing to the deposition of another 
layer over PEG.  
  
Chapter 5  143 
 
 
Figure 5.6 Cyclic Voltammetry in 10 mM PBS containing 10 mM ferro/ferricyanide [Fe(CN)6]3-/4-showing the 
changes in the current peaks upon modification of gold electrode. 
 
Such an assumption was further studied by cyclic voltammetry (CV) in the presence 
of a redox couple from -0.4 V to 0.45 V in 10 mM PBS containing 10 mM 
ferro/ferricyanide [Fe(CN)6]
3-/4- (Figure 5.6). CV showed significant increases in the 
current of the peak corresponding to the redox reaction after modification of an 
electrode with PPy (black curve). Electro-deposition of PEG caused a decrease in the 
current of many folds, which is due to the blocking effect on charge transfer after an 
association of insulating material such as PEG (blue curve). However, after ANTA 
attachment, an increase in electrochemical signal was observed (pink curve). This 
could be attributed to the electrostatic repulsion between the ANTA molecules 
because of carboxylic acids and possible stabilisation of the whole layer. 
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5.2.2.1 FT-IR characterisation 
The electrochemical grafting of PEG on PPy film was further characterised with 
Fourier Transform Infrared spectra (FT-IR) and was compared with PEG adsorbed on 
the gold surface and just PPy film as controls (Figure 5.7). FT-IR was measured using 
a Spectrum 100 FT-IR spectrometer (PerkinElmer, U.K.) equipped with an attenuated 
total reflectance (ATR) diamond crystal. For FT-IR, SPR gold chips were used. 
 
Figure 5.7 FT-IR analysis of PEG adsorbed on gold chip and PPy layer before and after modification with PEG. 
 
From the FT-IR spectrum of PEG, we can see characteristic peaks of primary amine 
bonds at 3566 cm-1 and 1623 cm-1, that can also be assigned to the –OH and C=O 
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groups. For unmodified PPy, peaks at 1623 cm-1, 1539 cm-1 and 1441 cm-1 
corresponding to C-N and C=C vibrations were observed. Modification of PPy by 
PEG led to the appearance of -OH and -C=O vibrations at 3364 cm-1  and 1709 cm-1, 
respectively, confirming the presence of carboxylate groups on the surface and 
modification of the polymer. The presence of PEG`s alkyl chain is confirmed by the 
peak at 2934 cm-1. Also, a decrease in intensity of C=C bond stretching was observed, 
which could be attributed to the attachment of PEG to double bonds present in the PPy 
structure, and confirming the mechanism of the reaction. 
 
5.2.2 Association of anti-AMACR DNA aptamers 
In order to provide a different detection mechanism, PPy-PEG material was associated 
with ANTA/Cu2+ complex as a redox marker. Formation of such a complex has been 
widely studied and is known to be very stable (Khan et al. 2006). 
The complex between ANTA and a copper ion was formed by the interaction of the 
metal in sodium acetate buffer, according to the procedure described by Chebil et al 
(Chebil et al. 2010). The time for copper ions immobilisation was crucial for this 
process and was extensively optimised (Appendix I.3). An optimal time of 25 minutes 
was selected which demonstrated a maximum signal change of ca. 30 %. Finally 
histidine-tagged anti-AMACR DNA aptamers were immobilised on the surface by 
coordination of copper with two N-imidazole rings of the modified aptamers. For 
immobilisation, 0.5 µM DNA aptamer solution was used. 
The formation of a biolayer was monitored using square wave voltammetry (SWV). 
SWV was performed in 10 mM PBS (pH 7.4) in the potential range from -0.3 V to 0.4 
V with conditioning time of 120 s, modulation amplitude of 20 mV and frequency of 
50 Hz. Figure 5.8 shows a characteristic oxidation peak of copper 0.15 V vs. Ag/AgCl 
of copper after attachment on ANTA. This peak can be attributed to the reaction 
Cu2+/Cu+ that occurs on the electrode surface. 
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Figure 5.8 SWV characterization of copper ions immobilization followed by immobilization of DNA aptamers 
measured in PBS pH 7.4. 
 
Copper peaks were also investigated by incubating the electrode at different layer 
formations, results from which are presented in Appendix I.3. When the PPy modified 
electrode was dipped in copper acetate, the recorded plot showed an absence of 
oxidation peaks corresponding to copper. After modification of PPy with PEG, 
voltammogram showed a small peak of at 0.3V which could be due to a non-specific 
interaction of copper with the carboxylate (carboxylic acid) groups of PEG. However, 
an intense copper peak at 0.15 V was observed when the electrode was further 
modified with ANTA depicting the specific coordination of copper molecules with 
ANTA molecules. 
The charge exchanged during redox process allows calculation of the surface coverage 
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Where, Q is the charge under the cathodic or anodic waves, n is the number of 
electrons involved in the redox process, F is the Faraday constant, and A is the area of 
the electrode. Based on the equation (5.1) we calculated the average coverage of the 
surface as 3.9 + 0.4 pmol.cm-2.  
A reduction in the current corresponding to this peak was observed after attachment 
of His-tagged DNA aptamers. This could be related to the low electron transfer to the 
surface during the redox process due to the attachment of the large molecules such as 
DNA. Such behaviour was previously observed when PPy was associated with redox 
markers such as ferrocene (Miodek et al. 2015) or copper complex (Chebil et al. 2013). 
 
5.3 Anti-fouling properties of PPy-PEG-ANTA/Cu2+ complex 
In order to evaluate the selectivity performance of the manufactured sensor, it was 
important to test its cross reactivity and nonspecific binding with other PCa 
biomarkers with a constant incubation time of 30 min at ambient room temperature. 
The fabricated aptasensor showed a significant variation of oxidation current peak of 
Cu2+ when it was incubated with 10 nM AMACR in 10 mM PBS, pH 7.4. The DNA 
aptamer, being specific to AMACR, showed a decrease in copper peak signal of 36.8 
+ 1.6 % of relative current changes measured at 0.15 V vs. Ag/AgCl (Figure 5.8). This 
decrease is due to the blocking effect of electron transfer after attachment of proteins 
(Khan et al. 2006). The sensor was then tested with other biomarkers for PCa such as 
10 nM prostate specific antigen (PSA, Fitzgerald, USA), 10 nM PSA-α1-
antichymotrypsin (PSA-ACT, Lee Biosolutions, USA) and 10 nM human kallikrein 2 
(hK2, R&D systems, UK). The aptasensor showed an efficient selective performance 
where the signal change was less than 3% in the presence of these other proteins, when 
compared to PBS alone.  
Since the main idea was to demonstrate an improved anti-fouling chemistry, the 
aptasensor was tested with the most abundant protein present in blood called human 
serum albumin (HSA). For the same, the electrodes were dipped in a solution 
containing 4% w/v HSA in buffer and biosensor response was recorded. The 
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aptasensor demonstrated an excellent antifouling efficiency by showing a signal 
change of less than 4% (Figure 5.9 left).  
 
Figure 5.9 Selectivity study with other biomarkers for prostate cancer (bar graph, B). Relative current changes 
ΔI/I0, where ΔI=(I0-I), where I0 is the peak current prior addition of the DNA target and I after incubation of the 
sensor with certain concentration of target. Bars represent mean from 4 independent electrodes with standard 
deviation. SWV depicting the efficacy of PEG surface (A) over β-Alanine surface (C). 
 
In order to underline the anti-fouling effect of PEG surface, we investigated another 
molecule such as β-alanine (H2NCH2CH2COOH) to replace the PEG. β-Alanine was 
deposited onto the PPy layer in the same way that PEG was deposited and an 
aptasensor was manufactured. This β-alanine-based aptasensor was incubated with 4% 
(w/v) HSA in buffer and the electrochemical signal change was monitored as before 
(Figure 5.9). A significant relative current variation of up to 25% was recorded, 
demonstrating a poor anti-fouling efficiency for this aptasensor without PEG.  
 
5.4 Analytical performances of biosensor 
A wide range of AMACR concentrations were used from 1, 10, 100 fM; 1, 10, 100 
pM; 1, 10 nM in both 10 mM PBS buffer and human plasma spiked samples (1 to 10 
dilution in 10 mM PBS, pH 7,4). The concentration of the AMACR stock solutions 
were determined by UV-visible spectroscopy. 
The formation of a biolayer, as well as detection of the target, were also successfully 
monitored using the SWV method by measuring the Cu2+/Cu+ redox signal variation 
at 0.15 V vs. Ag/AgCl. The PEG aptasensor was initially tested with a wide range of 
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AMACR concentrations from 1 fM – 10 nM in 10 mM PBS pH 7.4, where a decrease 
in redox signal was observed with increasing AMACR concentrations. After 30 
minutes incubation with each concentration, the variation in current of oxidation peak 
of ANTA/Cu2+ was observed. This variation was proportional to the amount of protein 
captured by aptamers. Based on the variation of current corresponding to ANTA/Cu2+ 
redox signal, a calibration curve was obtained as a function of AMACR concentration 
(Figure 5.10). The aptasensor demonstrated an excellent response. The sensor could 
potentially detect AMACR concentrations down to 5 fM. Limit of detection (LOD) of 
0.15 fM was calculated using 5 independent samples using the method described by 
Armbruster et al. (Armbruster and Pry 2008). 
  
Figure 5.10 Dose response obtained using square wave voltammetry with different concentration of AMACR in 
10 mM PBS, pH 7.4 buffer. Relative current changes ΔI/I0, where ΔI=(I0-I), where I0 is the peak current prior 
addition of the DNA target and I after incubation of the sensor with certain concentration of target. 
 
After successful testing in buffer, the aptasensor was tested with human plasma 
samples. The electrodes were initially stabilised in 1 to 10 dilution of human plasma 
in 10 mM PBS buffer without AMACR protein until stable copper peaks were 
obtained. Upon stabilisation, human plasma samples spiked with AMACR were 
tested. The recorded signal after stabilisation was used as a reference to calculate 
relative changes in current during detection of protein. Again a wide range of AMACR 


























































Chapter 5  150 
 
A dose response curve is plotted in Figure 5.11. A reduction in signal change was 
observed when human plasma was used, which can be attributed to the blocking effect 
by the histidine residues present in human plasma proteins (Jones et al. 2005). 
Nevertheless, the sensor demonstrated a good response down to concentrations of 5 
fM with a LOD of 1.4 fM. The dose response curve is represented with a logarithmic 
scale in order to demonstrate the large dynamic range of detection and exhibits a linear 
response between 1 fM and 1 nM. 
  
Figure 5.11 Calibration curve in AMACR spiked human plasma samples using SWV delta current. The plot of the 
relative changes of the current peak vs. concentration of DNA target measured at 0.15 V. Relative current 
changes ΔI/I0, where ΔI=(I0-I), where I0 is the peak current prior addition of the DNA target and I after 
incubation of the sensor with certain concentration of target. 
 
Figure 5.11 (right) shows the SWV curves obtained with different concentrations of 
AMACR in human plasma. The sensor starts saturating at around 10 nM. These 
measurements were highly reproducible with standard deviations variation from of 
0.3-1.2 % for 5 independent repeats. Furthermore, the efficiency of the sensor could 
be further improved by replacing copper ions with ferrocene (Miodek et al. 2015). 
 
5.5 Surface plasmon resonance as a validation technique 
Surface plasmon resonance (SPR) technique was also used to study the biolayer 

























































Chapter 5  151 
 
prepared in water containing 0.5 M LiClO4. Two cycles of pyrrole polymerisation as 
explained in section 5.2 was performed on the SPR chip in order to retain the SPR 
signal. Finally, 5 cycles of PEG deposition were performed on the modified SPR chip 
with PPy. Polymerisation and PEG deposition was performed outside the SPR cell 
using µAUTOLAB III / FRA2 potentiostat as described in section 5.2. Such a 
polymerisation caused an increase in the RI of the gold layer due to deposition of the 
PPy layer (Appendix I.5).  All the steps after PEG deposition were performed using 
SPR. Figure 5.12 shows the µRIU (refractive index unit) changes at different 
association steps.  
 
Figure 5.12 SPR curve showing association of different molecules on modified PPy film 
 
After activation by EDC/NHS reaction for 5 minutes, ANTA was immobilised using 
7 mM ANTA in 10 mM PBS (pH 8.5) for 10 min at a flow rate of 25 µL/min. A change 
of 191 µRIU was observed. Followed by ANTA immobilisation, copper was 
immobilised using 3.5 mM copper acetate dissolved in 20 mM acetate buffer (pH 4.6) 
for 10 min at the same flow rate as above. A change of 118 µRIU was observed after 
copper immobilisation. Finally after washing with 10 mM PBS, excess copper was 














 = 255 

2













Chapter 5  152 
 
removed. Activated His-tagged DNA aptamers as described in the method section 
were immobilised by flowing 0.5 µM DNA aptamers in 10 mM PBS (pH 7.4) for 20 
min at the same flow rate as above. DNA aptamers showed a change of 225 µRIU in 
the SPR signal.  
After the immobilisation of the DNA aptamers, the chip was left in the 10 mM PBS 
(pH 7.4) buffer until stable. Once stable different concentrations of AMACR were 
flowed. Real time SPR response curves were obtained as shown in Figure 5.13. 
 
Figure 5.13 Real time SPR curves obtained with different concentrations of AMACR (A). Dose response obtained 
with different concentrations of AMACR (B). Data points represent mean value from three independent samples 
with standard deviation. 
 
The dose response obtained from 3 samples is shown in Figure 5.13. The graph 
obtained shows an appreciable association of target from 1 nM and almost reaching 
saturation phase at 100 nM. The low sensitivity observed could be attributed to the 
limit of SPR detection and also added by the thickness of the biolayer on the bare gold 
SPR chip. Nevertheless, SPR data confirms the layer by layer formation of the 
biosensor strategy proposed in this Chapter with successful detection of AMACR. 
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5.6 Summary 
This Chapter has presented a simple method of manufacturing a highly sensitive 
electrochemical aptasensor for detection of AMACR. It was also demonstrated that by 
electro-engineering PEG on the surface of a PPy film, anti-fouling properties can be 
significantly enhanced without loss of electrical properties because of PPy. The 
modified PPy film with PEG-NTA/Cu2+-Aptamer was successfully used to detect 
AMACR in both spiked buffer and human plasma samples. A low sensitivity of 5 fM 
was attained with a LOD of 0.15 fM in buffer and 1.4 fM in human plasma 
respectively. The sensor also demonstrated good selectivity when challenged with 
other prostate cancer biomarkers and HSA. This approach can be easily extended to a 
wide range of other biomarkers, by employing their specific aptamer probes. 
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Chapter 6. Electrochemical sensing of 
miRNAs  
 
This Chapter reports the development of a sensitive electrochemical platform for the 
detection of MicroRNAs (miRNAs). The platform was developed using peptide 
nucleic acids (PNA) as probes on gold electrode surfaces to capture target miRNAs. 
A simple amplification strategy using gold nanoparticles (AuNPs) has been employed 
where the inherent charges of the nucleic acids have been exploited. Electrochemical 
impedance spectroscopy (EIS) was used to 
monitor the changes in capacitance upon any 
binding event, without the need for any 
redox markers. On the same chip, by using 
thiolated ferrocene, a complementary 
detection mode was developed where the 
increasing peaks of ferrocene were recorded 
using square wave voltammetry (SWV) with 
increasing miRNA concentration. Thus, 
giving a dual-mode detection using the same 
chip. 
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6.1 Background 
MicroRNAs (miRNAs) are a class of noncoding genes that are transcribed as a RNA 
sequence of around 22 nucleotides long (Calin et al. 2002). More than twenty years 
after the first report about miRNA (Chalfie et al. 1981; Lee et al. 1993), there has been 
many reports on the miRNAs role in gene expression and regulation. Many reports 
have shown their importance in various biological processes in the human body 
including regulation of target genes (Bartel 2004), cellular proliferation and 
differentiation (Esquela-Kerscher and Slack 2006), cell death (Griffiths-Jones et al. 
2006), translational and transcriptional regulation of their expression (Zieglschmid et 
al. 2005). It was only in the last decade that miRNAs have shown its significance in 
human diseases like cancer (He et al. 2005; Lu et al. 2005; Ramaswamy et al. 2001). 
For instance, miR-155 and miR-21 are up-regulated in breast cancer, but miR-91 has 
been found to be down-regulated in breast cancer. Other miRNAs can be related to 
more than one type of cancer. Many recent studies show that miR-145 is a tumour-
suppressive miRNA, that is down-regulated in several cancer types, including bladder 
cancer (Ichimi et al. 2009), colon cancer (Akao et al. 2007), breast cancer (Spizzo et 
al. 2010), ovarian cancer (Nam et al. 2008) and prostate cancer (PCa) (Esquela-
Kerscher and Slack 2006).  
For PCa, miR-145 is a well-characterised tumour-suppressor with an important 
regulatory role since it can protect from cancer cell invasion and metastasis (Wang et 
al. 2015). Since miRNAs have been reported to act like finger prints of a disease 
including PCa, it therefore, makes them a promising tool as a biomarker. 
Conventionally, technologies used for miRNA study include Northern blotting 
(Valoczi et al. 2004), in situ hybridisation (Catuogno et al. 2011), quantitative 
polymerase-chain reaction (qPCR) (Chen et al. 2005) and miRNA microarray. All 
these techniques are powerful but complex and hence restricted to central laboratories. 
Consequently, there is a pressing need to develop simple and sensitive techniques to 
quantify levels of miRNAs in a portable and inexpensive way (Lu et al. 2005; Ren et 
al. 2013). 
To take up such a challenge, electrochemical biosensors find their right candidature, 
thanks to their varied advantages such as specificity, portability, and low cost (Wang 
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2006). There are several reports on detection of miRNAs using electrochemical 
approaches. EIS has been widely used to quantify target miRNA hybridisation down 
to femtomolar levels with nanoparticles (Peng and Gao 2011) or with enzyme 
amplification (Ren et al. 2013a). Other electrochemical techniques such as differential 
pulse voltammetry (DPV), can be applied with EIS for complementary information or 
use independent and achieve a limit of detection over picomolar level (Kilic et al. 
2012).  
However, the developed biosensors reported lack simplicity in the fabrication process. 
This Chapter reports the development of a simple and sensitive electrochemical 
detection platform for miRNA using PNA as probes. PNA was used since it presents 
many advantages such as neutral charge and higher stability than DNA probes. 
Furthermore, the PNA/miRNA duplex with mismatches are less stable than a 
DNA/miRNA duplex with the same mismatches (Demidov et al. 1994; Ray and 
Norden 2000). A simple amplification strategy using positively charged AuNPs have 
been employed. For the detection, EIS was used without redox markers to monitor the 
changes in the dielectric properties of the bilayer through capacitance changes. 
Exploiting the availability of AuNPs on the surface with PNA/miRNA duplex, 
thiolated ferrocene was used to provide an amperometric detection using SWV.  
 
6.2 Materials and Methods 
6.2.1 Instruments  
The experiments were carried out with a CompactStat potentiostat (Ivium 
Technologies, The Netherlands) and a three-electrode cell system: Ag/AgCl (KCl) 
reference electrode (BASi, USA) connected via a salt bridge filled with 10 mM 
phosphate buffer (PB, pH 7.4), Pt counter electrode (ALS, Japan) and gold working 
electrode (2.0 mm diameter from CH Instruments, USA).  
The non-Faradaic impedance spectrum was conducted in 10 mM PB (pH 7.4) 
measurement buffer over a frequency range from 100 kHz to 100 mHz, with a 10 mV 
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a.c. voltage superimposed on a bias d.c. voltage of 0 V with respect to the open circuit 
potential.  
The Faradaic impedance spectrum was conducted in 10 mM PB (pH 7.4) measurement 
buffer containing 10 mM of the ferro/ferricyanide [Fe(CN)6]
3-/4- redox couple 
(hexacyanoferrate II/III) over a frequency range from 100 kHz to 100 mHz, with a 10 
mV a.c. voltage superimposed on a bias d.c. voltage of 0.2 V vs. Ag/AgCl (which 
corresponds to the formal potential of the redox couple). 
 
6.2.2 Oligonucleotides 
The HPLC purified synthetic oligonucleotides were purchased from Sigma Aldrich, 
UK in lyophilized form while PNA probe sequences were purchased from Cambridge 
Research Biochemical, UK. The sequences are shown in Table 6.1. 
Table 6.1 miRNA sequences and PNA probes used in this work. The full complementary sequence in the first row 
corresponds to mir-145 sequence. AEEA is a glycol linker of nine atoms (8-amino-3,6-dioxaoctanoic acid). 
Full comp sequence (miR145) 3’- UCC CUA AGG ACC CUU UUU GAC CUG - 5’ 
Non comp-sequence 3’- AAA UGC CUA UAG ACC CUU GAC CUG - 5’ 
1 mismatch sequence 3’- UCC CUA UGG ACC CUU UUU GAC CUG - 5’ 
2 mismatch sequence 3’- UCC AUA AGC ACC CUU UUU GAC CUG - 5’ 
Full comp sequence for PNA probe 1 3’- TCT TCT TCT TCT TCT TCT TCT TCT - 5’ 
PNA probe1: SH-C6-AEEA- AGA AGA AGA AGA AGA G 
PNA probe2: SH-C6-TTT AGG GAT TCC TGG  
PNA probe3: SH-C6-AEEA-TTT AGG GAT TCC TGG  
 
6.3 Biosensor Fabrication 
Gold disk working electrodes with a radius of 1.0 mm were cleaned as detailed in 
Chapter 3 and Chapter 4. Clean gold electrodes were then co-immobilised with a 
thiolated ssPNA probe sequence and MCH in 50% dimethyl sulfoxide (DMSO, Sigma 
Aldrich, UK), 50% ultra-pure water (v/v) immobilisation solution for 16 hours in a 
humidity chamber. An optimised ratio of 1:5 was adopted from the literature (Keighley 
et al. 2008). After immobilisation, electrodes were rinsed with surplus MilliQ water 
to remove any unattached thiols. In order to ensure complete thiol coverage of the gold 
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surface, the electrodes were thereafter backfilled with 1 mM MCH for 1 hour. 
Electrodes were then rinsed with MilliQ water and placed in the measurement buffer 
for 1 hour to stabilise the SAM. 
The functionalised surface was then used to capture target miRNA or DNA sequences, 
which makes the surface negatively charged; finally, positively charged gold 
nanoparticles were used to electrostatically bind to the PNA-miRNA or PNA-DNA 
double-strand (Figure 6.1). As the last step, 50 µM thiolated ferrocene (6-
(Ferrocenyl)hexanethiol, Sigma, UK) was added to the surface where ferrocene 
covalently binds to free spaces on the attached AuNPs.   
 
Figure 6.1 Schematic of the biosensor. (a) Immobilised PNA probes. (b) Capture of target oligo (DNA/miRNA). 
(c) Electrostatic interaction of positively charged AuNPs with PNA/DNA or PNA/miRNA hybrid and finally (d) 
attachment of thiolated ferrocene to attached AuNPs. 
 
Preparation of positively charged AuNPs was adopted as reported by Kim et al (Kim 
et al. 2008). Shortly, an optimised ratio of hydrogen tetrachloroaurate (HAuCl4, Sigma 
Aldrich, UK) and branched poly-(ethylenimine) (PEI, MW∼25 kDa, Sigma Aldrich, 
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UK) was mixed overnight using vigorous stirring to produce AuNPs. Before 
experiments, the AuNPs were washed three times using centrifugation and re-
dispersion in Milli-Q water. 
For the binding studies, different concentrations of target DNA/RNA, non-
complementary DNA/RNA and 4% bovine serum album (BSA) were prepared in 10 
mM PB, pH 7.4. 
The presented work was divided into two aspects. The first aspect includes the study 
of a PNA sequence with AGA repeats to be tested as a proof of principle. The second 
study incorporated the use of PNA probe specific to miRNA145 sequence. 
 
6.3 Investigation of strategy using EIS technique 
EIS in Faradaic mode was used to investigate different binding steps to evaluate the 
strategy. The EIS measurements were performed in the presence of 10 mM of the 
ferro/ferricyanide [Fe(CN)6]
3-/4- redox couple to monitor the application of the 
strategy. Initially, the PNA immobilised biosensor was tested with positively charged 
AuNPs to study the nonspecific interactions. From Figure 6.2 (red curve) a negligible 
change in the Rct of the system is observed. Similar tests were performed with 4% BSA 
and 100 nM of non-complementary DNA sequence resulting in a signal change of less 
than 2%.  
After successful evaluation of the system with non-specific interactions, the sensor 
was tested with 100 nM complementary DNA sequence. This interaction resulted in a 
change of Rct from 1.2 kΩ to 12.8 kΩ (blue curve). This increase could be attributed 
to the formation of a PNA/DNA duplex, making the electrode surface highly 
negatively charged. Such a surface provides increased repulsion to the redox ions in 
the solution to reach the electrode surface and thus, increasing the Rct of the system. 
Finally, positively charged AuNPs were added, which electrostatically bind to the 
PNA/DNA duplex only. On binding of AuNPs a decrease in the Rct of the system is 
observed (pink curve). Such a decrease could be attributed to screening of negative 
charges of the PNA/DNA duplex with positively charged AuNPs. It is worth 
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mentioning that the Rct of the system does not return to its initial value. This could be 
attributed to the fact that although AuNPs are screening the charges, the mass loading 
effect still causes an increased physical barrier to the redox couple. 
 
Figure 6.2 EIS Characterisation of binding events using PNA based biosensor. Black curve represents PNA 
based biosensor. Red curve represents non-specific binding of AuNPs. Blue curve represents the hybridisation of 
target DNA with PNA probes and finally pink curve represents the electrostatic interaction of AuNPs with 
PNA/DNA duplex. 
 
6.4 Non-Faradaic EIS Measurement  
EIS in Faradaic mode has been used to investigate the applicability of the strategy. 
However, such a strategy of using positively charged nanoparticles (gold, silver, and 
zirconium) has been reported earlier. For instance, Zhang et al. in 2009 developed an 
electrochemical based DNA biosensor based on the use of positively charged silver 
(Ag) nanoparticles (Zhang et al. 2009). In the study, PNA based probe was 
immobilised on the surface of gold electrodes which were used to capture target DNA. 
On hybridisation, the surface of the electrode becomes negative due to PNA/DNA 
duplex. Finally, positively charged Ag nanoparticles were added which 
electrostatically bind to PNA/DNA duplex which is used as a label through a 
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characteristic solid-state Ag/AgCl reaction. Later in 2010, Kim et al. reported the 
development of naked eye detection platform using PNA probes on glass surfaces and 
AuNPs as an amplification strategy (Kim et al. 2010). In the study, on the 
hybridisation of DNA to PNA, a negatively charged surface is formed which when 
incubated with positively charged AuNPs, results in the electrostatic attachment of 
AuNPs to PNA/DNA duplex. Later, an amplification step was introduced wherein the 
presence of metal enhancement solution, the AuNPs on the surface of the electrode 
grow in size resulting into visualisation via an optical scanner or naked eye. In this 
study, we utilise the same strategy but employing a simplified EIS measurement. EIS 
was measured in the absence of a redox couple to monitor the changes in capacitance 
of the system at the electrode/electrolyte interface as a result of the binding event and 
attachment of positively charged AuNPs. The PNA functionalised electrodes were 
initially stabilised in 10 mM PB (pH 7.4) before conducting the experiments. After 
stabilisation, the electrodes were exposed to different concentrations of 
complementary DNA targets prepared in 10 mM PB buffer (pH 7.4) over an 
incubation period of 30 minutes. In order to evaluate the capacitance of the system, a 
complex capacitance was defined as explained in Chapter 2 (Figure 6.3). 
 
Figure 6.3 Left represents impedance plots of the system while right represents Cole-Cole plot representing 
capacitance of the system. Black curve shows the capacitance of PNA probe on the surface. Slight decrease in the 
capacitance is observed with hybridisation of target oligo (red curve) which is significantly increased on binding 
with AuNPs. 
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Figure 6.3 (left) shows a typical EIS response when performed in the absence of redox 
couple. The high impedance values observed are attributed to ultra-slow charge 
transfer from the solution to the electrode surface. Although nothing constructive can 
be hypothesised by looking at the Nyquist plot, when the impedance data is converted 
into its respective capacitance data, Cole-Cole capacitance plots can be obtained. With 
these plots, the capacitance of the system can be estimated by the diameter of the 
obtained semicircle (Figure 6.3 right). From Figure 6.3 (right), the black curve 
represents the biosensor. On incubation with 100 nM target DNA over 30 minutes, the 
red curve was obtained. A very small change of less than 5% decrease in capacitance 
was observed on binding with target DNA. Such a small signal change could be 
attributed to the presence of the long linker (AEEA) between the PNA probe and the 
gold surface. PEG linker (AEEA, C21H23NO6) results in the binding event happening 
far away from the surface and well above the Debye length of the system, leading to 
the screening of the DNA charges. Nevertheless, when the sensor was incubated with 
AuNPs, a huge change in capacitance was observed due to specific electrostatic 
binding between AuNPs and PNA/DNA duplex. Such a response could be attributed 
to changes in the dielectric properties of the bio-layer due to the presence of polymer 
capped AuNPs. 
At this point of electrochemical platform development, it was imperative to investigate 
selectivity studies with stringent controls to prove that the signal change is due to the 
specific binding event. The fabricated PNA-based sensor was tested with (i) just 
positively charged AuNPs on the immobilised PNA probes, (ii) 100 nM of non-
complementary oligonucleotides and (iv) 4% Bovine Serum Albumin (BSA, Sigma 
Aldrich, UK). The results demonstrated less than 1% changes in capacitance of the 
system making it a potential platform for real clinical samples (Figure 6.4). 
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Figure 6.4 (A) Graph representing signal change on incubating the sensor with (B) nonspecific targets like BSA, 
non-complementary DNA and AuNPs. 
 
After successful selectivity performance of the sensor, a dose response was performed 
using a wide range of target DNA concentrations. The results are presented in Figure 
6.5 with the current detection strategy where a very low detection limit of 1 fM was 
observed. Again an insignificant change in capacitance was observed on binding with 
target DNA (black bars) but a clear trend could be observed after the AuNP 
amplification step shown in red bars.  
 
Figure 6.5 Dose response. Black bars represent changes in capacitance on binding with target oligo while red 
bars represent amplification in capacitance change on binding with AuNPs. 





























Chapter 6  168 
 
6.5 Open Circuit Potential as an alternative mode of detection 
technique 
Since the strategy employed utilises the change in the net charge on the surface of the 
electrode, Open Circuit Potential measurements (OCP) were used as another potential 
technique to monitor changes in potential because of the binding event. OCP 
measurements and optimisation were performed by Wong (2016). Such a 
measurement was carried out using a custom made in-house electronic measurement 
system based on an INA116 ultra low input bias current instrumentation amplifier with 
a cell (Estrela et al. 2008, Formisano et al. 2015). The setup used consisted of 1.6 mm 
diameter gold disc working electrodes (ALS Ltd, Japan), a Hg/Hg2SO4 (K2SO4) 
reference electrode placed into a salt bridge, and a platinum wire for grounding the 
solution in the electrochemical cell. The OCP was measured in real time in a solution 
of 10 mM PB (pH 7.4). Two working electrodes were measured simultaneously at the 
same time through two different channels for the small changes in potential due to 
electrode surface modification, by using a common reference electrode. 
By using the OCP technique, slight changes in the electrochemical interface can be 
picked up by the system. Such changes are attributed to charge change upon DNA 
hybridisation and attachment of positively charged AuNPs. Figure 6.6 (left) illustrates 
a typical response curve generated using an OCP setup. After the system reaches a 
stable value, 1 µM target DNA was injected into the cell. As DNA hybridisation 
occurs, the potential drops due to the attachment of negatively charged complementary 
strand DNA to neutrally charged immobilised PNA probes. A stable value from 
hybridisation is achieved after half an hour and an average change of 4.8 mV is 
observed. Then, positively charged AuNPs were injected and an average increase of 
+19.9 mV was achieved. This is attributed to the attraction of the positive charges on 
the AuNPs to the negative charges on the PNA/DNA layer.  
Again, the potential changes monitored upon target DNA hybridisation were lower 
than expected: less than 5 mV for 1 µM of DNA target which was the highest 
concentration tested. It is worth mentioning that the experiments were performed 
without a flow cell and the OCP results in different concentrations are shown in Figure 
6.6 right. The likely reason for such small changes could be again due to the presence 
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of the long linker used for the PNA probe along with the excess of complementary 
strand DNA that is flowing in the solution, which hinders the potential change due to 
charge floating in the bulk solution. This possible reason also causes a higher potential 
change upon injecting AuNPs to the blank test. Although the current results do show 
that the changes due to attachment of AuNPs are distinguishable between blank and 
PNA/DNA, a further improvement can be made. To enhance the signal and reduce the 
background noise an extra rinsing step after each injection, which can rinse away the 
excessive molecules (DNA/AuNPs), can be incorporated in the measurement strategy. 
Nevertheless, there is still a clear difference between potential changes on blank and 
the tested concentrations of target DNA. Additionally, the decrease in the 
measurement cell volume can significantly decrease the time needed to get a stable 
signal on a binding event, which would be investigated in our future experiments. 
 
Figure 6.6 Real time OCP signal (left) and Dose response with OCP setup. Bars represents average from two 
independent electrodes. Blue bars represent binding with target oligo while yellow bars represent AuNPs 
amplification (right). 
 
6.6 Effect of linker size on non-specific interactions 
The size of the PNA linker was also investigated in this study. A C6 thiol linker can 
be used in place of C6-AEEA linker as a PNA modification that can be co-immobilised 
on the gold surface. As expected, by reducing the linker length from C6-AEEA to C6, 
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a significant variation in the capacitance of above 5% was observed upon incubation 
with the complementary miRNA strand. However, what was more important in this 
particular electrochemical platform development, was to test its selectivity efficiency. 
For the same, the biosensor was constructed using both modifications of PNA (C6 and 
C6-AEEA) with MCH on the gold surface. Electrodes were subsequently tested with 
just AuNPs without any hybridisation with target DNA. EIS in Faradaic mode as 
described in section 6.2 was used to monitor the changes in Rct. Figure 6.7 illustrates 
impedance plots recorded from the EIS experiment. A significant non-specific 
interaction of around 30% was observed as a result of the reduction in Rct after 
incubation of PNA based biosensor with C-6 linker with AuNPs. A decrease in Rct is 
a result of attachment of positively charged AuNPs to the electrode surface which 
consequently results in a decrease in the resistance to negatively changed redox couple 
in the solution.  
 
Figure 6.7 Faradaic EIS plots of PNA based biosensor. (Left) Represents C6-Linker modified PNA as a probe for 
biosensor fabrication and the change in Rct after incubating with AuNPs. (Right) Represents C6-AEEA Linker 
modified PNA as a probe for biosensor fabrication and the change in Rct after incubating with AuNPs. 
 
Such an observation indicates that the SAM formed on the gold surface is not efficient 
enough to prevent non-specific interactions. As compared to C6 linker, when a C6-
AEEA linker was employed, a significant reduction in the non-specific interaction of 
less than 3 % was observed showing an enhanced anti-fouling efficiency, thanks to the 
PEG-like linker. As explained in Chapter 3 and Chapter 5, PEG due to its hydrophilic 
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nature forms hydration a shell in the solution which helps to prevent non-specific 
interactions. As a result, for further experiments, only C6-AEEA modification of PNA 
probe was used to reduce the background noise. 
 
6.7 One chip-dual mode electrochemical platform for detection of 
mir145 
With the successful development of the electrochemical platform for the detection of 
DNA in the solution, the biosensor was used for the detection of miRNAs. For the 
study, PNA probe 2 was used which was partially complementary to mir145 taken as 
a case study. Before going directly to the EIS measurement in non-Faradaic mode, the 
new PNA sequence was characterised using Faradaic EIS mode. Figure 6.8 represents 
the impedance curve recorded with PNA probe 2. The black curve represents the initial 
impedance of the electrode with PNA probe 2.  
 
Figure 6.8 EIS Characterisation of binding events using PNA based biosensor. Black curve represents PNA 
based biosensor. Red curve represents non-specific binding of AuNPs. Blue curve represents the hybridisation of 
mir145 with PNA probes and finally pink curve represents the electrostatic interaction of AuNPs with 
PNA/mir145 duplex 
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The biosensor was tested with just AuNPs for non-specific interactions and the red 
curve was obtained demonstrating negligible signal change. On incubation with 100 
nM mir145 over 30 minutes, a significant change in the Rct from 2.9 kΩ to nearly 12 
kΩ occurred (represented by the blue curve). Finally, the electrodes were incubated 
with positively charged AuNPs and a significant decrease in the Rct from 12 kΩ to 4 
kΩ was observed. The observations recorded confirmed the binding events using the 
previously described strategy. 
 
6.7.1 Capacitive Biosensor 
The detection of different concentrations of mir145 was successfully monitored using 
EIS in non-Faradaic mode by estimating the changes in the capacitance upon a 
molecular binding event. The PNA-based biosensor was initially tested with a wide 
range of mir145 concentrations from 1 fM to 100 nM in 10 mM PB pH 7.4, where an 
increase in the change in the capacitance was observed with increasing miRNA 
concentrations. After 30 minutes incubation at each concentration, the variation in 
capacitance was proportional to the amount of captured mir145. Figure 6.9 (right) 
shows the calculated capacitance from EIS data, diameter of the semicircle of which 
gives an estimate of the capacitance of the system An initial capacitance of 0.243 µF 
was observed with PNA-based sensor (C1) which changed to 0.241 µF after 
incubating with 1fM miR-145 (C2), leading to a change of -0.82%. However, after 
incubating with AuNPs, the capacitance increased to 0.254 µF (C3), leading to change 
of +5.4%. Based on the variation of capacitance corresponding to attachment of 
AuNPs, a calibration curve was plotted as a function of mir145 concentration. The 
biosensor demonstrated an excellent response (Figure 6.9). The sensor could 
potentially detect miRNA concentrations down to 1 fM with nearly 6 % change. A 
LOD of 0.37 fM was calculated using 4 independent samples as described by 
Armbruster et al. (Armbruster and Pry 2008).  
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Figure 6.9 Left shows a typical Cole-Cole plot obtained with PNA-based sensor before and after hybridisation 
with 1 fM miR-145 (black and blue respectively) and AuNP attachment (pink). A zoom-in version of Cole-Cole 
plot shows the changes in capacitance upon a molecular binding event. Right represents a calibration curve and 
data points represent average changes in capacitance from a minimum of three independent samples on binding 
with AuNPs at different concentration of miR-145. 
 
6.7.2 Amperometric Biosensor  
With successful application of simple amplification strategy to detect mir145 using 
capacitance measurements, the setup was explored for additional applications. One 
such application explored the availability of AuNPs on the surface of the electrode. 
Formisano et al. in 2015 demonstrated the use of AuNPs on the electrode surface as a 
possible platform to immobilise thiolated ferrocene molecules. Such a modified 
AuNPs with ferrocene was used as a redox indicator by monitoring the oxidation peaks 
of ferrocene (Formisano et al. 2015). Similarly, in this present strategy, the electrodes 
were incubated with 50 µM thiolated ferrocene over a period of 30 minutes (Figure 
6.10). The square wave voltammetry (SWV) technique was used to monitor the 
oxidation peaks of ferrocene. SWV was performed in 10 mM PB (pH 7.4) in the 
potential range from -0.4 V to 0.7 V vs. Ag/AgCl with conditioning time of 120 s, 
modulation amplitude of 20 mV and frequency of 50 Hz.   
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Figure 6.10 Schematic of amperometric detection strategy. 
 
After specific interaction of AuNPs with PNA/mir145 duplex, thiolated ferrocene was 
flowed through the system, allowing the thiolated ferrocene to covalently bind to the 
free available spaces of AuNPs. The PNA based biosensor was tested with a wide 
range of mir145 concentrations from 1 fM to 100 nM in 10 mM PB pH 7.4, where an 
increasing oxidation peak of ferrocene was observed (Figure 6.11) after the final step 
of thiolated ferrocene flow.  
 
Figure 6.11 Dose response. Data points represent average ferrocene peaks and standard deviation recorded 
using square wave voltammetry (SWV) from three independent samples on the binding of thiolated ferrocene with 
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From Figure 6.11 (left), it can be seen that the peak current increases for increasing 
miRNA concentrations from 1 fM to 1 pM, after which the peak current start getting 
saturated resulting in similar peak currents. Such a saturation could be due to 
aggregation of AuNPs at a higher mir145 concentration resulting in decreased charge 
transfer. A similar effect could be seen in the SWV recording (right) where as we 
move toward higher mir145 concentration, a wider ferrocene peak was observed 
which could be attributed to the non-homogeneous assembly of ferrocene near the 
electrode surface. It is worth mentioning that a high background current of nearly 1 
µA was recorded. Such a current could be due to two probable reasons. Firstly, due to 
the non-specific interaction of ferrocene to the electrode surface and secondly, due to 
the presence of even a small amount of AuNPs due to non-specific interaction which 
could be used as a platform where ferrocene can attach. Nevertheless, when the blank 
measurement was compared with the lowest mir145 concentration used, a six time 
higher ferrocene peak current was recorded.  
 
6.7.3 Selectivity Study 
The developed PNA based biosensor was challenged with stringent controls in order 
to investigate the selectivity of the sensor. For the study, 100 nM concentration of 
mir145 was compared with 100 nM of RNA sequence with 1 mismatch, 2 mismatches 
and a non-complementary RNA. The results from both capacitance measurement and 
SWV is presented in Figure 6.12.  
In both types of measurements, the signal change observed with 100 nM of RNA 
sequence with 2 mismatches and a non-complementary RNA showed negligible signal 
change when compared with 100 nM mir145. However, with 1 mismatch sequence, a 
significant change in the signal was observed with both the techniques. Such an 
interaction could be due to the choice of the mismatch. As shown in Table 6.2, the 
mismatch is in the middle of the sequence, which is the most stable position. 
Nevertheless, the signal change observed was 50 % lower than what was observed 
with mir145. The significant non-specific interaction observed could be reduced by 
adding another parameter of temperature. By using a temperature close to the melting 
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point of the PNA/mir145 duplex (ca. 70.3 °C), the non-specific binding of mismatches 
can be greatly reduced (Giesen et al. 1998).  
 
Figure 6.12 Selectivity study. All the oligonucleotide concentration were 100 nM. 
 
6.8 Summary 
In this Chapter, a simple electrochemical PNA-based biosensor with AuNPs 
amplification for the detection of miRNA or DNA was presented. It has been 
demonstrated how AuNPs can disrupt the dielectric biolayer of the sensor, leading to 
significant changes in the capacitance of the system. With the current system, a LOD 
of 0.38 fM was achieved. Table 6.2 lists some of the state of art technologies to detect 
miRNAs via electrochemical methods. The current technology reported in this 
Chapter demonstrates a simple amplification strategy with LOD lower or comparable 
to those reported in the literature. 
Table 6.2 List of state of art technologies to detect miRNAs 
Detection 
Method 
Electrode  MiRNA Strategy employed LOD Reference 
Amperometric 






complex on AuNPS as the 
amplification element 
 
3.96 pM Zhou et al. 2012 
Amperometric 
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Amperometric 





miR-21 AuNP as an amplification 
step 
45 fM Xia et al. 2013 
Amperometric 

















miR-21 AuNPs as an amplification 
step 
3 fM Liu et al. 2014 
Amperometric 









AuNPs as an amplification 
step 
99.2 fM Peng et al. 2014 
Amperometric 


























miR-21 Thiol 0.36 fM Li et al. 2016 






Mir145 AuNPs as an amplification 
step 
0.37 fM This study 
 
OCP measurements, as another simple cost effective detection tool, has been 
demonstrated to detect low levels of target oligonucleotides. Furthermore, a dual-
mode detection was developed by using thiolated ferrocene which specifically binds 
to free spaces of present AuNPs. Such a technique provides a validation data to back 
up the changes in capacitance. The presented application can be extended to the 
detection of oligonucleotides specific for various other diseases. Of significant 
importance is that the detection techniques can easily be expanded into arrays for the 
parallel screening of panels of DNAs or miRNAs.  
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Chapter 7.  Conclusions and Outlook 
 
With the aim of improving diagnosis in the field of PCa detection, the work in this 
dissertation is a step towards the development of oligonucleotide-based biosensors for 
multiple PCa biomarker detections. DNA aptamers represent a challenging and 
fascinating venue and a possible replacement to antibodies for the development of 
biosensors. The use of natural and synthetic nucleotides is still developing and paving 
the way towards advanced biosensor development. It can be seen from the literature 
how researchers from different fields are coming together to realise high-throughput 
oligonucleotide-based biosensors for use with complex matrix samples such as clinical 
or environmental. The ease of manipulation of oligonucleotides, controlled surface 
chemistry approaches and “straightforward” charge distribution, makes them optimal 
bioreceptors for biosensing applications. 
By combining electrochemical techniques and oligonucleotide-based probes, modern, 
label-free and robust biosensors can be developed. Such a biosensor using relatively 
inexpensive electrochemical equipment could denote future low-cost point-of-care 
(PoC) diagnostic tools. Moreover, the commercialisation of electrochemical 
biosensors has been fuelled right after the first glucose test in a PoC format. However, 
the process of commercialisation of oligonucleotide-based biosensors for the detection 
of PCa biomarkers is still at an early stage and requires further developments. With 
the aim of exploring the electrochemical techniques coupled with a fine tuning of 
surface chemistry, in this dissertation several oligonucleotide-based systems of PCa 
diagnostic interest have been developed in order to provide insightful factors that 
could be investigated for developing oligonucleotide-based biosensors. Since the 
strategies to adopt can differ substantially according to the probe and the target, four 
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types of systems were taken into consideration, exploring different biomarkers for 
PCa. These consisted of an impedimetric DNA aptamer-based sensing of PSA, an 
aptasensor for quantification and glycoprofiling of PSA, an AMACR aptasensor based 
on PPy-PEG surface chemistry and a PNA-based detection of miRNA. Surface 
chemistry comprises an important part in the development of promising biosensors. 
Easier fabrication would enable the development of the biosensors for mass-
production and would give commercial feasibility. This dissertation has highlighted 




Despite the issues including PSA as a reliable PCa biomarker, this biomarker has been 
chosen for a proof of concept in the project. PSA has been widely used for PCa 
screening and, to date remains an important biomarker for PCa detection with its 
various isoforms. However, there is only a very limited number of published reports 
on PSA detection using DNA aptamers and an even lower number using 
electrochemical detection techniques with aptamers. In Chapter 3, PSA aptasensor 
experiments showed that features such as the DNA aptamer coverage density as well 
as the protein charge effect, are important factors to be optimised. The fine-tuning 
between these factors has been investigated in the perspective of optimising an 
aptamer-based impedimetric sensing of PSA. Incorporation of spacer molecules like 
MCH or sulfo-betaine enables optimisation of the sensor surface for better detection 
and prevents non-specific binding. The maximum percentage change of Rct upon 
binding with DNA aptamers was obtained with samples prepared by co-
immobilisation of thiolated DNA aptamers and MCH with 1% DNA aptamer mole 
fraction. Moreover, a negative Rct signal change upon binding of PSA to DNA aptamer 
has also been reported. This shift is probably indicating that the prevalent effect on Rct 
is due to the screening of the charges on DNA aptamers by bound PSA. The work also 
reports for the first time the use of sulfo-betaine with DNA aptamers. Although the 
optimisation of the surface density was a challenge, the fabricated aptasensor with 
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sulfo-betaine surface chemistry could potentially be used to detect PSA levels down 
to 1 ng/mL, which falls in the clinically relevant range (1-10 ng/ml). Whereas, with 
the MCH based PSA aptasensor the lowest concentration of PSA that could be 
detected was 60 ng/mL. Both the PSA aptasensor fabrication processes, i.e. with MCH 
and sulfo-betaine, were compared for their capability to prevent fouling. It was clearly 
seen that PSA aptasensors with MCH surface chemistry gave a very high non-specific 
binding with HSA, whereas PSA aptasensor with sulfo-betaine showed negligible 
non-specific signals. Furthermore, a discussion on the effects of buffer was presented. 
By changing buffer conditions during the EIS measurements, instability of SAM could 
take place which can therein result in changes in Rct regardless of having the analyte 
in the solution. The study showed how important it is to perform stability tests of the 
fabricated aptasensors in order to obtain reliable data. To the best of the author’s 
knowledge, this was the first report on the buffer effects, which should be taken into 
consideration on the development of impedimetric oligonucleotide-based biosensors. 
To address the challenge of direct immobilisation of sulfo-betaine with thiolated DNA 
aptamers, different surface chemistry strategies could be employed in future work. For 
example, the combination of ternary SAM with screen-printed gold electrodes 
(Miodek et al. 2015, Campuzano et al. 2011) would potentially aid to form a compact 
SAM with sulfo-betaine and thiolated DNA aptamers since sulfo-betaine has two 
sulphur groups which can therein form bridges on a rough surface like screen printed 
electrodes. Then MCH can be used to fill all the free spaces on the gold electrodes.  
The second system in this dissertation demonstrates the use of DNA aptamers for 
parallel sensing of biomarkers in a sandwich-type assays. The resulting assay could 
not only quantify PSA but also, potentially profile glycoprofiling of PSA in a 
microfluidic channel. An alternative detection (chemiluminescence) was used with an 
optical readout system. Replacing the antibodies in a classical ELISA configuration 
has enabled the development of sophisticated assays which are more robust, 
reproducible and economical. The integration of quantification of PSA with multi-
glycan profiling of fPSA in a microfluidic channel could serve as a potential platform 
for PoC devices in PCa diagnosis. A sensitive quantification of PSA of 0.5 ng/mL was 
achieved. Multi-glycan profiling where the specific lectin (SNA) could differentiate a 
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response from the control lectin (MAA II) at fPSA concentration down to 3 ng/mL 
was also demonstrated. Although the literature reports many methods for direct 
glycoprofiling, based on recognition elements such as lectins, anti-carbohydrate 
antibodies, or other glycan binding proteins, these bio recognition elements are 
specific to glycans and not a particular protein, leading to cross-reactivity of the 
recognition element with other components present in the sample, thus leading to false 
positives. Therefore, the system presented in Chapter 4, where antibodies are replaced 
with aptamers, could revolutionise the approach to glycoprofiling by decreasing false 
positives. The assay developed needs further investigation for its application with real 
clinical samples. Continuing from this, an efficient surface chemistry could be studied 
(for example PEG-based) in the place of using ethanolamine for enhanced anti-fouling 
properties. Finally, with advanced microfluidic techniques, the detection area could be 
further minimised to reduce the reagents used and potentially develop an array-like 
system.  
The sandwich assay developed could be potentially translated to various other sensing 
platforms, including electrochemical platforms. For example, researchers at the 
Slovak Academy of Sciences, Slovakia have reported the development of various 
types of lectin-based biosensors with lectins as the bio-recognition elements (Bertok 
et al. 2013, Kluková et al. 2014). More recently, the group reported the development 
of an antibody-based ELISA-type impedimetric biosensor for the glycoprofiling of 
PSA with lectin as the detector molecule (Pihikova et al. 2016a, Pihikova et al. 2016b). 
However, using such approach with an impedimetric biosensor, there can be a 
compromise with the signals obtained with the lectins. The reason being that the 
impedimetric sensing is limited by Debye length; having an antibody (~160 kDa) as 
the primary recognition layer immobilised over a binary SAM of MUA and MCH 
takes the biolayer to the upper limit of the Debye length. Furthermore, the immobilised 
antibodies will also be in a random orientation, resulting in loss of capturing sites for 
PSA. Consequently, the major part of binding of lectins (~130 kDa) to captured PSA 
(~30 kDa) will occur way beyond the Debye length and hence cost the signal change 
due to the screening of charges. To address such an issue, the group is currently 
working on replacing the primary antibody with DNA aptamers in order to translate 
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the system presented in Chapter 4 onto electrochemical and SPR platforms to increase 
the sensitivity of the sensor and reduce the non-specific binding of lectins.    
The third system demonstrates the use of polymeric films to develop aptasensors for 
AMACR detection. It presents a study on the careful selection of DNA aptamers for 
designing a biosensor. Indeed, the efficiency of the aptamer to capture its target 
depends largely on the Kd value which was also seen with two different sequences of 
DNA aptamers for AMACR. DNA aptamer (AMC-51) reported by Yang et al. (Yang 
et al. 2014) showed significantly higher binding capabilities as compared to AM-
310_2 from Base Pair Biotechnologies. The Chapter also reports a simple strategy to 
modify PPy films with PEG molecules on gold surfaces through covalent linkage. 
Such a strategy omits prior modification of pyrrole monomers. An alternative sensing 
mechanism is being proposed where poly-histidine modified aptamers were 
immobilised to the surface via a ANTA/Cu2+ redox complex covalently attached to 
the PPy-PEG adduct. Protein/aptamer interactions were monitored through variation 
of the copper redox signal, using the SWV technique. The Chapter demonstrates that 
the PPy-PEG-ANTA/Cu2+ hybrid material is characterised by enhanced anti-fouling 
properties and sensitivity. The aptasensor demonstrated an excellent antifouling 
efficiency by showing a signal change of less than 4%. The PEG surface was further 
challenged with the β-alanine surface. The β-alanine-based aptasensor showed a 
significant relative current variation of up to 25%, demonstrating a poor anti-fouling 
efficiency for this aptasensor without PEG. The aptasensor was able to detect AMACR 
down to 5 fM both in the buffer and spiked human plasma with a LOD of 0.15 fM and 
1.4 fM, respectively. Furthermore, the efficiency of the sensor could be further 
improved by replacing copper ions with ferrocene as demonstrated in literature 
(Miodek et al. 2015). Also, the system can be further investigated with other metal 
ions like nickel, lead, zinc, etc in order to perform multiplexing (Johnson et al. 2005, 
Davis et al. 1999).  
The trend towards the development of aptasensors for PSA and AMACR requires 
further investigation into their use as an alternative to antibodies. Overall, the 
development of aptamer-based biosensors for biomarker detection is expected to 
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attract increasing interest because of its ease of synthesis and the possibilities of 
multiple modifications. 
Developments in biochemistry and molecular biology have led to a deeper 
understanding of the role of oligonucleotides and showed that the functions they play 
are far greater than originally expected. This leads to new worlds of biosensing 
applications, where oligonucleotide-based biosensing approaches can have an 
unparalleled impact on clinical diagnosis, prognosis, and monitoring. The increasing 
demand for enhanced efficiency and to overcome some of the drawbacks of using 
naturally occurring oligonucleotides, has enabled biochemists to come up with 
synthetic analogues such as PNA, which have further increased the prospects of novel 
biosensing approaches. 
In the fourth system, a sensitive electrochemical platform was developed for the 
detection of miRNAs and/or DNAs using PNA probes. miRNAs have shown 
significance in human diseases like cancer and can act as blueprints of the disease. 
Especially in cancer, miRNA expression levels can potentially give information about 
the stage of a disease. The Chapter demonstrated the development of a simple 
detection technique for miRNA using PNA as probes. It exploits the inherent charges 
of nucleic acids for the development of a powerful amplification strategy with AuNPs. 
The strategy developed could be easily translated on multiple detection platforms such 
as non-Faradaic EIS measurements, potentiometric measurements, and amperometric 
detection. For the detection, EIS was used without redox markers to monitor the 
changes in the dielectric properties of the bilayer through capacitance changes. Upon 
molecular interactions near the electrode surface a redistribution of the solvent 
molecules and of ions is initiated, which causes the changes in the electrochemical 
double layer. However, such type of systems based on non-Faradaic approach have 
not been extensively reported in the literature, probably because they are believed to 
be more complicated in analysing the data and extracting the signals of interest. 
Nevertheless, such a strategy further simplifies the assay because redox markers are 
not needed. Also, a dual-mode detection was demonstrated by exploiting the 
availability of AuNPs on the surface with PNA/miRNA duplex, thiolated ferrocene 
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was used to provide an amperometric detection using SWV. A dual mode can be used 
as a validation detection technique to compare the sensor’s performance. With the 
PNA-based system, a LOD of 0.38 fM was achieved. Another simple detection 
technique based on the measurement of variations of the OCP by employing an ultra-
low input bias current instrumentation amplifier circuit. OCP measurement can be 
recorded in real-time and continuously. In this approach, two working electrodes were 
measured at the same time through two different channels simultaneously for the 
potential changes, by using a common reference electrode. Such an instrument allows 
the provision of future development of an array of sensors. The importance of PEG 
for the enhanced anti-fouling properties was demonstrated by comparing a PEG-like 
linker (AEEA) with a non-PEG-like linker (C-6 thiol). By employing AEEA, the non-
specific interactions were reduced from 30 % to 2.5 %. The simple dual-mode strategy 
holds great promise to reduce false positives and can be easily expanded into arrays 
for the parallel screening of panels of DNAs or miRNAs. Although we used the entire 
spectrum in EIS measurement, it is possible to measure EIS at a single frequency to 
accelerate the acquisition of signals.  
 
7.2 Future work 
The work presented in this dissertation has fostered several collaborations with other 
research groups across Europe for extended application of DNA aptamers on various 
other platforms. Some of the work done, and not presented in this dissertation, include:  
 
7.2.1 Aptamers and molecularly imprinted polymers 
As described in Chapter 1, DNA aptamers have some limitations such as e.g. nuclease 
degradation. To prevent this, a novel strategy was developed in collaboration with 
Cardiff University on the design and evaluation of a new synthetic receptor sensor 
based on the combination of DNA aptamers and molecular imprinting to overcome 
some of the challenges faced by both conventional molecular imprinting and DNA 
aptamers (Figure 7.1, Jolly et al. 2016).  
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Figure 7.1 Schematic representation of the sensor fabrication. The aptamer-PSA complex is first immobilised on 
the gold surface utilising thiol chemistry (a) with subsequent electropolymerisation of dopamine around the 
complex to produce a molecularly imprinted surface (b). Washing of the electrode allows for removal of PSA 
whilst retaining aptamer-lined, imprinted polymeric cavities, the so-called “apta-MIP” (c). Reintroduction of the 
template molecule results in rebinding within the imprinted sites (d). Cyclic voltammetry in the presence of redox 
marker for monitoring of the fabrication process (e) (Jolly et al. 2016). 
 
A thiolated DNA aptamer with established affinity for PSA was complexed with PSA 
prior to being immobilised on the surface of a gold electrode. Controlled 
electropolymerisation of dopamine around the complex served to both entrap the 
complex, holding the aptamer in, or near to, it’s binding conformation, and to localise 
the PSA binding sites at the sensor surface. The PSA was then removed from the 
template. It was proposed that the molecularly imprinted polymer (MIP) cavity would 
act synergistically with the embedded aptamer to form a hybrid receptor (apta–MIP), 
displaying highly selective aptamer pockets to capture the cancer biomarker. 
Electrochemical impedance spectroscopy was used to evaluate subsequent rebinding 
of PSA to the apta–MIP surface. The apta–MIP sensor showed high sensitivity with a 
linear response from 100 pg/ml to 100 ng/ml of PSA and a limit of detection of 1 
pg/ml, therefore showing recognition properties superior to that of aptamer alone. The 
study was further translated to an extended gate MOSFET (metal-oxide-
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semiconductor field effect transistor) for the detection of PSA in human serum 
(Tamboli et al. 2016).  
 
7.2.2 Aptamer and memristive devices 
DNA aptamers for PSA detection are also being used in the development of a 
biosensor based on memristive devices in collaboration with the École Polytechnique 
Fédérale de Lausanne (EPFL), Switzerland. Such an approach is based on the memory 
effects that are widely appearing in nature (Lehn et al. 2007). Pronounced hysteresis 
in electrical characteristics is a unique signature of memory effects in electronic-based 
devices (Wu and McCreery 2009). These systems are known as memristive systems 
or passive systems that fall under the domain of non-linear circuit theory and possess 
the capability of memory as they can maintain an electronic state. In these structures, 
the memory effect depends upon charge carriers' rearrangement at the nanoscale level 
due to external perturbations (Pershin et al. 2011). The research group at EPFL earlier 
demonstrated that two-terminal Schottky-barrier silicon nanowire devices exhibit 
memristive behaviour of their electrical response when functionalized with antibody 
films and was used for bio-detection purposes (Carrara et al. 2012).  
 
Figure 7.2 Schematic illustrating the affinity based (Physical adsorption) fabrication process of the memristive 
aptasensor based on silicon nano wire (Tzouvadaki et al. 2016). 
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In this collaboration, we further investigated the hysteretic properties of memristive 
silicon nanowires functionalized with DNA aptamers as an alternative application of 
such devices (Figure 7.2). With this novel approach, PSA is detected with a limit of 
detection down to 23 aM (Tzouvadaki et al. 2016).  
 
7.2.3 One step simple and fast deposition of aptamers  
In collaboration with the University of São Paulo, Brazil, the use of the 
electrochemical grafting protocol to directly immobilise DNA aptamers specific to 
PSA and Her2 on the polypyrrole film is being investigated (Figure 7.3). Such an 
approach, if successful, will provide an easy one-step highly controlled immobilisation 
strategy. Using the EIS technique, a change of 140% in Rct has been observed with 10 
µg/mL PSA using PSA specific DNA aptamers, while no signal change was observed 
with control experiments where a random DNA was immobilised with the same one-
step strategy and incubated with 10 µg/mL PSA. The research group would like to see 
how the sensor behaves in a complex medium and what kind of sensitivity could be 
attained using the approach. 
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7.2.4 Aptamers and nano devices 
In collaboration with the University of Applied Sciences Kaiserslautern, Germany, 
two other biosensor devices have been investigated with the use of DNA aptamers for 
PSA detection. The first system is based on potentiometric field-effect nanodevices. 
Amine terminated DNA aptamers were immobilised on silicon nanowire field effect 
transistors (SiNW FET) using silane chemistry and changes in the threshold voltage 
of the transistor was monitored upon PSA binding. A detection limit of 1 ng/mL PSA 
was obtained (Rani et al. 2016). In the second system, reduced graphene-oxide thin 
film transducers have been used to electrochemically deposit AuNPs from gold 
chloride solutions. Such a modified surface was used to immobilise thiolated DNA 
aptamers specific to PSA. The fabricated aptasensor was used to detect PSA using the 
EIS technique where a detection down to 1 pg/mL was achieved (Lu et al. 2016). Both 
these systems are being developed in an array format, so that easy multiplexing can be 
performed by incorporating multiple receptors for different PCa biomarkers. 
 
7.2.5 Aptamers and real-time drug detection 
With the successful use of DNA aptamers for protein detection, DNA aptamers were 
further investigated to detect small molecules such as cancer drugs. Therapeutic drug 
monitoring helps patients to maintain the therapeutic concentration of drugs in the 
circulatory system. A novel biosensor for the monitoring of the small molecule 
tenofovir (287.2 g/mol, which is an antiretroviral drug) using specific DNA aptamer 
was developed in collaboration with the École Polytechnique Fédérale de Lausanne, 
Switzerland. The biosensor (aptaFET) comprises the high selectivity of the aptamer 
as the recognition element and high sensitivity of field-effect transistors (FET) as a 
signal transducer (Figure 7.4).  
  
Chapter 7  195 
 
 
Figure 7.4 Binary SAM of TFV-aptamer and MCH as sensing surface of biosensor. In the inset: chemical 
structure of TFV with red colour for Oxygen, purple for phosphorus, light blue for carbon, white for hydrogen 
and dark blue for nitrogen. Schematic of AptaFET. Binding reaction is transformed to electric signal through 
FET and observed as Id-Vgs shift. TFV is indicated by red circle (Aliakbarinodehi et al. 2016). 
 
The bio-interface of this sensor is a binary self-assembled layer of the specific aptamer 
for the drug and MCH. A surface chemistry similar to what has been reported in 
Chapter 3 (section 3.2.1) for the PSA aptamer was used for the DNA aptamer specific 
to the drug tenofovir. The fabricated aptaFET demonstrated a linear range between 1 
nM and 100 nM of tenofovir, and saturation of the surface after 100 nM. The 
calculated dissociation constant, Kd, is equal to 5.8 ± 0.5 nM, and the calculated LOD 
is equal to 4.6 nM. Two nonspecific drugs (abiraterone and enzalutamide) and one 
nonspecific aptamer (aptamer specific to prostate specific antigen) were used as 
stringent control candidates. Negligible shifts were observed with the controls, when 
compared to the specific response at similar concentrations (500 nM). The aptaFET 
was further used in the real-time monitoring of the drug as well as detection in pure 
human serum (Aliakbarinodehi et al. 2016). 
In conclusion, the development of oligonucleotide-based biosensor devices is an 
interdisciplinary field and rely on very distinct aspects such as characterisation of bio-
recognition probes with its respective analytes, immobilisation onto electrode 
surfaces, development of anti-fouling surface chemistries, sensor design, and 
fabrication, microfluidics, etc. Several oligonucleotide-based systems were analysed 
and practical applications for different biomarkers for PCa detection have been 
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demonstrated. By a strategic coupling of different optimisation steps reported in this 
dissertation, effective and low-cost oligonucleotide-based sensors could be realised 
and integrated into multiplexed systems. These studies not only demonstrate the 
enormous potential but how they can be used for a wide range of other biomarkers for 
various diseases that exploit target/probe features similar to those of the systems here 
reported. Furthermore, the development of a multiplexed platform for parallel sensing 
of different biomarkers of PCa would help assist clinicians with deeper information 
on the pathological and physiological state of the patient (in particular the disease). 
Such a device could be represented as a point-of-use device that can provide first 
assessment of the patient’s state which would accelerate the diagnosis and or prognosis 
speed. Not only limiting to diagnosis, the device can be used for surveillance purposes 
in order to monitor patients at risk or those being treated (either post-surgery or during 
medication).   
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Appendix  
I-1. Attachment of PEG to the PPy surface. 
 
Figure I-1: Electro-oxidation of PEG onto PPy layer performed by cycling the potential between 0.0 and 1.1 V, 
during 5 cycles, in H20 containing 0.5 M LiClO4 . 
The surface of PPy film was modified with PEG. The modification was 
performed by scanning the potential between 0 and 1.1 V during 5 cycles until 
saturation of the surface (Figure S-1). During the oxidation of PEG radicals on the 
amine groups, –NH•+ were formed which then interacted with aromatic groups of PPy 
interrupting its double bonds and resulting in covalent attachment. Figure I-1 shows 
the presence of a peak at 0.99 V with the current 3.05 µA corresponding to amine 
groups oxidation. After five cycles of scanning the potential, the current corresponding 
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I-2 Optimisation of PEG deposition 
In order to obtain an intense oxidation peak of ANTA/Cu2+ redox complex and 
efficient AMACR detection, it was essential to perform various optimisation steps, to 
optimize the thickness of polypyrrole (PPy) layer, the amount of attached PEG 
molecules, and the ANTA/Cu2+ complex.  
In this work, PPy was electro-polymerised on the gold surface using cyclic 
voltammetry as explained in Chapter 4. Thickness of PPy layer strictly depends from 
conditions of polymerisation such as range of potential, number of cycles or 
concentration of pyrrole monomer. The range of potential and concentration of pyrrole 
monomer were chosen based on literature, while number of cycles should be studied. 
Initially, three cycles of pyrrole electro-deposition was chosen to optimise the electro-
oxidation of PEG. However, the optimal parameters of PEG deposition should also be 
chosen based on the efficiency of further steps such as ANTA and cooper attachment. 
Covalent grafting of ANTA on PPy-PEG via EDC/NHS chemistry and copper 
immobilisation were fixed to 30 min for both.  
Electrochemical impedance spectroscopy (EIS) was used to evaluate the different 
optimisation steps. Since PEG is an insulating polymer, it was expected an increase in 
the charge transfer resistance (Rct) values upon grafting of PEG on a PPy film. In these 
experiments 1 mM PEG dissolved in water containing 0.5 M LiClO4 was electro-
generated on polymer by scanning the potential in different range from 0.0 to 1.0 V, 
0.0 to 1.1 V and 0.0 to 1.2 V vs. Ag/AgCl for 1 to 10 cycles. Figure S2a shows the Rct 
values obtained after PEG deposition in different potential range and for different 
number of cycles. A significant increase in the Rct was observed by increasing both 
the number of cycles and the potential range of deposition, signifying higher amount 
of attached molecules.  
The next step of optimisation of PEG deposition was to attach ANTA to the 
carboxylate groups present on the free end of PEG chain and Figure I2a shows the 
obtained Rct. From Figure I2a, it was seen that there was not a significant change in 
the Rct when PEG was attached to the surface for 1 and 2 scanning potential cycles in 
almost all the potential range chosen. 
  




Figure I-2: Charge transfer resistance (Rct) after deposition of PEG using different potentials and cycles (a). Rct 
obtained after attachment of ANTA to PEG (b). Number of copper molecules immobilised on ANTA at different 
PEG deposition parameters(c). Correlation of amount of ANTA deposited to number of copper molecules 
immobilised at PEG deposition potential of 0 to 1.1 V (d). 
From Figure I2b, it was seen that there was not a significant change in the Rct when 
PEG was attached to the surface for 1 and 2 scanning potential cycles in almost all the 
potential range chosen. For 3, 5 and 10 cycles significant differences in Rct are 
observed confirming successful attachment of ANTA to the PEG. However, AMACR 
detection was performed through amperometric signal of ANTA/Cu2+ redox complex 
and all optimum parameters should be determined by studying the electrochemical 
response of copper ions being immobilised. This was measured by amperometric 
methods. Electrochemical signal of copper was presented in form of amount of 
immobilised molecules. The charge exchanged during redox process allows 
calculation of the surface coverage of immobilised copper ions, following the 
equation: 
Γ=Q/nFA (1) 
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Where, Q is the charge under the cathodic or anodic waves, n is number of electrons 
involved in the redox process, F is the Faraday constant, and A is the area of the 
electrode(see Figure I2c). Clearly, potential range from 0.0 V to 1.1 V of PEG 
deposition showed the best result, which has also been reported in literature where 
electro-grafting of dendrimers PAMAM was performed over a PPy layer (Miodek et 
al. 2015). Saturation of amount of copper was observed after 5 cycles (Figure I-2d) 
and hence the protocol for PEG deposition was optimised at 5 cycles with a scanning 
potential in range of 0.0 to 1.1 V vs. Ag/AgCl. 
I-3 Optimisation of thickness of PPy layer and time for copper immobilisation 
After successful optimisation of the deposition of PEG, the effect of thickness of PPy 
on amount of immobilised ANTA/Cu2+ complex was investigated. PPy was grown on 
the gold surface using cyclic voltammetry (CV) through different number of cycles. 
After PEG deposition and association of ANTA/Cu2+, the corresponding copper redox 
signals were recorded and converted to amount of immobilised molecules as described 
in previous section (see Figure I-3a). It was observed that two cycles of electro-
polymerisation gave the best response. The next step was to optimize the time for 
copper immobilisation, since high quantity of redox molecules might reduce the 
variation in the signal upon target binding. The time for copper binding was varied 
between 5 and 30 minutes. After immobilisation of His tagged DNA aptamers for 30 
min, the signal change was measured upon binding of 1 nM AMACR to the aptamer.  
 
Figure I-3a: Number of copper molecules immobilised on the electrode modified with PPy electro-polymerised by 
different number of cycles. 
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Figure I-3b:  Effect of time of copper immobilisation on electrochemical signal changes upon binding of 1 nM 
AMACR in 10 mM PBS (pH 7.4) with DNA aptamer. 
Figure I-3b shows the amount of copper immobilised (red bars) whilst AMACR 
binding is shown by blue points (by variation of ANTA/Cu2+ redox signal using square 
wave voltammetry (SWV) in 10 mM PBS pH 7.4). Square wave voltammetry was 
performed in 10 mM PBS (pH 7.4) in the potential range from -0.3 V to 0.4 V with 
conditioning time of 120 s, modulation amplitude of 20 mV and frequency of 50 Hz. 
Optimised conditions were at 25 minute copper immobilisation, which maximized the 
redox signal variation after incubation of electrode with AMACR. 
I-4 Characterisation of ANTA/Cu2+electrochemical signal 
Immobilization of copper on PPy-PEG-ANTA surface was studied using CV. Cyclic 
Voltammetry was performed in 10 mM PBS (pH 7.4) in the range from -0.2 V to 0.35 
V without redox couple Figure I8a shows apparition of Cu2+/Cu+ oxidation peak after 
incubation of modified electrode in copper acetate solution, confirming efficiency of 
process (Figure I4a). 
The non-specific attachment of copper on electrode surface was also studied. For this 
purpose electrodes on different steps of fabrication were dipped in solution of copper 
acetate (CuAc) and analysed using SWV (Figure I4b). When the PPy modified 
electrode was dipped in CuAc, the recorded plot denotes the absence of oxidation 
peaks corresponding to copper (black curve). After modification of PPy with PEG, 
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voltammogram shows a small peak of at 0.3V which could be due to a non-specific 
interaction of copper with the carboxylate (carboxylic acid) groups of PEG. 
 
Figure I-4: Cyclic Voltammetry in 10 mM PBS buffer pH 7.4 before and after immobilization of copper on 
PPy-PEG-ANTA layer (a). Square Wave Voltammetry recorded after dipping electrodes modified on 
different steps showing non-specific and specific attachment of copper at different layer formation (b). 
However, a significant copper peak at 0.15 V was observed when the electrode was 
further modified with ANTA depicting the specific coordination of copper molecules 
with ANTA molecules. 
I-5 SPR detector scan data 
 
Figure I-5: Detector scan data of gold chip which was partially polymerised to show the comparison between plain 
gold surface and PPy modified gold surface 
 






































Voltage (V vs. Ag/AgCl)
 PPy
 PPy+PEG
 PPy+PEG+ANTA
